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ABSTRACT
Chronic low-level lead exposure reduces memory in children however the brain
mechanisms mediating these effects are not known. In previous studies we showed that early
lead exposure reduced olfactory memory and exploratory behavior in young mice, and reduced
microglia cell density in hippocampus/dentate gyrus. The present studies aimed to identify
additional behavioral tests that were sensitive to early low-level lead exposure in young mice;
and to examine whether microglia upregulated factors known to promote cell migration.
Seventy-two C57BL/6J male mice were exposed to 0 ppm (controls), 30 ppm (low-dose), or 430
ppm (high-dose) of lead acetate via dams’ milk from PND 0 to 28. Behavioral studies and a
microglial cell study were conducted. For behavioral studies, mice were tested for developmental
milestones (body weight, eye-opening, and righting reflex), muscle strength (inverted screen
test), exploratory activity and/or anxiety (open field), and olfactory memory (odor
habituation/dishabituation task). For microglia studies, levels of major histocompatibility
complex (MHC) II and C-C chemokine receptor 7 (CCR7) in hippocampal and brain microglia
were quantified with fluorescence activated cell sorting analyses (FACS). For behavioral studies,
it was found that chronic low-level lead exposure increased body weight and decreased
exploratory activity. For microglial cell studies, it was found that chronic low-level lead
exposure decreased MHC II and CCR7 surface expression in hippocampal microglia.
Exploratory analyses revealed additional effects in macrophages and immune cells. These results
suggested that chronic low-level lead exposure disrupts exploratory behavior, alters body weight,
and disrupts the early neuroimmune system in young mice. Future studies should examine
whether alterations in memory and exploratory activity are mediated either by trafficking of
microglial cells outside of brain and/or disruption of MHC II and CCR7.
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CHAPTER 1
INTRODUCTION
Lead is a heavy metal that is toxic to humans. Lead can alter a variety of body systems
including the central nervous system (CNS), the immune system, the cardiovascular system, and
the renal system (WHO, 2010). Children, as compared to adults, are far more vulnerable to the
detrimental effects of lead and the CNS is exquisitely sensitive to its effects (CDC, 2013). Child
exposure to high levels of lead (yielding blood lead levels, BLLs, between 70 to 150 µg/dL) can
result in anemia, nephropathy, encephalopathy, and death (Gurer & Ercal, 2000, review). Child
exposure to high levels of lead is less likely to occur in the U.S. however child chronic exposure
to low-level lead is a major unresolved child public health problem particularly in lower
socioeconomic neighborhoods (WHO, 2010).
Recent events in Flint, Michigan are a stark reminder that chronic low-level lead
exposure continues to pose a serious threat for children nationwide. In April 2014, the water
supply in Flint, Michigan, was changed from Lake Huron to the Flint River. The problem was
that water from the Flint River had a chemical composition (high chloride to sulfate mass ratio
and no corrosion inhibitor) that caused increased leaching of lead from lead pipes into the water
supply. This resulted in an increase in child BLLs. Specifically, from 2014 to 2016, the
percentage of children with BLLs above 5 micrograms per deciliter (µg/dL), the current
threshold for “elevated” in the U.S., increased from 2.9% to 4.9% and to 6.6% in highest
exposure neighborhoods (Hanna-Attisha, LaChance, Casey Sadler, & Champney Schnepp,
2016).
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This is just one example of how large numbers of children can be exposed to low-level
lead. Lead-contaminated water is just one of many potential sources of child lead exposure. Over
9,600 industries in United States emit from 10 to 10,000 pounds of lead per year into the
environment (EPA, 2006) and air-borne lead can create high risk of exposure for children living
in close proximity to these industries. Other possible sources of lead exposure include
contaminated soil, lead paint in old housing, lead pipes, children’s jewelry, toys, and cosmetics
(EPA, 2015). In fact, lead is ubiquitous in our modern industrial environment.
Once lead is ingested or inhaled it can alter brain function. Over 50 clinical studies have
shown that children exposed to chronic low-levels of lead have diminished memory, poorer
cognitive-set shifting, and reduced fine-motor dexterity (e.g. Bellinger & Needelman, 2003;
Canfield et al., 2003; Franko, Palome, Brown, Kennedy & Moore, 2000; Gilbert & Weiss, 2006;
Jusko et al., 2008; Landrigan et al., 2006; Lanphear, Burgoon, Rust, Eberly & Galke, 1998;
Lanphear et al., 2005; Needleman, Schell, Bellinger, Levinton & Allred, 1990; Needleman,
Riess, Tobin, Biesecker & Greenhouse, 1996; Schnaas et al., 2000; Sobin, Flores-Montoya,
Gutierrez, Parisi & Schaub, 2015; Wasserman et al., 2000). Given the well-documented
detrimental effects of chronic low-level lead exposure on brain and behavior, the Centers for
Disease Control and Prevention (CDC) for many years have stated that for children, there is no
“safe” level of lead exposure (CDC, 2012). Recent studies in our laboratory have shown that
14% of children living in lower socioeconomic neighborhoods in the El Paso Border region
have BLLs > 5 µg/dL, and over 50% have BLLs between approximately 2.5 and 7 µg/dL (Sobin
et al., 2015.) These are BLLs at which deficits in memory have been detected.
Currently, the only approach to intervention is source removal. The environmental
sources of low-level lead exposure are often multiple however and result from current conditions
2

as well as historical accumulation, and can be very difficult to identify and remove. The brain
mechanisms underlying effects on memory of chronic low-level lead exposure are not
understood. It is necessary to understand how chronic low-level lead exposure alters behavior
and brain in order to identify approaches other than source removal for primary prevention and
early intervention in children. New animal models are needed to understand these deficits.
1.1

Behavioral Effects of Chronic Low-Level Lead Exposure in Animals
1.1.1 Studies examining the behavior of adult animals. In an early study in adult rats,

developmental milestones and exploratory activity were examined following early lead exposure
(Reiter, Anderson, Laskey, & Cahill, 1975). Two generations of Sprague-Dawley rats were pretreated with one of three lead treatment levels. These included 0 parts per million (ppm)
(controls), 5 ppm (low-dose), and 50 ppm (high-dose). After this, rats were mated and the first
generation (F1) of rats were exposed to the same treatment via dams’ milk. After weaning, rats
continued the same treatment until post-natal day (PND) 180. At PND 90, the F1 rats were mated
and their pups (F2) received the same treatment exposure. Rats from the F1 and F2 generations
(N = 115) were tested for developmental milestones. Five pups from 9 to 11 litters from the F1
and F2 generations were tested behaviorally beginning at PND 120.
The developmental milestones tested included the startle response, righting reflex, and
the day at which animals (males and females) opened their eyes. For the startle response, a toy
clicker was used to make a clicking sound behind the head of the rats. After hearing this noise,
rats that had developed the response were expected to present a muscle contraction on their
limbs. For the righting reflex test, rats were held upside down (holding them from the neck and
the tail) and were placed approximately 30 centimeters (cm) above a table and were released.
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Animals that have developed the righting reflex were expected to turn mid-air and land with their
four paws on the table. The day of full eye-opening was also recorded.
For examination of exploratory ambulation, male rats were tested on a residential maze
(76 cm x 60 cm) with ad libitum access to food and water. Rats were tested from PND 120 to
125. The maze was equipped with infrared light beams that allowed the automatic recording and
rating of animal behavior. Exploratory ambulation was recorded on a Xerox microcomputer
every hour for five days.
For examining the stimulant effects of d-amphetamine on locomotion, on day five
immediately after testing, rats were challenged with 4 mg/kg of d-amphetamine and 20 minutes
(min) after injection they were returned to the residential maze. The outcome variable was the
number of times that the animals broke the laser beams.
For the statistical analyses of developmental milestones and exploratory ambulation, ttests were used. (No significant differences between the F1 and F2 generations were detected
thus data were averaged for both generations). With regard to developmental milestones, it was
found that eye-opening for the low-dose group was delayed by one day as compared to controls;
the righting reflex was delayed by one day for the low-dose group and two days for the highdose group as compared to controls. No differences for the startle response were found. Also, the
lead-exposed animals had decreased exploratory ambulation as compared to controls. Similarly,
after the amphetamine challenge, locomotion was decreased in lead-exposed animals as
compared to controls. These results suggested that chronic low-level lead exposure delayed the
development of the nervous system, impaired locomotion, and reduced the sensitivity of animals
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to the stimulatory effects of d-amphetamine. It was also suggested that changes in exploratory
ambulation might be a result of motor pathway/s disruption.
In a similar study, adaptation to a novel environment and exploratory ambulation of adult
rhesus monkeys exposed chronically to low-levels of lead were examined (Ferguson & Bowman,
1990). Eight rhesus monkeys were exposed to one of two treatments via nasogastric intubation.
The control group (n = 4) was exposed to sodium and the experimental group (n = 4) was
exposed to 0.7 mg/kg of lead of body weight, dissolved in a milk formula, from PND 8/9 to 29.
From PND 42 to 356, the lead-exposed group received 3.0 mg/kg of lead of body weight as
described earlier and the control group received an equivalent dose of sodium (BLLs for all
animals were < 5 µg/dL at two years old; authors did not report specific BLLs at the time of
testing.)
For examining exploratory ambulation, the open field (OF) task was used. An arena (2.4
m x 2.0 m x 2.2. m) equipped as a play-room for the monkeys was used for testing. The arena
had wire mesh ledges, ramps, and a bar that traversed the room. On the floor of the OF, 27
sectors of equal size were created by demarcating them with chalk. Animals were habituated to
the arena from three months old to one year old. Animals were then allowed to mature to four
years old and were tested behaviorally.
Animals were tested once a week during six sessions. They were given 10 min to enter
the OF, if they did not enter it within the time allotted, they were pushed into it. Once in the OF,
they were allowed to explore it for 15 min and behavior was recorded with an Apple AIIE
microcomputer. At a later time, raters trained to reliability rated monkeys’ behavior. The
outcome variables analyzed were the latency to enter the arena (recorded manually with a timer),
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urinations and defecations (measures of anxiety), number of sectors entered, and frequency and
duration of 17 behaviors (described below) every 5 min. Immediately after monkeys completed
behavioral testing, blood was extracted via femoral venipuncture and was later analyzed for
BLLs with gas furnace atomic absorption spectrometry (GFAAS).
Behavior was analyzed with repeated measures analyses of variance (ANOVA) with
treatment as a between subjects factor and day of testing as a within subjects factor. Only five
out of the 17 behaviors recorded occurred frequently enough to be analyzed. These included time
inactive, exploratory activity (every time they manipulated the environment with their mouth,
hands, and feet), exploratory ambulation (number of quadrants crossed), self-directed behavior
(play activity), and vocalizations.
It was found that the lead-exposed monkeys had increased latencies to enter the OF as
compared to controls. Also, the lead-exposed monkeys displayed less inactive time, and had
increased exploratory activity, and increased quadrants crossed as compared to controls. No
significant effects were detected for urinations, defecations or vocalizations. These results
suggested that chronic low-level lead exposure delayed adaptation to a novel environment and
increased the exploration of a novel environment in adult monkeys. The authors suggested that
the adult lead-exposed animals had increased exploration of the environment because they had
memory impairments, i.e. they might have needed more time to encode environmental
information as compared to controls.
In another study of adult animals with early chronic low-level lead exposure,
exploratory ambulation, the stimulating effects of d-amphetamine on locomotion, gross motor
coordination, and running wheel behavior were examined in chronic low-level lead exposed
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adult mice (Leasure et al., 2008). Two lead exposure models were developed, a gestational lead
exposure model (GLE) and a post-natal lead exposure model (PLE). For the GLE model,
C57BL/6J mice pups, 12-18 litters per group, were exposed to one of four treatment conditions,
including 0 ppm (controls), 27 ppm (low-dose) (mean BLL 3 µg/dL at PND 21), 55 ppm
(moderate) (mean BLL 9 µg/dL at PND 21) and 109 ppm (high-dose) (mean BLLs 15 µg/dL at
PND 21) of lead acetate via dams’ drinking water, two weeks before mating and until PND 10 of
the pups. For the PLE model, pups were exposed to one of three treatment conditions, including
0 ppm (controls), 27 ppm (low-dose) (mean BLL 10 µg/dL at PND 21), and 55 ppm (moderate)
(mean BLL 25 µg/dL at PND 21) of lead acetate via dams’ drinking water from PND 0 to 21.
Mice from the GLE but not the PLE model were tested behaviorally when they matured to one
year old.
For examining exploratory ambulation and the possible stimulating effects of damphetamine on locomotion, mice were tested on the OF task. This task consisted of an
Optovarimax behavioral monitor (40 cm x 40 cm x 40 cm) equipped with laser beams that
detected ambulation. Mice were habituated to the arena for 15 min and they were tested for 30
min. The number of times that mice crossed the laser beams were detected automatically every 5
min during testing. After this, mice received a 3 mg/kg d-amphetamine challenge and they were
immediately placed back in the OF and were allowed to explore the arena for three hours.
For examining gross motor coordination, mice were tested on the rotarod (RR) task. This
machine had a rotating rubber barrel and a laser beam that automatically detected when an
animal fell from the barrel. Animals were trained to stay on the barrel while it rotated at a
constant speed of 5 rotations per minute (rpm) for 90 sec. After training, mice were tested in
three trials with an inter-trial interval (ITI) of one hour. During each trial, the rotating barrel was
7

set at 50 rpm for 90 sec and then the speed was increased by 0.1 rpm every 30 sec. The outcome
variable was the latency (in sec) for the animals to fall from the rotating barrel.
For running wheel behavior, mice were placed individually, for five consecutive days, in
home cages that contained a running wheel (Whatman type) and ad libitum access to food and
water. The running wheels had counters that recorded the distance travelled by the mice (in
meters). The outcome variable was the total distance travelled by mice. At a later time, animals
from the GLE and PLE models were sacrificed and BLLs were analyzed with a Lead Care I
device (Environmental Sciences Associates, Inc., Chelmsford, MA).
For the statistical analyses, possible differences between groups with regard to BLL and
body weight in mice from the GLE and PLE models were analyzed with two-way ANOVA
(treatment group x sex). Behavior for mice in the GLE model was analyzed with one-way
ANOVA and one-way repeated measures ANOVA.
With regard to BLL, the lead-exposed groups had increased BLL as compared to controls
in both the GLE and PLE models, however differences in BLL between groups were not detected
after PND 30 in the GLE model and after PND 60 in the PLE model. With regard to body
weight, it was found that male but not female mice from the GLE and PLE models had increased
body weight as compared to controls. With regard to behavior, it was found that for the OF task,
during the first 30 min of exploration, the lead-exposed male mice, but not female mice, had
decreased exploratory ambulation as compared to controls. And the low-dose male mice had
decreased exploratory ambulation as compared to the high-dose male mice. Additionally, after
the amphetamine challenge, it was found that lead-exposed male mice, but not female mice, had
increased locomotion as compared to controls. This suggested that lead-exposed male mice were

8

more sensitive to the effects of d-amphetamine on locomotion than unexposed mice. For the RR
task, lead-exposed male mice, but not female mice, stayed for shorter periods of time on the
rotating barrel as compared to controls. For running wheel activity, no differences between the
groups were detected.
These results suggested that chronic low-level lead exposure affected male but not female
mice with gestational chronic exposure to lead. Specifically, in male mice, increased body
weight, decreased exploratory ambulation, increased exploratory ambulation after an
amphetamine challenge, and decreased gross motor coordination were detected. It was suggested
that these effects might have not occurred simply because of increased body weight in male
mice, since all treatment groups had travelled relatively equal distances on the running wheel.
Instead, it was suggested that chronic low-level lead exposure might have altered motor
pathway/s and thus exploratory ambulation in male mice.
In a study of adult Wistar rats, exploratory ambulation and object recognition memory
were examined in female adults exposed to low-levels of lead (Azzaoui, Ahami, & Khadmaoui,
2009). Fourteen Wistar rats were exposed to one of two levels of lead nitrate, including 0 ppm
(control, n = 7) and 20 ppm (low-dose, n = 7). Rats were exposed to treatment via drinking water
from PND 90 to180. BLLs were not reported. Rats were tested behaviorally every 14 days from
the beginning to the end of the intoxication period.
For examining exploratory ambulation, rats were tested on the OF task. They were first
habituated to an open top wooden box (100 cm x 100 cm x 40 cm) that had its floor marked into
25 quadrants. After habituation, rats were placed on the center of the arena and exploratory
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ambulation was recorded for 7 min. The outcome variable was the number of times that the rats
crossed each quadrant with all four paws.
For examining object recognition memory, rats were tested with the novel object
recognition (NOR) task. Rats were habituated to a square arena (40 cm x 50 cm x 50 cm) for 5
min. After habituation, rats were placed back in the arena that had two identical objects located
in the upper left and upper right corners of the arena. Animals were allowed to explore these
objects for 5 min. After a 24 hour ITI, rats were placed back in the arena, but this time one of the
objects was replaced by a novel object (NO). The time that the rats spent exploring each object
was recorded. Object exploration was quantified when the animal had its nose ≤ 1 cm of
proximity to the object. If rats had an intact memory, they were expected to spend more time
exploring the NO as compared to the familiar object (FO).
For the statistical analyses of exploratory ambulation, a one-way repeated measures
ANOVA with treatment group as the between subjects factor and day of testing as the within
subjects factor were used. For the NOR task, first a discrimination ratio (DR) was calculated
with the following formula = (Time exploring NO / Time exploring NO + Time exploring FO), a
DR above 0.50 would mean that the rats spent more time exploring the NO as compared to the
FO. Differences between groups with regard to the DRs were also examined with one-way
repeated measures ANOVA as described above.
For exploratory ambulation, no significant differences between groups were found within
the first 12 weeks of testing. However at the end of the testing period, it was found that the leadexposed rats had increased number of quadrants crossed as compared to controls. For the NOR
task, no significant differences between groups were found within the first two to six weeks of
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testing. However during weeks eight and 10, low-level lead-exposed rats had diminished DRs as
compared to controls. These results suggested that chronic low-level lead exposure increased
exploratory ambulation and diminished object recognition memory in female adult Wistar rats.
In a similar study, exploratory ambulation, gross motor coordination, visuo-spatial
memory, and aggressive behavior of chronic low-level lead exposed adult mice were examined.
Sixty-six Balb/c mice were exposed to 0 ppm (controls, n = 30) or 20 ppm (low-dose, n = 36) of
lead acetate via dams’ drinking water from gestational day 8 until PND 21 (Kasten-Jolly,
Pabello, Bolivar, & Lawrence, 2012). BLLs were not reported. Animals were allowed to mature
to adulthood and then they were tested behaviorally. PND of testing was not reported.
To quantify exploratory ambulation, mice were tested in dim light sound-attenuating
chambers (65 cm x 55 cm x 65 cm) equipped with 16-beam activity monitors (42 cm x 42 cm x
30 cm). Mice were habituated to the chambers for one hour; after an ITI (inter-trial interval) of 5
min they were returned to the chambers and were allowed to explore them for 15 min. A PC
computer and a Digiscan software automatically recorded and rated mouse behavior. The
outcome variables examined were total distance travelled, resting time, rotations, habituation,
and speed. Additionally, in order to measure anxiety, the time spent and distance travelled in the
periphery of the arena (thigmotaxis) vs. the center of the arena were measured. (Thigmotaxis is a
behavior displayed when animals are anxious, Simon, Dupis, & Costenin, 1994.)
For examining gross motor coordination, animals were tested on the RR (rotarod) task.
The machine used for this study had four compartments (48 cm x 11 cm x 30 cm) and a rotating
rubber barrel. Mice were tested on three consecutive trials for 180 sec with ITIs of 20 min. Mice
were first habituated to the rotating barrel for one hour. After habituation, they were tested.
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During the first 60 sec of testing, the speed of the rubber barrel increased from 0 rpm to 15 rpm
and it was maintained at 15 rpm for 110 sec. During the last 10 sec of testing, the speed of the
barrel decreased from 15 rpm to 0 rpm. The outcome variable was the latency to fall from the
barrel. The Smartrod Windows software 1.7 was used to record automatically this latency.
For examining visuo-spatial memory, mice were tested on the Morris Water Maze
(MWM) task. Mice were placed in a 1.5 meters (m) diameter pool. Nontoxic white paint was
used to create opaque water. A hidden platform was located 1.5 cm below the surface of the
water. Mice were trained for four consecutive days, during eight trials, with ITIs of 45 min
(except for trials 4 and 5 that had ITIs of 60 min), to locate the hidden platform via swimming.
During each training trial, mice were given 60 sec to locate the hidden platform and were
allowed to stay on it for 30 sec. Mice that did not locate the platform within the allotted 60 sec
were placed on it manually.
After the last training trial, mice were given an ITI of one hour and then they were tested.
For testing, the hidden platform was removed from the water pool and mice were tested for 60
sec. If mice had an intact visuo-spatial memory, they were expected to spend more time in the
zone where the platform was previously located as compared to other zones in the water maze.
The automated Accutrak system was used to record behavior. The outcome variable was the time
spent swimming in the area where the platform was previously located.
For examining aggressive behavior, male mice were tested with the resident-intruder test
and were examined for litter-mate behavior at 10 months of age. For the resident intruder-test,
male mice that were not litter-mates (intruders) were housed, for 10 min, in pairs, in cages with
lead-exposed and unexposed male mice and mouse behavior was video-taped. The outcome
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variables included number of bites, chasing, wrestling, time before the first aggressive behavior
occurred, and behavior in the cage when mice interacted with their litter-mates. For litter-mate
behavior, the number of animals injured in each treatment group were recorded (what constituted
an injury was not reported in this study.)
For the statistical analyses of exploratory ambulation in the dim chambers, two-way
ANOVAs were used, with treatment group and sex as the between subjects factors. For gross
motor coordination in the RR, and for visuo-spatial memory in the MWM, mixed ANOVA
models were used. For the RR, treatment group and sex were the between subjects factors and
testing day the within subjects factor. For the MWM, treatment group and sex were the between
subjects factors and trial the within subjects factor. When significant effects were detected, posthoc analyses with Tukey’s honestly significant difference (HSD) were used. For the residentintruder test, a student t-test was used. For litter-mate behavior, the percentage of animals with
injuries were compared between lead-exposed and unexposed groups.
For exploratory ambulation, it was found that the low-level lead-exposed mice travelled
shorter distances, spent more time resting, and had diminished speed as compared to controls. It
was also found that males travelled more distance, spent less time resting, and had increased
speed as compared to females, regardless of treatment exposure. With regard to anxiety, it was
found that low level lead-exposed females had increased thigmotaxis as compared to leadexposed males and controls. For the RR task, no differences between groups were found. For the
MWM task, it was found that the low-level lead-exposed animals spent less time swimming in
the zone where the platform was previously located. For the resident-intruder task, it was found
that lead-exposed male mice had diminished bouts of aggressive behavior and increased latency
to display aggressive behaviors as compared to controls. On the other hand, for litter-mate
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behavior, it was found that 28% of lead-exposed male mice injured their litter-mates whereas
none of the control male mice injured their litter mates.
These results suggested that chronic low-level lead exposure diminished exploratory
ambulation, increased anxiety in females but not males, decreased visuo-spatial memory,
decreased male aggressive behavior towards intruders, and increased male aggressive behavior
towards litter-mates in adult Balb/c mice.
1.1.2 Summary of behavioral studies (adult animals). As evidenced on the five studies
described above, a wide-variety of behaviors were altered in adult animals as a result of chronic
low-level lead exposure. Some of the findings were consistent among studies and some were not.
Two of the studies found that chronic low-level lead exposure diminished memory; one
study found diminished visuo-spatial memory in adult male and female mice (Kasten-Jolly et al.,
2012) and another study found diminished object recognition memory in female adult rats
(Azzaoui et al., 2009). Visuo-spatial and object recognition memory are sub-served by different
pathways that overlap in the hippocampus/DG (Kee, Teixeira, Wang & Frankland, 2007; Takeda
et al., 2014). Thus, future studies could examine if chronic low-level lead exposure alters brain
pathways and regions associated with these two types of memories.
Findings were mixed with regard to gross motor function. One study detected diminished
gross motor function in lead-exposed males but not females (Leasure et al., 2008); another study
did not detect effects in gross motor function in males or females (Kasten-Jolly et al., 2012).
Similarly, findings were mixed with regard to exploratory ambulation. Two studies
detected increased exploratory ambulation (Ferguson et al., 1990; Azzaoui et al., 2009) whereas
two studies detected decreased exploratory ambulation (Kasten-Jolly et al., 2012; Reiter et al.,
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1975) and one study detected decreased exploratory ambulation in males but not females
(Leasure et al., 2008).
Findings were also mixed with regard to the locomotor stimulant effects of damphetamine in exposed animals. One study detected increased locomotion promoted by damphetamine in males but not females (Leasure et al., 2008) whereas another study detected
decreased locomotion in males (Reiter et al., 1975).
Several factors might have mediated mixed findings in gross motor function and
exploratory ambulation including differences in the lead exposure period time, sex tested, e.g.
some studies tested only males (Reiter et al., 1975) and some only females (Azzaoui et al.,
2009), PND at which the animals were tested, and type of species tested. Even though mixed
findings were detected, all of the studies suggested changes in exploratory ambulation. Future
studies should examine basic motor functions in order to more thoroughly characterize possible
motor deficits in animals.
Additionally, only one study examined developmental milestones (Reiter et al., 1975) and
aggressive behavior in animals (Kasten-Jolly et al., 2012). It was found that the development of
the righting reflex and eye-opening were delayed as a result of chronic low-level lead exposure.
This suggested that chronic low-level lead exposure delayed the development of the nervous
system. Future studies should examine what brain mechanisms are responsible for these delays in
development. Additionally, increased aggressive behavior was detected towards litter mates as a
result of chronic low-level lead exposure. This type of behavior is sub-served in part by the
amygdala (Nelson & Chiavegatto, 2000). Future studies could examine whether this brain region
is disrupted as a result of chronic low-level lead exposure in adult animals.
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The above described studies are very valuable for understanding the effects of chronic
low-level lead exposure in adult animals. However, none of these studies examined young
animals (except for the Reiter et al. study which examined developmental milestones). In order
to develop animal models that might be valuable for understanding effects in children, in our
laboratory, the effects of chronic low-level lead exposure have been examined in young mice
(PND 28) in three behavioral studies. These studies are described in detail below.
1.1.3 Studies examining the behavior of young animals. Our laboratory has
investigated the sensitivity of several behavioral paradigms to the effects of early chronic lead
exposure in pre-adolescent mice (PND 28). In one study (Flores-Montoya & Sobin, 2014),
exploratory activity, exploratory ambulation, and gross motor coordination of chronic low-level
lead exposed young mice were examined. Sixty-one C57BL/6J mice were exposed to one of
three treatment conditions, including 0 ppm (controls; n = 16), 30 ppm (low-dose; n = 26) (BLLs
ranged from 2 to 6 µg/dL), and 230 ppm (high-dose; n = 19) (BLLs ranged from 7 to 15 µg/dL)
of lead acetate via dams’ drinking water from PND 0 to 28. Mice were tested behaviorally at
PND 28.
For examining exploratory activity, mice were tested in the nose poke (NP) task. Mice
were placed in a square Plexiglas arena (16 in x 16 in x 16 in) that had an elevated platform with
16 evenly distributed 1 in diameter holes. Mice were initially placed in the right corner of the
arena and were allowed to explore it freely for 3 min. A video-camera was mounted at the level
of the arena and behavior was recorded. The outcome variable was the number of times that mice
poked their noses into the holes.
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For examining exploratory ambulation, mice were tested in the OF (open field) task.
Mice were initially placed in the right corner of a square Plexiglas arena (16 in x 16 in x 16 in)
that had four quadrants marked on the floor. Mice were allowed to explore the arena freely for 5
min. A video-camera was mounted at the level of the arena and behavior was recorded. The
outcome variable was the number of times that mice crossed into each quadrant with all four
paws.
For examining gross motor coordination, mice were tested with the RR (rotarod) task
(described on page 12 above.) Mice were placed on the RR machine and were allowed to
stabilize on it for 10 sec. After this, mice were tested in four trials with a duration of 300 sec per
trial and an ITI of 3 min. During the 300 sec trial duration, the rotating barrel was accelerated
from 3.5 rpm to 35 rpm. The outcome variable was the latency, in sec, that took the mice to fall
from the rotating barrel. After all behavioral tests were completed, mice were sacrificed and
heart blood was extracted for BLL analyses with ICP-MS (detailed description of ICP-MS is
given on page 52.)
For the statistical analyses of each outcome variable, general linear mixed model
(GLIMMIX) analyses with BLL and sex as fixed effects and litter as a random effect were used
to examine possible linear associations. Significant effects were detected for the NP task. As
BLL increased, exploration of the novel arena decreased for both males and females. On the
other hand, for the OF and RR tasks, no significant effects of lead exposure were found. These
results suggested that chronic low-level lead exposure reduced exploratory activity but not
exploratory ambulation or gross motor coordination in young (pre-adolescent) C57BL/6J mice.
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In a similar study (Flores-Montoya, Alvarez, & Sobin, 2015), the olfactory recognition
memory of young mice exposed chronically to low-levels of lead was examined. Thirty-three
C57BL/6J mice (13 females and 20 males) were exposed to one of three levels of lead acetate,
including 0 ppm (control; n = 10), 30 ppm (low-dose; n = 10) (BLLs ranged from 3 to 5 µg/dL),
and 330 ppm (high-dose; n = 13) (BLLs ranged from 10 to 20 µg/dL). Lead was administered via
dams’ drinking water from PND 0 to 28.
At PND 28, mice were tested on the novel odor recognition (NODR) task. This task
included a habituation trial (10 min), a training trial (10 min), and a testing trial (5 min) with ITIs
inter-trial intervals) of 5 min. For the habituation trial, mice were allowed to freely explore an
empty square arena (8 in x 8 in x 24 in). For the training trial, mice were allowed to explore two
identical odors placed in the upper right and upper left corners of the arena. For the testing trial,
one odor was replaced by a novel odor (NO). If odor recognition memory was intact, mice were
expected to spend more time exploring the NO as compared to the familiar odor (FO).
Behavioral testing was video-taped and behavior was later rated by raters blind to the
experimental condition. Immediately after behavioral testing was completed, animals were
sacrificed and heart blood was extracted for analyses of BLL with ICP-MS.
For the statistical analyses, a DR (discrimination ratio) was calculated with the following
formula = (time exploring NO / time exploring NO + time exploring FO). A DR greater than
0.50 meant that animals spent more time exploring the NO as compared to the FO. GLIMMIX
analyses with BLL and sex as fixed effects and litter as a random effect were used to examine
possible linear associations. It was found that as BLL increased, the DR decreased, regardless of
sex. However when visually inspecting the graphs of DRs for males and females, a linear
relationship between BLL and DR was evident in males but not in females. It could be that sex
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differences were not statistically significant because unbalanced numbers of males (n = 20) and
females (n = 13) were tested. Future studies should have a balanced number of males and
females, or should examine separately effects on males and females in order to more thoroughly
characterize these effects. To conclude, these results suggested that chronic low-level lead
exposure diminished olfactory recognition memory in young C57BL/6J mice.
In another study (Sobin, Flores-Montoya, & Alvarez, 2017), spatial memory and object
recognition memory in chronic low-level lead exposed mice as compared with controls was
examined. Fifty-two C57BL/6J mice (28 males and 24 females) were exposed to one of three
levels of lead acetate, including 0 ppm (control, n = 18), 30 ppm (low-dose, n = 16), and 430
ppm (high-dose, n = 18). Lead was administered via dams’ drinking water from PND 0 to 28.
And mice were tested behaviorally at PND 28.
For examining spatial recognition memory and object recognition memory, the object-inplace visual recognition (OIP) task was used. Mice were placed in the lower right quadrant of a
clear Plexiglas circular arena (72 cm diameter) with a 38 cm x 30 cm white and black striped
cardboard rectangle affixed to the upper left region as an orientation cue. The OIP task included
a spatial memory challenge test and an object recognition memory challenge test. For the spatial
challenge test, the memory of familiar locations vs. novel locations were examined. For the
object recognition challenge test, memory for familiar objects vs. a novel object was examined.
The OIP task consisted of seven trials that lasted 4 min and had an ITI of 2 min. Trial 1
was the habituation trial. Animals were placed in an empty arena and were allowed to explore it
freely. Trials 2, 3, and 4 were the learning trials for the spatial memory challenge test. During
these trials mice were exposed to five objects. Trial 5 was the testing trial for the spatial memory
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challenge. For this, one of the familiar objects (FOs) was displaced to a new familiar zone, and
another FO was moved to a novel zone. These zones were then called the displaced object (DO)
zones. During Trial 5, animals with an intact spatial memory were expected to spend more time
exploring the DO zones as compared to the non-displaced object (NDO) zones. Trial 6 was the
learning trial for the object recognition memory challenge test. During this trial, the objects
remained in the same place as in Trial 5. Trial 7 was the testing trial for the object recognition
memory challenge. For this, one of the FOs was replaced for a novel object (NO). During this
trial, animals with an intact object recognition memory were expected to spend more time
exploring the NO zone as compared to the FO zones.
The SMART software system (Harvard Pan Lab, Cambridge, MA) was used to demarcate
the boundaries of the zones surrounding each of the objects (nine zones) and one zone
demarcating the perimeter of the arena. Mouse behavior was recorded with a video camera
placed above the arena. Behavior was later rated automatically by the SMART software system
and processed for statistical analyses. Seven outcome variables were examined. Four outcome
variables corresponded to behavior within the zones of interest and three outcome variables
corresponded to behavior displayed in all zones within each trial. For the behaviors in the zones
of interest, the outcome variables included number of entries in zones, total time in zones,
immobile time in zones, and total rears (when the animals stood on their hind legs) in zones. For
the behaviors in all zones, the outcome variables included total distance travelled, total rears, and
total immobile time.
For the statistical analyses DRs (discrimination ratios) were calculated. For Trials 4 and
5, DRs for spatial memory were calculated with the following formula = (DO zones behavior /
DO zones behavior + NDO zones behavior). For Trials 6 and 7, DRs for novel object recognition
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memory were calculated with the following formula = (NO zone behavior / NO zone behavior +
FO zones behavior). For spatial memory, DRs above 0.40 indicated more exploration of the DOs
as compared to the NDOs. For novel object recognition memory, DRs above 0.20 indicated more
exploration of the NO as compared to the FOs.
General linear mixed model analyses (GLIMMIX) with lead exposure and sex as fixed
effects and litter as a random effect were used to examine possible effects of lead exposure
treatment for all outcome variables. With regard to behavior in the zones of interest, it was found
that the OIP task stimulated greater exploration of the DOs as compared to NDOs during the
spatial memory challenge test, and that it stimulated exploration of the NO as compared to the
FOs during the object recognition memory challenge test, however significant differences
between treatment groups were not detected. On the other hand, with regard to behavior in all
zones, it was found that low- and high-dose groups had increased global rearing behavior in
zones of object memory retrieval and away from zones of spatial memory retrieval. These results
suggested chronic low-level lead exposure altered the development of an exploratory behavior
(rearing) that is critical for learning and memory. Furthermore, the results suggested that the OIP
task is not sensitive to the effects of chronic low-level lead exposure in young mice however the
task is a valid measure of spatial and object recognition memory in young C57BL/6J mice.
Global alterations in rearing behavior, motor behavior, and exploratory ambulation must be
thoroughly characterized in future studies to understand their contribution to performance on
specific cognitive challenges.
1.1.4 Summary of behavioral studies (young animals). The three studies described
above are the only studies to date that examined effects of early chronic low-level lead exposure
in pre-adolescent animals and all three studies showed that early chronic exposure to low-level
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lead altered behavior in young animals. Some of the findings were consistent between the studies
and some were not.
Only one study examined exploratory activity (NP task). In this study, as BLL increased,
exploratory activity decreased (Flores-Montoya et al., 2014). In this same study, effects on gross
motor ambulation or exploratory ambulation were not observed. It was suggested that the
reduced exploratory activity in the NP task was due to diminished “curiosity” and/or increased
anxiety for exploring a novel environment. Brain areas associated with exploration of a novel
environment and specifically nose-poke behavior include the hippocampus (Brodkin, 1999;
Crusio, 1995) and the amygdala (Takeda, Tsuji, & Matsumilla, 1998).
Findings with regard to memory were specific to the type of memory tested. Deficits in
olfactory recognition memory were observed (Flores-Montoya et al., 2015). No effects however
were detected for object recognition memory or visuo-spatial memory, instead, increased global
rearing behavior was detected during memory retrieval. These results suggested that chronic
low-level lead exposure might alter visuo-perceptual orientation and perhaps learning in young
mice (Sobin et al., 2017).
Differences in the type of memory affected may be an important clue regarding the brain
areas most vulnerable to low-level lead exposure. Olfactory recognition memory, spatial and
object recognition memory are sub-served, in part, by the hippocampus (Kee et al., 2007; Takeda
et al., 2014), however, the pathways mediating each of these memories are distinct (Broadbent,
Squire, & Clark, 2004). Olfactory recognition memory is sub-served by pathways linking the
olfactory bulb, entorhinal cortex, and hippocampus (Brennan & Keverne, 1997). In contrast,
spatial memory is subserved by the visual cortex, parietal lobe, and hippocampus; object
recognition memory is subserved by the visual cortex, entorhinal cortex, and hippocampus
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(Eichenbaum, Yonelinas, & Ranganath, 2007; Wang, Gao, & Burkhalter, 2011). Thus, it might
be that in young animals, chronic low-level lead exposure specifically targets circuits associated
with entorhinal cortex and hippocampus.
Results from adult studies reviewed above further suggested that as animals age into
adulthood, the effects may expand to alteration of brain pathways also sub-serving spatial and
object recognition memory (Azzaoui et al., 2009; Leasure et al., 2012). Several hypotheses are
suggested by these findings and studies designed to specifically address the hypotheses are
needed.
The findings suggested another possibility as well. Early chronic lead exposure appeared
to globally increase rearing behavior. Thus another possibility is that excessive rearing behavior
interrupted memory based exploration and in this way obscured the quantification of memory
based exploration. In order to understand whether effects on rearing behavior are due to changes
in visuo-perception, learning and/or motor function, a battery of tests that include both
examination of cognition and simple tests of motor function must be conducted in order to more
thoroughly characterize these effects.
To summarize, chronic low-level lead exposure results in a wide-variety of behavioral
deficits in animals. In adult animals, deficits are evident in spatial memory and object
recognition memory, as well as in exploratory ambulation. In younger animals (perhaps with
high relevance to chronically exposed children), deficits in olfactory recognition memory and
exploratory activity, and increases in rearing behavior during a cognitive challenge are evident.
More behavioral studies examining the effects of chronic low-level lead exposure in young
animals are needed. Future studies should replicate memory deficits in young mice using
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olfactory recognition memory tasks and examine deficits in motor behavior using basic measures
of motor function. Tables 1 and 2 below give a summary of the behavioral studies discussed.

Table 1. Summary of behavioral findings of chronic low-level lead exposed animals
(behaviors measured in two or more studies).
Studies
Authors and year

Behavioral Findings

Species and
Strain

PND

Reiter et al. (1975)

SpragueDawley rats

120-125

Ferguson and
Bowman (1990)

Rhesus
monkeys

Leasure et al. (2008)

Memory

Gross Motor
Coordination

Exploratory
ambulation

…

…

decreased*

decreased

1,440

…

…

increased*

…

C57BL/6J
mice

365

…

decreased

decreased

increased

Azzaoui et al. (2009)

Wistar rats

90-180

decreased*

…

increased

…

Kasten-Jolly et al.
(2012)

Balbl/c mice

adulthood

decreased

no effects

decreased

…

Flores-Montoya et
al. (2014)

C57BL/6J
mice

28

…

no effects

no effects

…

Flores-Montoya et
al. (2015)

C57BL/6J
mice

28

decreased

…

…

…

Sobin et al. (2017)

C57BL/6J
mice

28

no effects

…

increased

…

*Represents effects that were replicated in two or more studies.
PND = post-natal day
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Locomotion,
d-amphetamine

Table 2. Summary of behavioral findings of chronic low-level lead exposed animals
(behaviors measured in one study).
Studies

Behavioral Findings

Authors and year

Species and
Strain

PND

Leasure et al.
(2008)

C57BL/6J
mice

365

Kasten-Jolly et al.
(2012)

C57BL/6J
mice

365

Flores- Montoya et
al. (2014)

C57BL/6J
mice

28

Exploratory
activity
(nosepoke task)

Aggression

Eye-opening

Righting
reflex

delayed

delayed

…

…

…

…

…

increased

…

…

decreased

…

Note. This table shows behavioral outcomes measured only in one study. PND = post-natal day.

1.2

Brain Mechanisms Underlying Disruptions of Behavior
The underlying brain mechanisms that drive behavioral deficits as a result of early

chronic low-level lead exposure are currently not known. Decreases in memory in children and
disruption of exploratory behavior and retrieval memory in young mice however suggest that
hippocampus may be a target of effects. Also, studies at higher levels of exposure have provided
evidence that interactions between the central nervous system and the neuroimmune system (e.g.
astrocytes and microglial cells) might be, in part, responsible for behavioral disruptions and have
suggested avenues of research for examining effects at lowest levels of exposure (e.g. Legare et
al., 1998; Liu, M.-C., et al., 2012).
1.2.1 Pathways of lead neurotoxicity. Lead can be neurotoxic for the brain via a direct
pathway and/or an indirect pathway. In the direct pathway, lead might cross the blood brain
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barrier (tightly packed endothelial cells that separate circulating blood from extracellular fluids)
and accumulate in astrocytes (Legare et al., 1998). Once lead is in astrocytes, it can bind to the
molecular chaperone, glucose-regulated protein 78 (GPR78) (Qian, Harris, Zheng & TiffanyCastiglioni, 2000) and lower the secretion of interlukin-6 (IL-6). Since IL-6 is neuroprotective, a
decrease in this cytokine can increase the likelihood of neurotoxicity (White et al., 2007, review).
In the indirect pathway, lead enters erythrocytes, binds with delta-aminolevulinic acid
dehydratase δ-ALAD (the second enzyme in the heme biosynthesis pathway) and causes levels
of its substrate, δ-ALA, to rise (Klaassen, 2006). Excessive δ-ALA in the brain blocks and
reduces the number of glutamate receptors (Villayandre, Paniagua, Fernández-López, & Calvo,
2005). Additionally, δ-ALA can block glutamate transporters, i.e. GLT-1, and thus increase the
levels of extracellular glutamate (Emanuelli, Pagel, Porciúncula, & Souza, 2003) which could
induce chronic microglia activation and neurotoxicity (Murugan, Ling, & Kaur, 2013, review.)
Although lead exposure has the potential to alter a variety of brain mechanisms and brain
regions via the indirect and/or direct pathways, because of the implications for learning,
examining mechanisms that could disrupt hippocampal function are of critical importance. In
fact, molecular studies have shown that the hippocampus is exquisitely sensitive to the effects of
lead exposure (Du et al., 2015; Liu, Chen, Zhang, Kuang, & Chen, 2015; Selvin-Testa, Loidl,
Lopez-Costa, Lopez, & Pecci-Saavedra, 1994).
1.2.2 The hippocampus as a memory center. The hippocampus is a brain structure that
supports memory acquisition, storage, and retrieval. When new information is acquired by the
brain, a “reverberating circuit” is activated. In this circuit, information travels first to the
entorhinal cortex, then to the dentate gyrus (DG), then to the cornus ammonis (CA) 3, then to
area CA1 of the hippocampus, and finally back to entorhinal cortex forming a loop (Brenan &
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Keverne, 1997; Hebb, 1949). (The pathway is referred to as the “perforant pathway” because of
its structure.) This circuit supports memory via activation of long-term potentiation (LTP)
(Lynch, 2004). LTP refers to a process that strengthens electrical signals in specific pathways
through repeated activation (Lynch, 2004). This process is a form of synaptic plasticity and is
supported, initially, by the birth of new synapses (synaptogenesis) and later by the increase in the
density of dendritic spines (protusions that are located on the dendrites of neurons, at the level of
the synapse) (Engert & Bonhoeffer, 1994; Hasegawa, Sakuragi, Tominaga-Yoshino & Ogura,
2015.)
1.2.3 Effects of lead on the hippocampus. How chronic low-levels of lead alter the
hippocampus is unknown. However in vitro and in vivo studies showed that a variety of
mechanisms that support memory were altered at higher levels of lead exposure. For example,
lead exposure has been shown to diminish synaptogenesis (Hu et al., 2014), decrease the density
of dendritic spines (Ge et al., 2015), block glutamate receptors, i.e. N-methyl D aspartate
receptors (NMDA receptors) (Neal, Worley & Guilarte, 2011), increase the spontaneous release
of neurotransmitters (Braga, Pereira, Marchioro & Albuquerque, 1999), decrease the evoked
release of neurotransmitters (Lasley & Gilbert, 1996), and reduce neurogenesis (Gilbert, Kelly,
Samsan & Goodman, 2005) in the hippocampus. Within the hippocampus, microglia are often a
focus of study because of their central role in pathway development and neurogenesis. At higher
levels of exposure, lead has been shown to activate microglia in the hippocampus (Kumawat,
Kaushik, Goswami, & Basu, 2014; Liu, M.-C., et al., 2012; Liu et al., 2015) and at lowest levels
of exposure, in the DG (dentate gyrus) of the hippocampus, lead reduced the number of
microglia cells while altering their morphological structure (Sobin et al., 2013). Microglia play
multiple functions in the brain, and for this reason, changes in the number, morphology, and/or
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function of microglia have profound implications for the early and perhaps life-long health of the
brain. The multiple functions that microglia play in the brain are described below.
1.2.4 Functional roles of microglia in the brain. Microglial cells comprise the
neuroimmune system and constitute from five to twelve percent of cells in the brain (Lawson,
Perry, Dri, & Gordon, 1990). Microglial cells are the innate immune system of the brain and thus
they are the first line of defense against an insult to the brain (Kreutzberg, 1995). These cells are
phagocytes and can display antigens (molecules that can induce an immune response) on their
surface (Magnus, Chan, Grauer, Toyka, & Gold, 2001). Microglial cells can be differentiated
from other populations of innate immune system cells because they express high-levels of
ionized calcium-binding adapter molecule (IBA) 1 (Ito, Tanaka, Suzuki, Dembo, & Fukuuchi,
2001), high levels of CD11b, and low-levels of CD45 (Derecki, Cronk, & Kipnis, 2012).
Microglial cells play different roles under non-pathological vs. pathological conditions
(Prinz & Prieller, 2014). Under non-pathological conditions, microglial cells present a ramified
form and are constantly surveilling the environment for a potential threat. On the other hand,
under pathological conditions, microglial cells morph into an amoeboid form and travel to
regions in the brain where a “threat” such as a toxin or a pathogen is detected. At the site of
threat microglia release pro-inflammatory and/or anti-inflammatory cytokines which facilitate
the removal of the detected threat and these might be beneficial or detrimental for the brain.
Microglial cells not only participate in neuroimmune processes, they also play an
important role in brain development and memory. Studies have shown that throughout the lifespan, microglial cells support synapse formation, brain pathway development, pruning, and
neurogenesis (Paolicelli et al., 2011; Ransohoff & Cardona, 2010; Schafer et al., 2012).
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Microglial cells are abundant in the DG (dentate gyrus) of the hippocampus (Sierra et al.,
2010). The DG is one of three brain areas where neurogenesis occurs (Pignatelli & Belluzi,
2010) and as described earlier, the DG forms part of the circuit that supports memory and LTP
(long-term potentiation) (Brenan & Keverne, 1997; Hebb, 1949).
Microglia cells are also known to support LTP (Justin et al., 2011), dendritic spine
formation (Parkhurst et al., 2013), and the maturation of NMDA receptors at the postsynaptic
terminals (Hoshiko, Arnoux, Avignone, Yamamoto & Audinat, 2012). Interestingly, studies have
shown that microglial activation reduced LTP (Griffin et al., 2006; Cox, Carney, Miller &
Lynch, 2012). Additionally, depleting the brain of microglia reduced the formation of
postsynaptic dendritic spines and diminished memory (Parkhurst et al., 2013). Thus, via multiple
processes, microglia contribute to brain development and synaptic plasticity, and thus memory.
1.2.5 Effects of lead on microglia. In vitro and in vivo studies showed that at highest
levels of exposure, lead activated microglial cells and caused neuronal death in the hippocampus.
For example, an in vivo study showed that in adult Wistar rats, chronic exposure to 100 ppm of
lead increased microglial activation, reduced LTP, and increased neuronal death in the
hippocampus (Liu, M.-C., et al., 2012). Similarly, an in vitro study showed that lead exposure
activated microglial cells which resulted in neuronal death via activation of caspase 3 (Kumawat
et al., 2014). Alterations in these mechanisms might be, in part, responsible for deficits in
memory at high levels of lead exposure.
It is unknown however whether the above mentioned mechanisms are also altered at
lowest levels of exposure. As stated previously, we must understand effects at lowest levels of
exposure because child studies have repeatedly shown detrimental effects on memory at lowest
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levels of exposure; and child exposure to chronic low-level lead is still likely to occur among
children living in low-income neighborhoods (WHO, 2010).
Because of the sensitivity of microglial cells in the hippocampus to lead and because of
the important role of microglia in neuroimmune processes and memory, in a recent study in our
laboratory the effects of chronic low-level lead exposure were examined in microglial cells in the
DG of the hippocampus of young C57BL/6J mice (Sobin et al., 2013). This is the only study that
has exposed animals in vivo to chronic low-levels of lead (BLLs ranged from 2.66 to 20.31
µg/dL) and examined the number and volume of microglial cells in the DG (dentate gyrus) of the
hippocampus of young mice. For this reason, and in order to understand effects in microglial
cells at lower levels of exposure, the findings of this study guided the development of the
hypotheses for this dissertation. This study is described in detail below.
In a study (Sobin et al., 2013), the number and volume of microglial cells in the DG of
the hippocampus and expression of cytokines in whole brain of chronic low-level lead exposed
and unexposed young mice were examined. Forty-six C57BL/6J mice were exposed to one of
three levels of lead acetate, including 0 ppm (control; n = 10), 30 ppm (low-dose; n = 10) (mean
BLL 2.64 µg/dL), and 330 ppm (high-dose; n = 10) (mean BLL 13.45 µg/dL). Lead was
administered via dams’ drinking water from PND 0 to 28. Heart blood was extracted for analyses
of BLL with ICP-MS (method described on pages 52).
For microglial cell analyses, at PND 28, mice were sacrificed (n = 30), brains were
perfused and harvested, and microglia were labeled using immunohistochemical methods (IBA1). The number and volume of microglial cells were counted with a Stereologer TM software
(Stereology Resource Center, Chester, MD) and analyzed with two-way ANOVA (group x sex).

When significant differences were detected, Tukey’s post-hoc tests were used.
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For cytokine expression analyses, at PND 28, mice were sacrificed (n = 16), brain tissue
was harvested and frozen on dry-ice. At a later time, brain lysates were prepared with
hippocampus and without hippocampus and were analyzed for neuroinflammatory markers
including IL-6, IL-10, TNF-α, iNOS, HO-1, and GRP78. Quantitative reverse transcriptase
polymerase chain reaction (qRT-PCR) was used to measure genetic markers of
neuroinflammation. Data were analyzed with a three way (group x sex x brain section) ANOVA.
With regard to the number of microglial cells in DG, it was found that the low and highdose groups had significantly fewer numbers of microglial cells as compared to controls, and that
the high-dose group had fewer number of microglial cells in the DG as compared to the low-dose
group and controls. With regard to the volume of microglial cells, it was found that the
morphological structure as indicated by cell size was highly variable in the low-dose group as
compared to cells in the control group; no significant difference between the control group and
the high-dose group were found.
With regard to cytokine expression analyses, a significant decrease only in IL-6 was
detected. Thus, these results did not support a general inflammatory model. Observed effects in
gene expression studies however must be interpreted with caution. This is because a change in
the level of a transcript does not necessarily result in a change in the level of the protein
produced. In other words, transcripts can be degraded before they are even translated into a
protein (Voge & Marcotte, 2012). Furthermore, transcript levels were averaged across different
types of cells, thus it is not known which types of cells down-regulated IL-6.
To summarize, chronic low-level lead exposure reduced the number of microglia in the
DG of the hippocampus and reduced IL-6 transcripts in whole brain. Because of the importance
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of microglial cells in brain pathway development, pruning, and neurogenesis, a reduction in the
number of these cells in the hippocampus are a plausible explanation for disruption of brain
development and thus reduced memory function at lowest levels of early chronic lead exposure.
Studies are needed to examine mechanisms that can explain why microglial cells were missing
and morphologically altered in the DG of the hippocampus of chronic low-level lead exposed
mice.
1.2.5.1 Why were the structure and number of microglia altered in the DG low-level
lead exposed mice? An obvious explanation for results from the Sobin et al. (2013) study could
be that microglial cells were missing in the DG because chronic low-level lead exposure resulted
in microglial cell death and/or reduced proliferation. Given our current understanding however of
microglial cell morphology (microglial cells become enlarged when they are activated), the ability
of microglial cells to uptake lead particles readily and preserve their viability (Etemad, 2013), and
increased proliferation of microglial cells when they are exposed to an environmental threat
(Mander, Jekabsone & Brown, 2006), an alternative explanation might be more plausible. Recent
findings by Iliff et al. (2012), Louveau et al. (2015), and Aspelund et al. (2015) that show the
presence of a lymphatic system in the brain might suggest a means by which microglial cells are
trafficked away from the DG in chronic low-level lead exposed animals and might explain why
the number of microglial cells were reduced in the DG of the hippocampus.
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1.3

The Lymph System
1.3.1 “Lymphatics.” The lymph system is a critical component of the immune system. In

the periphery, it includes lymphatic vessels and lymph nodes which are filled with lymph that is
made up of interstitial fluid (ISF). ISF is fluid that exists throughout the extracellular
environment and flows constantly between the tissues; it is collected into the lymph system
through lymphatic capillaries. Lymph provides the means by which immune cells and solutes
drain (Förster, Davalos-Misslitz & Rot, 2008, review).
When an immune cell from the innate immune system (e.g. a macrophage or a dendritic
cell) detects a toxin or a pathogen, it phagocytoses (takes in) the toxin, presents an antigen on its
own surface in the form of major histocompatibility complex (MHC) and upregulates the C-C
chemokine receptor 7 (CCR7). Specifically, upregulation of CCR7 initiates migration of the
macrophage and/or dendritic cell towards the chemokine ligands 19 and 21 (CCL19 and
CCL21). These ligands are expressed by endothelial cells of lymphatic vessels and stimulate the
migration of macrophages and/or dendritic cells into lymphatic vessels and lymph nodes. Once
these cells enter the lymphatic vessels, they access the nearest lymph node and present MHC to
T-lymphocytes (T-cells), thereby communicating that a tissue has sustained damage. T-cells can
then be activated and might initiate an adaptive response (humoral or cell-mediated) that can be
beneficial or detrimental for the tissue (Förster et al., 2008, review).
The lymphatic system in the periphery (“below the neck”) has been well-characterized
for hundreds of years and it has been assumed that the brain lacked classical lymphatic vessels
(Torgan, 2015). However, recent studies have shown that cerebrospinal fluid (CSF) drains via
the nasal mucosa and the dural sinuses into cervical lymph nodes (Liu, H., et al., 2012; Mathieu,
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Gupta, Macdonald & Yücel, 2013). These studies raised questions regarding what the specific
channels that drain CSF might be if in fact the brain lacked classical lymphatic vessels. Other
studies began to characterize a “glymphatic system” in the brain (Iliff et al. 2012) and these
important studies were followed by the astonishing recent discovery of the presence of
meningeal lymphatic vessels by Louveau et al. (2015) and Aspelund et al. (2015). These
findings are revolutionizing our understanding of a brain lymphatic system and provide entirely
new means by which the immune system directly impacts the brain. These studies are described
below.
1.3.2 The glymphatic system. In the absence of known lymphatic vessels in the brain
Iliff et al. (2012) examined whether there is a system in the brain that could act similarly as
lymphatic vessels in the periphery and clear solutes from the brain. Since it is known that the
brain is encircled by CSF (meningeal fluid) and that ISF within the brain carries solutes and
cells, the researchers investigated whether there was any channel that might drain these fluids
and thus serve as lymphatic-like structures for the brain. In order to investigate this question, the
direction of flow of CSF and ISF in the brain was examined.
To study CSF flow, in anesthetized mice, radio-labeled tracers were injected into the
lateral ventricles or into the cisterna magna (located in the subarachnoid space of the meninges in
the caudal region of the brain). After injections, the brains of the mice were retrieved, sliced with
a vibratome, fixed, and examined with fluorescence imaging. It was found that 30 min after the
injection into the lateral ventricles, the tracers localized in the zones surrounding the ventricles
but not in distal ventricular zones or in the brain. On the other hand, it was found that 30 min
after injection into the cisterna magna, the tracers moved (“flowed”) into brain tissue via the
spaces surrounding brain arteries (para-arterial spaces).
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To confirm these findings, mice were examined in vivo with two-photon laser scanning
microscopy to examine in real time the flow of CSF in cortical areas, and with an ex vivo model
using double-transgenic mice (that allowed the visualization of arteries and veins) to examine the
CSF flow within arteries and veins penetrating the brain.
The in vivo model showed that after injection of fluorescent tracers, the tracers localized
in the para-arterial regions of the cortex. The ex vivo model showed that the tracers that were
injected into the cisterna magna, moved almost immediately along para-arterial regions, starting
by areas near the basal ganglia and thalamus. On the other hand, about one hour after injection,
the tracers moved along surrounding veins (para-venous regions). Interestingly, it was found that
the majority of the tracers exited the brain mainly along the outer sides of the medial internal
cerebral veins and the lateral caudal ventral rhinal veins. ISF flow was also examined by
injecting a tracer in the extracellular space of the brain, close to the basal ganglia and thalamus.
Similar to the exit pathways of the CSF, it was found that the ISF exited via para-venous regions.
In summary, it was found that the para-arterial space, which is delimited by the end-feet
of astrocytes, is filled with CSF. Arterial pulsations provide a pumping action on the outside of
the artery that allows the CSF to recirculate throughout the brain (Hadazeck et al., 2006). On the
other hand, the para-venous spaces also delimited by the end-feet of astrocytes serve as a
drainage channel for both CSF and ISF and the researchers suggested that it drained ISF and CSF
into cervical lymph nodes. Because this “system” is dependent on glial cells (astrocytes) and
appears to serve the same function as that of the lymphatic system in the periphery (i.e. drainage
of solutes, among other possible functions) the researchers named this system the “glymphatic
system.”
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The findings by Iliff et al. (2012) were a great step towards understanding how the brain
might drain solutes and perhaps immune cells into the periphery. The discovery of the
glymphatic system stimulated other researchers to examine more thoroughly the vasculature of
the brain in the meningeal spaces. This examination led to the historical discovery that lymphatic
vessels in fact existed in the para-venous regions located in meninges. The meninges are
protective tissue layers that lie around the brain and spinal cord. They comprise the outer dura
mater, the arachnoid space, the sub-arachnoid space, filled with CSF, and the pia mater that is the
inner layer of the meninges and is the layer most proximal to the brain (Carlson, 2010).
1.3.3 The meningeal (or dural) lymphatic system. Studies that discovered the existence
of meningeal (or dural) lymphatics, published in June 2015, may be one of the most remarkable
discoveries in neuroscience in the past century. Given the significance of these studies, they will
be described in detail below.
In search for possible exit pathways of neuroimmune cells from the meningeal spaces
into the periphery, C57BL/6J adult mice were sacrificed and their skulls and meninges were
retrieved from the brain (Louveau et al., 2015). The meninges were then stained for markers of
endothelial cells (CD31), T-cells (CD3e), and MHC II-expressing cells. The authors found that
the majority of these cells were aligning along the dural sinuses (venous channels). These sinuses
are known to drain blood from the external and internal veins of the brain into the internal
jugular veins.
The authors then examined whether, along the dural sinuses, there was any structure that
expressed classical lymphatic-vessel markers. The dural meninges were labeled with a
lymphocytic endothelial cell marker, LVEY-1, and with the endothelial marker CD3. After
labeling, a 2-photon microscope was used to examine the stained meninges. It was found that
36

some vessels were positive for these markers and were located in close proximity to the sinuses.
In order to rule out the possibility that these vessels were simply venous vessels, before
euthanasia, animals received an intravenous (i.v.) injection of DyLight 488 lectin. This injection
revealed that the cells expressing LVEY-1 were not part of the vasculature. Additionally, the
LVEY-1 vessels were examined for additional markers, including PROXY 1 (which is a
transcription factor of lymphatic vessels), PDPN (a protein that is known to link lymphatic and
blood vessels), the vascular endothelial growth factor receptor (VEGFR3), and CCL21 (a CCR7
chemokine ligand). Remarkably, these vessels were positive for all of the markers described
above confirming that they were in fact lymphatic-like structures. The authors named these
vessels “meningeal lymphatic” vessels. Visualization of these vessels showed that they were
located throughout the transverse sinus, medial sagittal sinus, the olfactory bulb, and the eyes.
Given these findings, the functionalities of the meningeal lymphatic vessels were
analyzed to examine whether they drained CSF and immune cells into the deep cervical lymph
nodes (dCLNs). Adult mice were anesthetized and given an intravenous injection of fluorescein
and an intracerebroventricular (i.c.v) injection of a fluorescent dye (QDot655). Thin skull
sections were then examined visually with a multiphoton microscope and it was found that the
meningeal lymphatic vessels were filled with QDot655 but not fluorescein. Later a simultaneous
i.c.v. injection with QDot655 and Alexa 488 anti-LVEY1 showed that in fact, these vessels
drained CSF.
Additionally, the presence of T-cells and MHC II-expressing cells were examined by
labeling the cells with the antibodies described above. It was found that 25% of the T-cells and
14% of the MHC II-expressing cells located in the meningeal space were located within the
meningeal lymphatic vessels. The meninges were also labeled for makers of CD11c (that stains
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antigen presenting cells) and BB220 (a marker of B-cells). Cells expressing these markers were
found in meningeal lymphatic vessels.
Finally, in order to test whether these vessels connected to the cervical lymph nodes and
served as a drainage channel, i.c.v. injections of evans blue (a dye that is typically used to mark
lymphatic vessels in the periphery) showed that within two hours post-injection, the dye stained
the dCLNs (deep cervical lymph nodes) and a few hours later it stained the superficial cervical
lymph nodes (sCLNs). Additionally, the dCLNs and sCLNs were resected or ligated. It was
found that the resection of the dCLNs resulted in an accumulation of T-cells in the meningeal
zone. Ligation of the dCLNs but not of the sCLNs resulted in an increase in the diameter of
meningeal lymphatic vessels. These results suggested that the meningeal lymphatic vessels
drained CSF and immune cells directly into the dCLNs but not the sCLNs. These findings in
combination with previous findings from Iliff et al. (2012) (described above) for the first time
provided nearly indisputable evidence that brain lymphatic-like structures exist.
In another study, the possible presence of brain lymphatics was examined in PROX1GFP and Vegfr3+/LacZ reporter mice and wild-type (WT) mice (Aspelund et al., 2015). The skull,
meninges, and brain were labeled with fluorescent antibodies including antibodies against
LYVE1, PROX1, PDPN, CCL21, VEGFR3, and PECAM1 (a protein that is part of the junctions
of the endothelial cells).
After staining, a network of lymphatic vessels was visualized in the meninges. These
vessels expressed high levels of LYVE1, PROX1, PDPN, CCL21, VEGFR3, and low levels of
PECAM1, which are markers that are characteristic of lymphatic vessels. In areas of the inner
skull, these vessels were found to run along the transverse sinus, the retroglenoid vein, the rostral
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rhinal vein, and the major branches of the medial and anterior meningeal arteries. In the superior
outer skull, they were localized in the superior sagittal sinus, transverse sinus, rhinal veins, the
transverse sinus, the rostral rhinal veins, and the middle meningeal artery. Other lymphatic
vessels were observed running through the distal regions of cranial nerves. And in the dural
lining of the cribriform plate and from the skull into the nasal mucosa. These results provided
evidence that lymphatic vessels exist in the dura mater of the skull and drain outside of the skull
through the foramina along the base of the skull, and surround the arteries, veins, and cranial
nerves. The researchers named these vessels “dura mater” lymphatic vessels.
Once the researchers discovered the existence of these vessels, they investigated whether
they drained to dCLNs and sCLNs, and if CSF and ISF could be transported through the dura
mater lymphatic vessels. In order to examine this question, fluorescent tracers were injected in
the brain parenchyma of PROX1-GFP mice. After two hours of the injection, it was found that
these tracers entered through para-venous areas and into the CSF. Additionally, it was found that
these tracers drained into the dCLNs but not the sCLNs. The tracer was followed upstream of
the dCLNs and they appeared to drain from the base of the skull. Additionally, the efferent arm
of the lymphatic vessels was ligated and it was found that the dura mater vessels had increased
filling. The authors suggested that the dural lymphatic vessels absorb ISF and CSF and drain it to
the dCLNs.
The Vegfr3+/LacZ reporter mice were also used to study what happens in the absence of a
key molecule VEGFR3. They found that the lymphatic vessels on the superior and basal regions
of the skull were missing but not in wild type (WT) mice. Also, contrary to what was expected
mice did not have any sCLNs but they did have dCLNs. Additionally, whether the absence of
these dura lymphatic vessels would have an effect on ISF pressure in the brain and water content
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was examined. It was found that the absence of these vessels did not have any effect on this,
which suggested that there might be other alternative routes of ISF efflux. Also, injection of a
fluorescent dye in the cisterna magna revealed that transgenic (TG) mice had diminished
draining in the dCLNs as compared to controls. The researchers concluded that the dura mater
lymphatic vessels contribute to clear macromolecules from the brain.
To summarize, until June 2015, it was believed that there were no lymphatic vessels in
the brain. These very recent discoveries have shown that these vessels exist in the dura mater of
the meninges and are responsible for the drainage of cells into dCLNs, Figure 1 below.
Figure 1. Representation of the lymphatic system before and after the discovery of the
meningeal lymphatic vessels.
Before

Now

Note. On the left (before) schematic of the long-held belief that lymphatic vessels do not exist in the brain. Recently,
in June 2015, two independent laboratories showed that there are in fact lymphatic vessels in the brain. On the right
(now) schematic of the meningeal or dural lymphatic vessels (Torgan, 2015). Image retrieved from:
https://www.nih.gov/news-events/nih-research-matters/lymphatic-vessels-discovered-central-nervous-system
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1.3.4 How are the “glymphatics” and “meningeal lymphatic vessels” related?
Details regarding how the “glymphatics” and “meningeal lymphatic system” are
functionally related remains to be determined. Their anatomical proximity and similarity of
carried fluids, namely CSF and ISF, suggest that these two systems are closely related and
constantly exchange solutes and/or immune cells. It is logical to suggest that they serve functions
very similar to that of peripheral lymphatic vessels, and thus drain immune cells into the dCLNs
perhaps for antigen presentation (e.g. MHC II) to T-cells.
1.4

Can Microglia Traffic Towards Lymphatics?
Studies have shown that microglial cells upregulate proteins known to facilitate

trafficking of cells in the peripheral immune system and in this way facilitate migration of these
cells towards lymphatic vessels for antigen presentation to T-cells in adjacent lymph nodes. For
example, similar to peripheral immune cells, microglial cells upregulated MHC II (major
histocompatibility complex II) (Beyer, Gimsa, Eyüpoglu, Hailer, & Nitsch, 2000; Harms et al.,
2013) and CCR7 (C-C chemokine receptor 7) in response to exposure to an antigen (e.g.
liposaccharide) (Dijkstra, de Haas, Brouwer, Boddeke, & Biber, K., 2006). Also microglial cells
expressing CCR7 migrate towards the ligand CCL21 (Takahashi, Rochford, & Neumann, 2005),
which is expressed in meningeal (or dural) lymphatic vessels (Louveau et al., 2015; Aspelund et
al., 2015) and in peripheral lymphatic vessels.
As described earlier, in the periphery, when a tissue is exposed to a toxin or a pathogen,
innate immune cells (e.g. macrophages or dendritic cells) upregulate CCR7 and migrate towards
its ligands CCL19 and/or CCL21 and access lymphatic vessels and lymph nodes. Therefore, it is
plausible to hypothesize that after an insult to the brain (e.g. exposure to lead or increased brain
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ALA), microglia upregulate MHC II and CCR7, migrate towards meningeal (or dural) lymphatic
vessels and drain into dCLNs to communicate to T-cells that the brain tissue has sustained
damage.
1.5

Lead-Exposed Immune Cells Might Traffic Towards Lymphatics
There are no studies examining whether chronic low-level lead exposure causes the

upregulation of MHC II and CCR7 in microglia cells. Studies examining cells in the peripheral
immune system however showed that at higher levels of lead exposure, macrophages (which are
innate immune cells functionally similar to microglia) upregulated MHC II and primed T-cells
towards a Th2 phenotype (humoral immunity, i.e. increased antibody production) (Dietert &
Piepenbrink, 2006, review; Kasten-Jolly & Lawrence, 2014, review). This suggested that lead
exposure caused the migration of macrophages towards lymphatic vessels and lymph nodes for
antigen presentation of MHC II to T-cells. Since the peripheral immune system and
neuroimmune system are more tightly linked than previously thought (Louveau, Harris, &
Kipnis, 2015, review) it is plausible to suggest that chronic low-level lead-exposed microglial
cells behave similarly as lead-exposed macrophages in the periphery.
1.6

Summary of Studies
Early chronic low-level lead exposure is still common in some lower-income

neighborhoods throughout the U.S. and children are particularly vulnerable to its CNS effects.
Memory deficits and effects on learning are perhaps of greatest concern and have been shown in
both child and juvenile animal studies at lowest levels of lead exposure. It is necessary to
develop new models for determining the mechanisms by which lowest level lead exposure alter
the brain and specifically memory because no interventions are currently available for children
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chronically exposed to low-level lead. Studies of both adult and young animals have shown that
murine models are valuable for understanding memory effects in children at lowest levels of
exposure.
Studies at higher levels of exposure have provided the groundwork for studies at lowest
levels of exposure and have repeatedly shown the profound effects of lead on the CNS, the
immune system and the neuroimmune system. Lead can be toxic for the brain via direct and
indirect pathways. Lead can bind to the molecular chaperone GPR78 in astrocytes and reduce IL6 (Qian et al. 2000); also lead can bind with δ-ALAD in erythrocytes and increase circulating
and brain δ-ALA (Klaassen, 2006). Decreased IL-6 and increased δ-ALA are both potentially
neurotoxic.
Understanding the specific effects of low-level lead in hippocampus is necessary because
studies have shown that the hippocampus is exquisitely sensitive to the detrimental effects of
lead exposure (Du et al., 2015) and memory is a foundational cognitive skill for early learning
and for brain function throughout the lifespan. Studies have shown that lead altered a variety of
mechanisms associated with memory formation in the hippocampus (Braga et al., 1999; Ge et al.,
2015; Gilbert et al., 2005; Hu et al., 2014; Lasley & Gilbert, 1996; Neal et al., 2011). Studies
have shown that lead exposure activated microglial cells which in turn reduced LTP (long-term
potentiation), and caused neuronal death in the hippocampus (Liu et al., 2012; Kumawat et al.,
2014). It is unknown however whether the above mentioned mechanisms are altered at lower
levels of exposure and whether these mechanisms mediate memory deficits. Only one published
study thus far has examined effects at lowest levels of exposure in microglial cells (Sobin et al.,
2013) and showed abnormally reduced numbers of microglia in dentate gyrus. The specific
mechanisms by which these effects occurred are unknown. Microglial cells are critical for
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neural pathway development, neuroimmune protection of specific brain regions, and
neurogenesis throughout the lifespan. Altering the number or distribution of these cells could
have profound effects on brain development and neurocognitive function. Given that the CNS
and neuroimmune system are now understood to be inter-dependent (Louveau et al., 2015,
review) some of these deficits might be mediated by interactions between the CNS and the
neuroimmune system (e.g. microglial cells).
The recent discoveries of the glymphatic system (Iliff et al., 2012) that drains CSF mainly
along the medial internal cerebral veins and lateral caudal medial veins, and the discovery of the
meningeal (or dural) lymphatic vessels by Louveau et al. (2015) and Aspleund et al. (2015) that
are located in paravascular regions, provided the foundation for novel hypotheses regarding the
trafficking and abnormal distribution of microglial cells following early chronic low-level lead
exposure and the impact of these effects on memory. Whether microglial cells traffic to
meningeal (or dural) lymphatic vessels and to dCLNs (deep cervical lymph nodes) as a result of
chronic low-level lead exposure is not known. Studies examining effects of lead in peripheral
immune cells showed that lead increased MHC (major histocompatibility complex) II in
macrophages and predisposed T-cells towards a Th2 phenotype (Dietert & Piepenbrink, 2006,
review; Kasten-Jolly & Lawrence, 2014, review). Thus in the periphery, macrophages migrate
towards lymphatic vessels and lymph nodes for antigen presentation to T-cells. In the periphery,
migration of macrophages to lymphatics occurs via the C-C chemokine receptor 7 (CCR7).
Given that microglial cells are functionally similar to macrophages, are capable of
upregulating MHC II and CCR7 after they have been exposed to an antigen, and given that
meningeal (or dural) lymphatic vessels lie in close proximity to the brain, it is plausible to
suggest that as a result of chronic low-level lead exposure microglial cells upregulate MHC II
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and CCR7 and migrate to meningeal (or dural) lymphatic vessels and to dCLNs for antigen
presentation to T-cells. (If so, this could begin to suggest why microglial cells were missing in
the DG of the hippocampus at lowest levels of exposure.)
Animal models of chronic low-level lead exposure are needed to further test memory and
motor deficits and examine molecular mechanisms that could explain why microglia cells were
reduced in the DG of young mice with early chronic low-level lead exposure.
1.7

Models and Hypotheses
The studies described in this project are interdisciplinary and translational, and include

complementary behavioral and molecular studies.
1.7.1 Behavioral system model. For behavioral studies, thirty-six C57BL/6J male mice
were exposed to one of three treatment levels including 0 ppm (control), 30 ppm (low-dose) and
430 ppm (high-dose) via dams’ milk from PND 0 until PND 28. Mice were examined
behaviorally at PNDs 7, 14, 21 and 28 for developmental milestones. Following on results from
three previous studies conducted in our laboratory (described above on pages 16-21), at PND 28,
olfactory memory and motor function were assessed. After behavioral testing animals were
sacrificed and heart blood was retrieved for analyses of BLL with ICP-MS. It was hypothesized
that chronic low-level lead exposure would delay the development of the nervous system, would
reduce olfactory memory, and would disrupt basic motor functions in young C57BL/6J male
mice.
1.7.2 Neuroimmune system model. To examine immune factors that could promote
activation and trafficking of hippocampal microglial cells, thirty-six C57BL/6J mice were
exposed chronically to low-levels of lead as described above. At PND 28, animals were
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sacrificed, the cerebellum was removed, the two hemispheres were separated and left and right
hippocampi were dissected. FACS (fluorescence-activated cell sorting) analyses were used to
count the number of microglial cells in the hippocampus and examine the quantity of MHC II
and CCR7 in these cells. It was hypothesized that MHC II and CCR7 in the hippocampal
microglia of young C57BL/6J male mice would be upregulated.
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CHAPTER 2
METHODS
2.1

Animals
The animal procedures used for this study were conducted in compliance with the US

Public Health Service Policy on Humane Care and Use of Laboratory Animals (National
Research Council, 2011) and were approved by the Institutional Animal Care and Use
Committee (IACUC, Protocol #A201403-1). Mice of the strain C57BL/6J were purchased from
Jackson Laboratories and housed and bred in the Bioscience Research Facility at the University
of Texas at El Paso (UTEP). Male and female mice were group-housed by sex in ventilated
cages (22.22 cm x 36.83 cm x 13.97 cm) and with ad libitum access to food and water; with a
room temperature of 20º-26º C, relative humidity of 30 percent, and a 12 hour light-dark cycle.
At PND 60, 18 dams were mated with 9 sires (two females per male) by harem breeding.
Pregnancy was determined by vaginal plug. When pregnancy was determined, females were
removed to separate cages. Dams gave birth to litters of five to nine pups and culled to five pups
per litter. For this study, males but not females were tested because past studies (Leasure et al.,
2008; Flores-Montoya et al., 2015) showed that effects of chronic low-level lead exposure in
males and females often differed. (Determining the mechanistic basis for these sex differences is
of course important and future studies will examine effects in females.)
2.2

Lead Exposure
The methods for lead exposure that will be described have been previously shown by our

laboratory to reliably produce low and high BLLs in the selected mouse strain and are published
in peer reviewed journals (e.g. Flores-Montoya & Sobin, 2014; Flores-Montoya et al., 2015).
From birth to PND 21, dams were exposed to one of three treatment conditions via drinking
water. The control group was exposed to 0 ppm, the low-dose group was exposed to 30 ppm
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(mean BLL 4 µg/dL), and the high-dose group was exposed to 430 ppm (mean BLL 21 µg/dL)
of 99.4% pure lead acetate, Sigma Aldrich. Via this method, pups were exposed to lead via
dams’ milk. At PND 21, pups were weaned and placed in new cages (five mice per cage) and
continued treatment exposure via water bottles until PND 28.
2.3

Behavioral Studies
Thirty-six mice were examined behaviorally, N = 36 (controls = 11, low-dose = 12, high-

dose = 13). Specifically, they were observed for developmental milestones (eye-opening, body
weight, and righting reflex) and were tested behaviorally with the inverted screen test (muscular
strength), open field behavior test (exploratory behavior and anxiety), and odor habituation/dishabituation test (olfactory memory). All mice completed behavioral testing for the open field
task. Three mice however did not complete full testing for the rest of the tasks due to technical
errors. The final groups included a minimum of 11 animals per experimental group per test (one
more per group than numbers used in our previous studies showing significant group effects.)
At PND 28 and immediately after behavioral testing was completed, mice were
anesthetized with Avertin (250 mg/kg) and heart blood was collected for analyses of BLLs with
ICP-MS
2.3.1 Developmental milestones.
2.3.1.1 Eye-opening. C57BL/6J mice begin opening their eyes between PND 12 and
PND14 (Sundberg, Smith, & John, 2002) with full eye-opening occurring PND 15-16. Mice
were checked daily from PND 0 until they opened both eyes fully. The day of full eye opening
was recorded for each mouse.
2.3.1.2 Body weight. Mice were weighed at PND 7, 14, 21, and 28 (day of behavioral
testing).
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2.3.1.3 Righting reflex test. This is a simple test of vestibular locomotor spatial
displacement and overall body strength. Mice can be tested from PND 0 until they develop the
righting reflex (DiDonato & Bogdanik, 2011). Because pups were exposed to lead via drinking
dams’ milk beginning at PND 0, the righting reflex test was conducted first at PND 7 to allow
time for lead ingestion and distribution in experimental groups, and for three weeks thereafter at
PND 14 and 21.
For testing righting reflex, each mouse was removed from its cage and body weight was
measured and recorded. The mouse was then placed on its back and was lightly stabilized by the
experimenters’ index finger so that the mouse had its four paws up in the air. As the
experimenter released the index finger hold, another experimenter, blind to the experimental
condition, used a stopwatch to record the number of seconds required for the mouse to flip over
onto its stomach with all four paws touching the base. Mice were allotted 60 sec to right
themselves; all animals displayed a righting reflex within the allotted time.
2.3.2 Inverted screen test. This test was used to measure muscle strength. Mice have a
natural tendency to grab with their four paws and to use their muscular strength to hold on to a
screen that has been inverted. For this test, mice were placed individually on a 1/8th inch metal
mesh screen attached to a wooden frame box. The screen was then turned upside down and the
latency to fall into an open field arena was recorded.
2.3.3 Open field test. This task was used to examine mouse exploratory activity and
anxiety. In previous studies, our laboratory used a square arena with marked quadrants and
observed no differences between experimental groups and controls. To explore the sensitivity of
different approaches for these studies a circular Plexiglas arena (70 cm x 29 cm; area 3848 cm²)
was used and behaviors in the periphery and center of the arena were quantified. An
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environmental cue consisting of a cardboard rectangle with vertical black and white stripes (38 x
30 cm) was placed on the lower left area of the arena. At PND 28, mice were placed in the
circular arena and the SMART software system (Harvard PanLab Systems, Cambridge, MA)
connected to a video camera and mounted on top of the arena was used to demarcate two circles
on the floor of the arena, one in the periphery and one in the arena center. Mice were placed in
the upper right area of the arena and were allowed to explore it for 5 min. Mice were then
removed from the arena, placed in a holding cage and the floor of the arena was cleaned with
70% isopropyl alcohol to prepare for the next testing.
For measuring exploratory behavior and locomotor activity, the number of rears that mice
displayed in the periphery (along the walls of the arena) and center of the arena; and the total
distance travelled were quantified. For measuring anxiety, the distance travelled and time spent
in the periphery (thigmotaxis) were quantified (Simon et al., 1994).
2.3.4 Odor habituation/dis-habituation test. This task was used for examination of
olfactory memory. The methods used for this task followed published methods (Yang &
Crawley, 2009). At PND 28, mice were removed from their cage, and placed individually in a
new mouse cage scattered with home-cage bedding. The testing cage had a cotton-tip applicator
attached to the dispenser hole of a water bottle. Animals were habituated to the new cage and the
cotton-tip applicator for 30 min.
After habituation, animals underwent the testing trials. For these trials, mice were
habituated and dishabituated to five odors consecutively. Three of these odors were non-social
odors and two were social odors. Animals were exposed to the non-social odors via three cottontips that were dipped (for 2 sec) in distilled water, almond extract (McCormic® food-edible

50

product, 1:100 dilution), or orange extract (McCormic® food-edible product, 1:100 dilution).
Animals were exposed sequentially to social odors via two cotton-tips that had been treated with
two different unfamiliar social cage scents (social scent 1 and social scent 2). The social cage
scents were obtained by dipping each cotton-tip (for 2 sec) in the bedding of one of two
unfamiliar mouse cages.
Animals were tested in 15 consecutive trials (the complete test lasted 59 min per animal).
Animals were first exposed for three consecutive trials, with an ITI (inter-trial interval) of 1 min,
to a cotton-tip with distilled water (3 min, control exposure). Then they were exposed for three
consecutive trails, with an ITI of 1 min, to a cotton-tip with almond, orange, unfamiliar social
cage scent 1, and unfamiliar social cage scent 2 (3 min each for experimental exposures). After
behavioral testing was completed for each mouse water bottles were cleaned with 70% isopropyl
alcohol and fully dried.
A video camera was mounted at the level of the mouse cages and behavior was recorded.
Odor exploration was measured by recording the number of seconds the animals had their noses
within < 2 cm of proximity to the cotton-tips. At a later time, video-taped behavior was
examined by specially trained raters blind to experimental condition. Animals with an intact
memory were expected to spend less time exploring the familiar odors (habituation) and they
were expected to spend more time exploring a novel odor (dishabituation).
2.3.5 Blood collection. Immediately after behavioral testing, mice were weighed and
anesthetized with Avertin (approximately 0.5 ml, depending on body weight). Once mice were
unresponsive to corneal touch and paw pinch tests, 50 µL of heart blood per animal was retrieved
via right auricle puncture. Blood samples were refrigerated for later ICP-MS analyses.
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2.3.6 Inductively coupled plasma mass-spectrometry (ICP-MS) analyses of blood
lead.

2.3.6.1 Instrumentation. For ICP-MS analyses an Agilent 7500ce ICP/MS equipped
with an octople reaction system and a CETAX AS20 autosampler was used (Agilent, Santa
Clara, CA). The samples were introduced into plasma using a Micro-Mist U-series nebulizer
(Glass expansion, West Melbourne, Australia) and a double-pass quartz spray chamber. The
parameters set for the instrument were carrier gas 0.78/1 min, make up gas 0.15 1/min,
radiofrequency power 1420 W, and spray chamber temperature 2ºC.
2.3.6.2 Sample treatment analyses. Certified whole blood standards were analyzed (Le
Centre du Toxicologie du Quebec, Canada) to establish the reproducibility of the instrument
results. Sample blood standards were prepared as described (Agilent technical note no. 59880533 EN). A propylene tube was filled with 5.58 ml of water (18 M Ὠ DI: Labconco WaterPro
PS Station, Kansas city, MO), 300 µl of whole blood, 60 µl of internal standard solution
containing a 100 ppb each germanium, yttrium, and terbium in 5% nitric acid (Fisher Optima:
ThermoFisher Scientific, Walthman, MA) and 60 µl aqueous 10 ppm gold in 3% hydrochloric
acid solution (EMD, chemicals, Gibbstown, NJ). Internal standards were added to every sample
to identify and correct instrument drift; internal standards were also used when building the
calibration curve. The final internal solution was 20-fold, the final internal standard
concentration was 1 ppb, and the final gold concentration was 100 ppb. A six-point external
calibration curve was prepared from a lead concentration stock solution in 1% nitric acid. ICPMS standard solutions containing the elements in 2% nitric acid were obtained from inorganic
ventures (Christiansburg, VA). Samples were vortexed and centrifuged for 1 min at 2,000 rcf,
and the supernatant was analyzed by ICP-MS.
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2.3.7 Statistical analyses of behavioral data. All data was analyzed with SPSS Version
23.0. Data were entered, checked for accuracy, and examined for missing values, distribution
properties, and outliers. Additionally, tests for homogeneity of variance and distribution
properties were conducted in order to determine adequate statistical analyses for examining
possible effects of lead exposure in observed differences and described in detail below in the
relevant section.
2.3.7.1 Blood lead levels. One-way ANOVA was used to examine test differences
between groups with regard to BLLs.
2.3.7.2 Developmental milestones.
Eye-opening. The day that mice opened their eyes was recorded and results were
displayed as percentages. Chi-square test was conducted to test possible differences between
groups.
Body weight (4 time points). Body weight was measured at four developmental time
points including PNDs 7, 14, 21, and 28 (time of sacrifice). General linear model analyses with
treatment group as the between subjects factor and PND (of body weight measurement) as the
within subjects factor were used to examine possible significant main effects of treatment group
and PND on body weight and the interaction (group x PND).
Righting reflex (3 time points). Righting reflex was measured at four developmental time
points including PND 7, 14, and 21. General linear model analyses with treatment group as the
between subjects factor and PND (of righting reflex measurement) as the within subjects factor
were used to examine possible significant effects of treatment group and PND on righting reflex
and the interaction (group x PND).
2.3.7.3 Inverted screen test (1 time point, PND 28). Muscle strength was measured at
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PND 28. Independent samples median tests (non-parametric analyses) were used to examine
possible differences between groups with regard to latency to fall from the inverted screen.
2.3.7.4 Open field test (1 time point, PND 28). Generalized linear model analyses were
used to examine possible differences between groups with regard to outcome variables measured
in open field. The Poisson distribution was specified for models predicting count data (number of
rears). The Gaussian distribution was specified for models predicting continuous data (total
distance travelled, distance travelled in the periphery, and time spent in the periphery).
2.3.7.5 Habituation/dishabituation test (1 time point, PND 28). General linear model
analyses with treatment group as the between subjects factor and trial (of the odor) as the within
subjects factor were used to examine possible significant effects of treatment group and trial on
odor exploration and the interaction (group x trial).

2.4

Microglia Cell Study
Thirty-six male animals (controls n = 12, low-dose n = 12, and high-dose n = 12) were

sacrificed at PND 28. Immediately after sacrifice, brains were retrieved and the left and right
hippocampi were dissected. In order to ensure sufficient number of microglial cells for detecting
possible significant differences between groups, the hippocampi and brains of three mice (from
within each treatment group) were combined, yielding a total number of N = 12 samples (control
samples n = 4, low-dose samples n = 4, high-dose samples n = 4). Hippocampal and brain
microglial cells were examined with FACS (fluorescence activated cell sorting) analyses for
possible differences between treatment groups with regard to percentage and number of cells and
presence of MHC II and CCR7 on the cell membrane surface. Additionally, in order to better
understand effects of lead on the neruoimmune system, exploratory analyses were conducted to
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examine the same parameters described above in macrophages and percentages of immune cells
(lymphocytes and monocytes) in hippocampus and brain.
2.4.1 Fluorescence-activated cell sorting (FACS) analyses
2.4.1.1 Apparatus. FACS is a technique used in flow cytometry that allows the sorting
and counting of different types of cells by detecting the proteins that they express. Because cells
within each animal are identical genetically but differ greatly with regard to the proteins that they
express, cells can be sorted by anti-body labeling of the proteins/molecules that they uniquely
express or express in higher or lower quantities as compared to other populations of cells.
FACS techniques can be used with cell lines or with primary cells extracted from whole
organism tissue. Although much more challenging, for the purposes of these studies, we
conducted the studies using primary cells from mouse hippocampus and brain. Briefly, the
tissues of interest were first dissected, and the cells of the tissues were dissociated into singlets.
After this, the proteins expressed in the cells of interest were labeled with primary antibodies that
were directly conjugated to a fluorescent molecule (fluorophore). (Fluorophores of different
colors must be carefully selected for labeling of different molecules of interest.) Labeled single
cells were then run through a flow cytometer. One cell at a time entered a small nozzle with a
laser beam passing perpendicularly through it. When a cell passed through the laser, it scattered
light, and when a fluorophore passed through the laser, it excited the fluorophore’s electrons.
Once the electrons decayed to a ground state they emitted excess energy as a photon of light. The
scattered light was collected by photomultiplier tubes and the data measuring the amount of light
scattered and fluorescent properties were collected by a computer and displayed on a graph.

55

Using computer software for FACS, the cells were gated (selected) in the graph by
demarcating the cells of interest and avoiding non-specific signals (that might be created simply
by adding antibodies.) The graph then allowed the examination of the presence of the cells of
interest by displaying the number of cells present, their size, and their internal complexity.
For the present study, the flow cytometer was adjusted to use a violet laser (excitation
wavelength 405) with one detector; a blue laser (excitation wavelength of 488 nm) with two
detectors; and a red laser (excitation wavelength 633 nm) with two detectors. The detector of the
violet laser included zombie violet (peak wavelength of 423 nm); the blue laser included FITC
(peak wavelength of 519 nm) and PE (peak wavelength of 612 nm). The detectors of the red
laser included APC (peak wavelength of 660 nm) and Alexa Fluor 700 (peak wavelength of 719
nm). The adjustment of these parameters allowed the detection of five different fluorophores.
2.4.1.2 Procedure. The methods used for this study closely followed published methods
(Derecki et al., 2012). At PND 28, each mouse was anesthetized and when the mouse was
completely unresponsive, forceps were used to pull up the chest skin of the mouse and the skin
was cut with sharp scissors exposing the chest. In order to eliminate blood contamination, mice
were perfused transcardially with pH 7.4 0.1M ice cold PBS. After this, the brain and the
hippocampus were dissected. The cells from the brain and hippocampus were then dissociated
into singlets and were labeled with the antibodies of interest.
Brain extraction and hippocampal dissection. Briefly, the skull was stripped of soft
tissues, the mandible and the skull were removed and the brain was immediately placed on a cold
surface for dissection. The cerebellum was then separated from the brain and the two
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hemispheres were separated using a scalpel. The left and right hippocampus were then visualized
with a magnifying lamp and dissected with spatulas.
Single cell suspensions. Brain and hippocampi cells were gently dissociated in 6 ml of
microglia media (1x PBS, 0.01 M HEPES, 3% FBS) by using the plunger of a 5 ml syringe and
70 micron screens. Cells from the brain and hippocampi were placed in separate 15 ml falcon
tubes containing 3 ml of isotonic percoll and 1 ml of microglia media. Cells were then gently
transferred using a Pasteur pipette into a 15 ml falcon tube containing 2 ml of 70% percoll and
centrifuged at 500 g for 30 min (acceleration 9 with no break at room temperature). At the
interface between isotonic percoll and 70% percoll the immune cells formed a visible a layer.
The supernatant was then aspirated until 3 ml of liquid was left in the falcon tube. Using a 1 ml
pipette cells were collected from the immune cell interphase layer and placed into FACS tubes.
After this, percoll was washed from cells with 2 ml of microglia media and counted by
hemocytometer.
Labeling of microglial cells with antibodies. Microglial cells were labeled with primary
antibodies conjugated to a fluorophore. The selection of the antibodies for identifying microglial
cells were determined following published methods (Cronk et al., 2015; Derecki et al., 2012;
Louveau et al., 2015). Cells were labeled with a cocktail of antibodies that labeled dead cells
and markers expressed by microglial cells (and macrophages only.) These antibodies were
zombie dye (for labeling of dead cells) (1 µl), anti-mouse CD11b conjugated with PE (0.5 µl);
anti-mouse CD45 conjugated with Alexa 700 (2.5 µl); anti-mouse MHC II conjugated with FITC
(0.5 µl); and anti-mouse CCR7 (4B12) conjugated with APC (0.5 µl). The antibody
concentrations were determined by titrating the antibodies on brain and hippocampus tissue.
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Three controls were used to ensure appropriate detection of the cells of interest and
markers of interest. The controls included an unstained sample of cells (used to determine
whether the labeled cells emit higher fluorescence than the auto-fluorescence emitted by
unstained cells) (see Appendix B), fluorescence minus one procedures (FMOs) to identify the
gates for CD45, MHC II and CCR7 (see Appendix B), and an fc blocker was used to avoid nonspecific binding of antibodies.
For establishing the unstained sample of cells, single cell preparations of the brain and
hippocampi were run in FACS without prior manipulation (cells were not labeled with
antibodies.) For establishing FMOs, single cell preparations from the brain were used. One
FMO included PE CD11b, APC CCR7 (AB12), and FITC MHC II, but excluded Alexa 700
CD45 (this was used to establish the gate for microglial cells and macrophages). Another FMO
included PE CD11b, Alexa 700 CD45, and FITC MHC II, but excluded APC CCR7 (4B12) (this
was used to establish the gate for microglial cells and macrophages expressing CCR7); another
FMO included PE CD11b, Alexa 700 CD45, APC CCR7 (4B12), but excluded FITC MHC II
(this was used to establish the gate for microglial cells and macrophages for MHC II.)
Cells were first counted by hemocytometer and were adjusted to ≤ 200,000 cells/100µl
per sample. Cells were then blocked for 15 min with fc blocker. After this, cells were labeled
with the appropriate cocktail of antibodies for 30 minutes (at 4ºC) and were protected from light.
Cells were then placed in FACS tubes and analyzed. All samples were run simultaneously in
the flow cytometer (Gallios, Beckman Coulter Lifesciences, Indianapolis, IN) in the core facility
of the Biosciences Research Building, UTEP.
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In order to identify the cells of interest, cells were first gated into singlets and then
immune cells of interest were detected and gated. After this, microglia and macrophages were
identified via CD11b and CD45 positive markers; and then MHC II and CCR7 markers were
gated (detailed explanation of gating procedures and figures is given below). Flow Jo Version
10.30 was used to gate the cells of interest.
Gating strategy for single cells. Immune cells can form doublets and/or cluster, and this
in turn can confound effects when examining cells in FACS. For this reason, doublets were
identified and eliminated from the analyses. The strategy used for the present study for selecting
single cells and eliminating doublets consisted of plotting the cells on the x-axis for forward
scatter area (displaying the size and the area of the cells) and the y-axis for forward scatter height
(displaying the size and the height of the cells). See Figure 2 below for a representative image of
the gating strategy.
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Figure 2. Representative image of gating strategy of single cells. Cells were plotted with
regard to their area (x-axis) and height (y-axis). Single cells were selected based on the shape of
the distribution. Cells that were closer together and formed an angle of approximately 45 degrees
were selected. The rest of the cells (outliers) were not included in further gating strategies and
analyses because they were most likely to represent doublets or clusters of cells.

Gating strategy for immune cells. Once single cells were selected, they were plotted on
the x-axis for forward scatter area (representing the size and area of the cells) and on the y-axis
for side scatter area (representing the internal complexity of the cells). See Figure 3 below for a
representative image of the gating strategy of immune cells.
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Figure 3. Representative image of gating strategy of immune cells. Cells were plotted for
forward scatter area (x-axis) which represents the size of the cells and for side scatter area (yaxis) which represents the internal complexity of the cells. Cells that were not gated included
dead cells (cells that were very small and/or had very high internal complexity) and granulocytes
(cells that had large internal complexity). (Dead cells were excluded using this gating strategy
instead of gating with zombie dye because zombie dye results suggested that the dye did not
readily detect dead cells.)
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Gating strategy for microglia and macrophages. Microglial cells can be distinguished
from other immune cells because they have a high expression of CD11b (PE fluorophore) and
low expression of CD45 (Alexa 700 fluorophore). On the other hand, macrophages have a high
expression of CD11b and high expression of CD45 (Derecki et al., 2016). For this reason,
macrophages and microglial cells can be identified by plotting CD11b and CD45 in the x and yaxis. For this study, CD11b expression was plotted on the x-axis and CD45 expression was
plotted on the y-axis. Microglia and macrophages were then selected as described above. See
Figure 4 below for a representative image of the gating strategy for microglia and macrophages.

Figure 4. Representative image of gating strategy for identifying microglia and
macrophages. Immune cells were plotted on the x-axis for PE CD11b and on the y-axis for
Alexa 700 CD45. The images shown are highly similar to others in the literature illustrating the
distributions of these cells (Wlodarczyk et al., 2015). Gated cells that were high in CD11b and
lower in CD45 were selected as microglia. Gated cells that were high in CD11b and higher in
CD45 were selected as macropahges.
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Gating strategy for MHC II and CCR7 “single positives” and MHCII/CCR7 “double
positives” in microglia and macrophages. Once microglia and macrophages were gated, each
type of cell was plotted on the x-axis for CCR7 expression (APC fluorophore) and on the y-axis
for MHC II expression (FITC fluorophore). See Figure 5 below for a representative image of the
gating strategy for microglia MHC II and CCR7 and Figure 6 for a representative image of the
gating strategy of MHC II and CCR7 on macrophages.

Figure 5. Representative image of gating strategy for identifying MHC II “single positve”,
CCR7 “single positive”, and “double positive” cells (MHCII/CCR7) in microglia. Microglial
cells were plotted on the x-axis for APC CCR7 expression and on the y-axis for FITC MHC II
expression. The CCR7 “single positive” quadrant represents cells that express CCR7 but not
MHC II. The MHC II “single positive” quadrant represents cells that express MHC II but not
CCR7. The MHCII/CCR7 “double positive” quadrant represents microglial cells that
simultaneously express MHCII and CCR7.
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Figure 6. Representative image of gating strategy for identifying MHC II “single positve”,
CCR7 “single positive”, and “double positive” cells (MHCII/CCR7) in macrophages.
Macrophages were plotted on the x-axis for APC CCR7 expression, and on the y-axis for FITC
MHC II expression. The CCR7 “single positive” quadrant represents macrophages that express
CCR7 but not MHC II. The MHC II “single positive” quadrant represents macrophages that
express MHC II but not CCR7. The MHCII/CCR7 “double positive” quadrant represents
macrophages that simultaneously express MHCII and CCR7.
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2.4.2 Outcome variables measured. It was hypothesized that low-level lead exposure
would cause the up-regulation of MHC II and CCR7 in hippocampal microglia of pre-adolescent
mice. The outcome variables measured for the primary hypotheses and also exploratory analyses
examining possible effects of chronic low-level lead exposure on macrophages and immune cells
(lymphocytes and monocytes) are described below.
2.4.2.1 Microglia in hippocampus and brain. Thirteen outcome variables were
measured for microglia in hippocampus and brain. These variables included microglia
percentage of parent population (number of microglial cells gated relative to total number of
immune cells gated), microglia number, microglia MHC II and CCR7 mean fluorescence
intensity (MFI, measured as geometric mean); “single positive” MHC II percentage of parent
population, number, and MFI; “single positive” CCR7 percentage of parent population, number,
and MFI; and “double positive” (MHC II/CCR7) percentage, number, and MFI (see Figure 5).
2.4.2.2 Macrophages in hippocampus and brain. Thirteen outcome variables were
measured for macrophages in hippocampus and brain. These variables included macrophage
percentage of parent population (number of macrophages gated relative to total number of
immune cells gated), macrophage number, macrophage MHC II and CCR7 MFI; “single
positive” MHC II percentage of parent population, number, and MFI; “single positive” CCR7,
percentage of parent population, number (count), and MFI; and “double positive”
(MHCII/CCR7) percentage, number, and MFI (see Figure 6).
2.4.2.3 Immune cells in hippocampus and brain. Two outcome variables were
measured for immune cells in hippocampus and brain. These variables included immune cell
percentage of parent population (number of immune cells gated relative to total number of cells
in the sample) and immune cell number (see Figure 3).
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2.4.3 Statistical analyses of FACs data. After gating the cells of interest, the percentage,
count, MFI, and coefficient of variation for each of the outcome variables described above were
obtained with Flow Jo Version 10.30. Data were entered, checked for accuracy, and examined
for missing values, distribution properties, and outliers and analyzed with SPSS Version 23.0.
Tests of homogeneity of variance and normality distribution were conducted (see Appendix A)
and guided the selection of the statistical analyses for each outcome variable.
As is common for FACS data, tests of homogeneity of variance and distribution
properties revealed that data was highly variable and non-normally distributed. For this reason,
non-parametric tests were used to examine possible statistical significant differences between
groups. For examining possible differences in percentage of parent populations, chi-square tests
were run. When significant effects were detected in chi-square tests, independent samples
median tests were run to determine which comparisons accounted significant model effects. For
examining outcome variables other than percentages, independent samples median tests were run
to examine possible significant differences between groups.
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CHAPTER 3
RESULTS

3.1

Behavioral Studies Results
Results of first set of behavioral studies examining effects of early chronic low-level lead

exposure in pre-adolescent mice, and providing the foundation for the current work, were
described in the introduction and served as the basis for the additional behavioral studies here
described. To summarize, in previous published studies, early chronic low-level lead exposure
was associated with decreased exploratory activity measured on the unbaited nosepoke task
(Flores-Montoya & Sobin, 2014) and decreased novel odor recognition in a two-choice paradigm
(Flores-Montoya et al., 2015). In addition, an object in place task revealed significant
differences in rearing during memory retrieval suggesting memory retrieval disruption in young
mice (Sobin et al., 2017) (see Appendix C).
The purpose of the second set of behavioral studies here described was to explore
whether any other paradigms, or modifications of our previous paradigms, would increase
sensitivity to effects at preadolescence of early chronic low-level lead exposure. For these
studies, we tested whether developmental milestones (body weight, eye-opening, and righting
reflex), muscle strength measured with the inverted screen test, open field behavior in a large
circular (rather than smaller square) arena, and/or odor habituation/dishabituation at preadolescence (PND 28) in C57BL6/J mice would improve detection of outcomes following early
chronic low-level lead exposure. It was hypothesized that lead exposure would delay the
development of the nervous system, reduce olfactory memory, and disrupt basic motor functions
in young male C57BL/6J mice.
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3.1.1

Descriptive statistics for blood lead levels (BLLs) and behavioral outcomes.

Below is a summary of descriptive statistics for BLLs and behavioral outcomes in young
C57BL/6J mice with and without early lead exposure. (Statistical tests of observed differences
are given in the following section.) Data were examined for homogeneity of variance and
distribution properties. The selection of tests for evaluating statistical significance in observed
differences was based on the variability and distribution properties of the outcomes measured.
(See Appendix A, Tables 25-29 for detailed results from tests of homogeneity of variance and
distribution properties.)
3.1.1.1 BLLs. As shown in Table 3 below, the low-dose and high-dose groups had
higher mean BLLs as compared to controls. Similarly, the high-dose group had higher mean
BLLs as compared to the low-dose group.
Table 3. BLLs means and standard deviations (SDs) in young C57BL/6J mice with and
without early lead exposure.
Lead exposure group

Blood lead levels (µg/dL)
0 ppm
30 ppm
430 pm

0.556 ± 0.4980
4.24 ± 0.61
21.30 ± 7.03

3.1.1.2 Developmental milestones.
Eye-opening. As shown in Table 4, 27% of animals in the low-dose and control groups
opened their eyes at PND 15 and 73% of animals in each of these groups opened their eyes at
PND 16. Among high-dose animals, 100% opened their eyes at PND 16. (Chi-square test was
not statistically significant, χ2 (df = 2) = 3.67, p > 0.05).
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Table 4. Eye-opening in C57BL/6J mice with and without early lead exposure.
Eye-opening day

0 ppm
n = 11

30 ppm
n = 11

430 ppm
n = 11

PND 15

27%

27%

0%

PND 16

73%

73%

100%

Body weight. As shown in Table 5 below, for PND 7 and 14, groups had very similar
mean body weights. For PND 21 and 28 however the low-dose group appeared to have higher
mean body weight as compared to the control and high-dose groups. At PND 28, the high-dose
group appeared to have decreased mean body weight as compared to the control group.
Table 5. Body weight means and SDs of young C57BL/6J mice with and without early lead
exposure.
0 ppm
n = 11

30 ppm
n = 11

430 ppm
n = 11

Body Weight
PND 7
PND 14
PND 21
PND 28

3.44 ± 0.90
7.78 ± 0.64
9.03 ± 0.63
14.75 ± 1.81

3.97 ± 0.29
7.56 ± 0.74
10.23 ± 0.49
16.37 ± 0.69

3.79 ± 0.43
7.39 ± 1.42
9.32 ± 1.59
13.68 ± 1.64

Righting reflex. As shown in Table 6, at PND 7, 14, and 21 lead-exposed mice
appeared to be faster in displaying the righting reflex as compared to controls. This apparent
difference was especially pronounced at PND 7, and less apparent as the animals aged.
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Table 6. Means and SDs for righting reflex in young C57BL/6J mice with and without early
lead exposure.
0 ppm
n = 11
Righting reflex test
PND 7
PND 14
PND 21

30 ppm
n = 11

9.28 ± 12.14
0.79 ± 0.30
0.26 ± 0.05

2.77 ± 2.48
0.64 ± 0.16
0.19 ± 0.04

430 ppm
n = 11
3.74 ± 3.30
0.43 ± 0.18
0.22 ± 0.07

3.1.1.3 Inverted screen test. As shown in Table 7 below, at PND 28 mice in the lowdose group appeared to have the shortest latency to fall (fell most quickly) from the inverted
screen as compared to controls and high-dose mice. Additionally, high-dose animals appeared to
have a shorter latency to fall from the inverted screen as compared to controls.

Table 7. Means and SDs for latency to fall from inverted screen test in young C57BL/6J
mice with and without early lead exposure.
0 ppm
n = 11
Latency to fall

30 ppm
n = 11

69.54 ± 59.03

22.04 ± 18.84

430 ppm
n = 11
41.16 ± 44.85

3.1.1.4 Open field
Rearing in periphery. As shown in Table 8, low-dose animals displayed approximately
32% fewer rears as compared to controls; and 23% fewer rears as compared to high-dose
animals, in the periphery of the arena. Similarly, high-dose animals displayed approximately
12% fewer rears as compared to controls.
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Rearing in center. As shown in Table 8, low-dose mice reared approximately 58% less
as compared to controls, and 63% more as compared to high-dose animals in the center of the
arena. Also, high-dose mice reared approximately 75% less as compared to controls.
Total distance travelled. As shown in Table 8 below, low-dose animals traveled
approximately 1% more in the open field arena as compared to controls and approximately 4%
less as compared to high-dose animals. High-dose animals traveled approximately 11% more in
the periphery as compared to controls.
Distance in periphery. As shown in Table 8 below, low-dose animals traveled
approximately 4% more as compared to controls whereas low-dose mice travelled approximately
7% less as compared to high-dose animals.
Time in periphery. As shown in Table 8 below, low-dose animals spent approximately
5% more time in the periphery as compared to controls and 3% less time as compared to highdose animals. High-dose animals spent approximately 8% more time in the periphery as
compared to controls.
Table 8. Means and SDs for open field behaviors in young C57BL6/J mice with and
without early lead exposure.
0 ppm
n = 11

30 ppm
n = 12

430 ppm
n = 13

Rear number
Periphery
Center
Distance Traveled
Total
Periphery
Time in Periphery

34.18 ± 1.76
1.82 ± 0.41

23.08 ± 1.38
0.75 ± 0.25

29.92 ± 1.52
0.46 ± 0.188

4092.13 ± 157.69
3034.5 ± 118.7

4132.29 ± 150.98
3188.09 ± 113.68

4309.85 ± 145.06
3401.73 ± 109.22

0.7716 ± 0.018

0.8118 ± 0.018

0.8343 ± 0.017

71

3.1.1.5 Odor habituation/dishabituation task.
Habituation. The habituation trials of this task tested how quickly animals habituated to
an odor presented to them in three sequential trials. Decreased exploration time of a familiar odor
indicated habituation.
Non-social odors. As shown in Table 9, all mice decreased exploration of the cotton
swab from trial 1 to trial 3 for water and almond. Specifically, for water, exploration time
decreased by about 82% for control mice, 77% for high-dose mice, and 63% for low-dose mice.
For the almond scent, exploration time decreased approximately 70% for low-dose mice, 63%
for control mice, and 36% for high-dose mice. For the orange scent, only high-dose animals
decreased their exploration time (approximately 30%) whereas low-dose and control animals
increased their exploration time by about 1%.
Social odors. As shown in Table 9, all mice decreased exploration of the non-social odors
from trial 1 to trial 3, with the exception of the control animals which had increased exploration
of social scent 2. For social scent 1, exploration time decreased approximately 77% for low-dose
mice, 75% for high-dose mice, and 61% for control mice. For social scent 2, exploration
decreased by about 45% for high-dose mice and 25% for low-dose mice, while exploration
increased by approximately 57% for control mice.
Dishabituation. These dishabituation trials tested whether mice differentiated between a
habituated odor (Trial 3 of a habituated/familiar odor) and a new (Trial 1 of the changed scent).
Increased exploration time of the new odor meant recognition of novelty and thus odor
dishabituation.
As shown in Table 9, control animals appeared to increase their exploration by
approximately 75% from water Trial 3 to almond Trial 1 and high-dose animals increased their
exploration by about 25%. On the other hand, exploration time decreased by approximately 56%
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in low-dose animals. From almond Trial 3 to orange Trial 1 control and low-dose animals had a
small increase in exploration whereas high-dose animals had a decrease in exploration. For
orange Trial 3 to social scent 1 Trial 1, exploration time increased approximately 10-fold in highdose animals, 2-fold in control animals whereas low-dose animals only increased exploration by
about 44%. With regard to exploration from social scent 1 Trial 3 to social scent 2 Trial 1, an
increase of approximately 5-fold was observed for low-dose animals and approximately 5% for
high-dose animals. On the other hand, control animals had a decrease in exploration of about
17%.

Table 9. Means and SDs for odor exploration time in habituation/dishabituation task in
young C57BL/6J mice with and without early lead exposure.
Group

0 ppm
n = 11

30 ppm
n = 11

430 ppm
n = 11

Water

Trial 1
Trial 2
Trial 3

15.42 ± 10.93
6.64 ± 4.28
2.80 ± 3.09

19.69 ± 26.61
7.79 ± 5.87
7.31 ± 8.42

16.66±22.58
8.44±9.49
3.77±4.56

Almond

Trial 1
Trial 2
Trial 3

4.92 ± 5.16
1.35 ± 2.16
1.83 ± 3.03

3.22 ± 1.88
2.95 ± 2.29
0.95 ± 1.45

4.71±6.36
1.94±2.14
3.03±3.34

Orange

Trial 1
Trial 2
Trial 3

2.29±4.09
0.61±1.31
2.32±3.54

2.03±2.55
0.46±0.63
2.23±6.65

1.24±1.98
0.90±1.51
0.88±2.45

Social Scent 1

Trial 1
Trial 2
Trial 3

7.87±12.73
3.97±9.18
3.05±6.23

3.21±10.33
4.56±12.08
0.71±2.12

10.93±16.61
3.80±5.92
2.77±4.73

Social Scent 2

Trial 1
Trial 2
Trial 3

2.52±8.37
2.63±5.69
3.97±11.19

5.56±8.52
3.20±6.44
3.17±5.55

2.91±4.39
2.83±4.99
2.17±4.7
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3.1.2

Tests of homogeneity of variance and distribution properties and selection of

inferential statistics. The descriptive statistics above illustrate high variability and non-normal
distributions for many of the behavioral outcome variables. Tests examining the assumptions of
homogeneity of variance and distribution properties were conducted in order to determine the
appropriate statistical tests (parametric vs. non-parametric) to use for testing observed
differences. Specifically, for tests examining possible between group differences measured at
one time point (i.e., PND 28) including the screen strength test and open field behavior, Levene’s
test statistic was used to examine the assumption of homogeneity of variances and Kolmogorov
Smirnov (KS) test statistic was used to examine the assumption of normality of distribution.
Additionally, for tests examining possible effects of lead exposure measured at multiple
developmental time points (i.e., body weight, righting reflex, and odor habituation/dishabituation
task) Mauchly’s test of sphericity was used to examine the assumption of homogeneity of
variance. This tested whether the variances across time points (within subjects) were equal; and
KS tests were calculated to examine the assumption of normality for these outcomes (see
Appendix Tables 25-29.) In some instances, when the assumption of homogeneity of variance
was met but assumptions of normality were not met, general linear model was selected because it
tends to be robust for violations of assumptions of normality.
3.1.2.1

Developmental milestones

Body weight. Mauchly’s test of sphericity did not suggest unequal variances. Similarly,
KS test statistic did not reveal significant deviations from normality, with the exception of PND
14 (low-dose group, see Appendix A, Table 27). General linear model analyses examining main
effects of group and PND on body weight and the interaction (group x PND) were used to
examine possible effects of treatment group and PND on body weight.
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Righting reflex. Mauchly’s test of sphericity revealed unequal variances. For this reason,
the Greenhouse-Geisser correction was used for tests examining possible significant effects of
treatment group and PND on righting reflex. Also, the KS test statistic did not reveal deviations
from normality at PND 14, however it revealed deviations from normality at PND 7 and PND 21
(see Appendix A, Table 27). General linear model analyses examining main effects of group and
day of testing and the interaction (group x PND) were run to examine possible effects of lead
exposure on righting reflex.
3.1.2.2

Inverted screen. Levene’s test indicated unequal variances, F (df = 2) = 4.77,

p < 0.05. Additionally, KS test revealed that data in the low-dose group did not follow a normal
distribution, F (df =11) = 0.325, p < 0.01. For this reason, a non-parametric test, the independent
samples median test, was used to examine possible differences between treatment groups with
regard to muscular strength.
3.1.2.3 Open field. The KS test did not reveal significant differences between groups
with regard to normality of the distribution for continuous data variables (distance travelled and
time). As expected, for count data variables (number of rears in the center of the open field), KS
revealed that data were not normally distributed (see Appendix, Table 27). For this reason, a
generalized linear model with Poisson distribution was used to examine possible differences
between groups for count data (rears); a Gaussian distribution was used to examine possible
differences between groups for continuous data (distance travelled and time.)
3.1.2.4 Odor habituation/dishabituation task. Mauchly’s tests of sphericity revealed
that sphericity was violated for all trials with the exception of social scent 2. For this reason, the
Greenhouse-Geisser correction was used in tests of possible significant effects. The KS tests
revealed that some variables were normally distributed and others were not. Specifically,
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deviations from normality were obvious for the social odor task (see Appendix A, Tables 28 and
29). Possible significant differences between groups and within groups in odor exploration
during habituation and dishabituation trials were examined with general linear model analyses
with group and trial as main effects and the interaction (group x trial).
3.1.3

Results of inferential tests of behavioral outcomes.

3.1.3.1 Blood lead levels: demonstration of the exposure model. One-way ANOVA
detected statistically significant differences between groups in BLLs at time of sacrifice (PND
28), F (df = 2, 36) = 82.99, p < 0.01. Post-hoc analyses with LSD revealed that the low-dose
group had significantly higher BLLs as compared to the control group, (M diff = 3.68, SEM =
1.78, p < 0.05), and significantly lower BLLs as compared to the high-dose group, (M diff =
17.06, SEM = 1.71, p < 0.01). Similarly, the high-dose group had significantly higher BLLs as
compared to the control group (M diff = 20.75, SEM = 1.74, p < 0.01) (see Figure 7).

Figure 7. Blood lead levels measured in µg/dL in C57BL/6J young mice with and without
early chronic lead exposure.
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3.1.3.2 Developmental milestones.
Body weight. General linear model analyses revealed a significant main effect of group
on body weight, F (df = 2, 30) = 9.48, p < 0.01, a significant main effect of PND on body
weight, F (df = 2, 60) = 347.32, p < 0.01, and the interaction (group x PND), F (df = 4, 60) =
4.05, p < 0.01. For main effect of PND on body weight, it was found that mice weighed more as
they aged, from PND 14 to PND 21 (M diff = 0.87, SEM = 0.29), p < 0.06, and weighed more
from PND 21 to PND 28 (M diff = 0.824, SEM = 0.25), p < 0.03. For the main effect of group
on body weight, mice in the low-dose group weighed significantly more as compared to controls
(M diff = 0.86, SEM = 0.29), p < 0.01, and as compared to high-dose mice (M diff = 1.25, SEM =
0.29), p < 0.01. No significant difference was detected between the high-dose and control
groups. With regard to the interaction, it was found that mice in the low-dose group gained
significantly more weight than mice in the control group and high-dose group from PND 21 to
PND 28, F (df = 2, 60) = 5.37, p < 0.01. (See Figure 8, below and Appendix A Table 1).

Figure 8. Body weights at PNDs 14, 21, and 28 measured in young mice with and without
early lead exposure.
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Righting reflex. General linear model analyses detected a significant main effect of PND
on righting reflex, F (df = 2, 60) = 14.31, p < 0.01. Specifically, it was found that all mice gained
speed in accomplishing the righting reflex from PND 7 (M = 5.27, SEM = 1.28) to PND 14 (M =
0.622, SEM = 0.039), and from PND 14 to PND 21 (M = 0.22, SEM = 0.01). No significant
main effects however were detected for group, or for the interaction (treatment x PND) (see
Figure 9 below and Appendix A Table 2).

Figure 9. Righting reflex measured at PNDs 14, 21, and 28 in young mice with and without
early lead exposure.
3.1.3.3 Inverted screen test. Independent sample median test did not detect significant
differences between groups.
3.1.3.4 Open field test.
Rearing in periphery. Generalized linear model analyses revealed significant differences
between groups with regard to rearing number in the periphery of the open field, X² (df = 2) =
25.58, p < 0.01 (controls M = 34.18, SEM =1.76; low-dose M = 23.08, SEM = 1.38; high-dose
M = 29.92, SEM = 1.51). Post-hoc analyses revealed that the low-dose group displayed
significantly less rearing in the periphery as compared to the control group (M diff = 11.10, SEM
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= 2.24), p < 0.01, and as compared to the high-dose group (M diff = 6.84, SEM = 2.05) p < 0.01
(see Figure 10 below and Appendix A Table 3). No significant difference was detected between
the high-dose and control group.

Figure 10. Rearing number in the periphery of open field arena in young C57BL/6J mice
with and without early chronic lead exposure.
Rearing in center. Generalized linear model analyses controlling for litter revealed
significant differences between groups with regard to rearing number in center of the open field,
X² (df = 2) = 11.43, p < 0.01 (controls M = 1.82, SEM = 0.41; low-dose M = 0.75, SEM = 0.25;
high-dose M = 0.46, SEM = 0.18). Post-hoc analyses revealed that the low-dose group displayed
significantly less rearing in the center of the arena as compared to the control group (M diff =
1.07, SEM = 0.477), p < 0.05. Similarly, the high-dose group displayed significantly less rearing
in the center of the arena as compared to the control group (M diff = 0.29, SEM = 3.13), p < 0.01.
(see Figure 11 below and Appendix A Table 3.) No significant difference was detected between
the low-dose and the high-dose group.
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Figure 11. Rearing number in the center of open field arena in young C57BL/6J mice with
and without early chronic lead exposure.
Distance travelled in periphery. Generalized linear model analyses of group differences
were not significant with regard to total distance travelled in the periphery of the open field.
Total Distance travelled. Generalized linear model analyses of group differences were
not significant with regard to total distance travelled in the center of the open field.
Time in periphery. Generalized linear model analyses of group differences were not
significant with regard to time spent in the periphery of the open field.
3.1.3.5 Odor habituation/dishabituation test.
Habituation to water. General linear model analyses detected a significant main effect
for trial, F (df = 2, 60) = 13.03, p < 0.01 (trial 1 M = 17.26, SEM = 3.67; trial 2 M = 7.62, SEM =
1.20; trial 3 M = 4.62, SEM = 1.01). Post-hoc analyses using least significant difference (LSD)
pairwise comparisons revealed that all mice independent of treatment group spent significantly
less time exploring the cotton swab with water from Trial 1 to Trial 2, (M diff = 9.63, SEM =
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4.14 , p < 0.01), and from Trial 1 to Trial 3 (M diff = 12.63, SEM = 3.03), p < 0.01. Similarly,
mice spent significantly less time exploring the cotton swab from trial 2 to trial 3 (M diff = 2.99,
SEM = 3.03), p < 0.01 (see Figure 12 below and Appendix A Table 4). Thus all mice habituated
to the cotton swab with water from Trial 1 to Trial 3. No significant main effects for group or the
interaction (Trial x Group) were detected.

Figure 12. Time exploring a cotton swab with water during the habituation phase of the
odor habituation/dishabituation task in young C57BL/6J mice with and without early
chronic lead exposure.
Habituation to almond. General linear model analyses detected a significant main effect
for Trial, F (df = 2, 60) = 6.83, p < 0.05 (Trial 1 M = 4.28, SEM = 0.84; Trial 2 M = 2.08, SEM
= 0.38; Trial 3 M = 1.94, SEM = 0.47). Post-hoc analyses with LSD revealed that all mice
independent of treatment group spent significantly less time exploring the cotton swab with
almond from Trial 1 to Trial 2, (M diff = 2.19, SEM = 0.83), p < 0.05, and from Trial 1 to Trial
3 (M diff = 2.34, SEM = 0.73), p < 0.05 (see Figure 13 below and Appendix A Table 4). On the
other hand, no significant difference was detected with regard to time exploring the cotton swab
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from Trial 2 and Trial 3. No significant main effects were detected for group or the interaction
(Trial x Group). Thus all mice habituated to the cotton swab with almond from Trial 1 to Trial 2.

Figure 13. Time exploring a cotton swab with almond during the habituation phase of the
odor habituation/dishabituation task in young C57BL/6J mice with and without early
chronic lead exposure.
Habituation to orange. General linear model analyses did not detect significant
differences between groups with regard to the time spent exploring the cotton swab with orange.
Habituation to social scent 1. No significant main effects of trial or the interaction (Trial
x Group) were detected with regard to the time spent exploring the cotton swab with social scent
1 (scent from a non-familiar mouse cage).
Habituation to social scent 2. No significant main effects of trial or the interaction (Trial
x Group) were detected with regard to the time spent exploring the cotton swab with social scent
2 (scent from a different non-familiar mouse cage).
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Dishabituation, water Trial 3/almond Trial 1. No significant main effects of trial or the
interaction (Trial x Group) were detected with regard to the time spent exploring the cotton
swabs.
Dishabituation, almond Trial 3/orange Trial 1. No significant main effects of trial or the
interaction (Trial x Group) were detected between groups with regard to the time spent exploring
the cotton swabs.
Dishabituation, orange Trial 3/social scent 1 Trial 1. General linear model analyses
revealed a significant main effect with regard to the time spent exploring the odors from orange
Trial 3 to social scent 1 Trial 1, F (df = 1, 30) = 7.37, p < 0.05 (orange Trial 3 M = 1.81, SEM =
0.80; social scent 1 Trial 1 M = 7.34, SEM = 2.35). Post-hoc analyses with LSD revealed that
all mice, regardless of treatment group, had increased time exploring the odor from orange Trial
3 to social scent 1 Trial 1 (M diff = 5.53, SEM = 2.04), p < 0.05. No significant main effects
however were detected for group or the interaction (Trial x Group). The result indicated that all
mice recognized social scent 1 as a novel stimulus.
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Figure 14. Time exploring a cotton swab with orange during Trial 3 and with social scent 1
Trial 1 during the dishabituation phase of the task in young C57BL/6J mice with and
without early chronic lead exposure.
Dishabituation, social scent 1 Trial 3/social scent 2 Trial 1. No significant main effects
of Trial or the interaction (Trial x Group) were detected with regard to the time spent exploring
the cotton swab with social scent 2 (that had a scent from a non-familiar mouse cage).
3.2

Summary of Behavioral Studies Results
Overall, effects of early lead exposure were observed for body weight at PND 28 and

rearing in the periphery and center of the open field arena measured at PND 28. With regard to
odor memory, animals in all groups habituated and dishabituated to some or most of the odors
presented however inconsistent results for habituation and dishabituation across odors among
controls suggested that the task may have been too long and/or too challenging for preadolescent mice. (See Appendix A Tables 4-6.) This will be considered in Discussion below.
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3.2.1 Developmental milestones.
3.2.1.1

Eye-opening. Daily observations revealed that 27% of mice in the control and

low-dose groups opened fully their eyes at PND 15, whereas 73% of the mice opened their eyes
at PND 16. On the other hand, 100% of the high-dose mice opened their eyes at PND 16. The
differences were not statistically significant but observed delays in the high-dose group might
suggest that other tests of neurological development should be tried.
3.2.1.2

Body weight. A significant main effect of group and PND on body weight and

the interaction (group x PND) were found. Specifically, low-dose mice had increased body
weight as compared to controls and high-dose groups, and significant weight gain in low dosemice occurred from PND 21 to PND 28. No significant difference however between the highdose group and control group was detected.
3.2.1.3 Righting reflex. A significant main effect of PND was found. That is, all mice
were faster at displaying a righting reflex from PND 7 to PND 21. No significant main effect of
group nor the interaction (group x PND) were detected.
3.2.2 Inverted screen test. Independent sample median test did not reveal significant
differences between groups with regard to mouse motor persistence (strength) despite the large
observed difference in faster fall time for low-dose animals.
3.2.3

Open field test.

3.2.3.1 Rearing in periphery. Mice in the low-dose group reared significantly less in
the periphery of the open field arena as compared to the control and high-dose group. No
significant difference was detected between the high-dose group and the control group.
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3.2.3.2 Rearing in center. Mice in the low-dose and high-dose groups had significantly
less rearing in the center of the arena as compared to controls. No significant difference however
was detected between the high-dose group and control group. The actual difference observed
however was quite small and its “clinical” significance is questionable.
3.2.3.3 Total Distance travelled. No significant differences between groups were found
with regard to the total distance travelled in the open field.
3.2.3.4 Distance travelled in periphery. No significant differences between groups were
found with regard to the distance travelled in the periphery of the open field.
3.2.3.5 Time in periphery. No significant differences between groups were found with
regard to the time spent in the periphery of the open field.
3.2.4

Odor habituation/dishabituation test.

3.2.4.1 Habituation. A significant main effect for trial during habituation to the cotton
swab with water and the cotton swab with almond was found. No significant main effect
however was detected for group or the interaction. Similarly, no significant main effects or the
interaction (Trial x Group) were detected for the habituation phase with orange, social scent 1 or
social scent 2.
3.2.4.2 Dishabituation. A significant main effect for trial during the dishabituation
phase of the task for time spent exploring orange Trial 3 to time exploring social scent 1 Trial 1
was detected. No significant main effect however was detected for group or the interaction. This
suggested that animals detected that that there was a novel odor however the test was not
sensitive to the effects of lead exposure. No significant main effects or the interaction were
detected for dis-habituation from almond Trial 3 to orange Trial 1, or for social scent 1 Trial 3 to
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social scent 2 Trial 1. Overall, the findings for the odor task suggested that the task was likely
too long, or too challenging for PND 28 mice. This will be considered in detail in Discussion
below.
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Table 10. Summary of significant effects in BLLS and behavior in young C57BL6/J mice
with and without chronic lead exposure.

Table 11. Summary of significant main effects and the interaction for habituation
dishabituation task (group x trial) in young C57BL6/J mice with and without chronic lead
exposure.
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3.3

Neuroimmune System Studies Results
Effects of early lead exposure were predicted for MHC II and CCR7 in hippocampal

microglia. It was hypothesized that chronic low-level lead exposure would cause the
upregulation of MHC II and CCR7 in hippocampal microglia of young C57BL/6J male mice.
With regard to microglia in brain (all other regions except hippocampus and excluding
cerebellum) effects on microglia were measured but no a priori hypotheses were proposed. The
results for hippocampal and brain microglia are shown below. In addition, exploratory analyses
of macrophages in hippocampus and brain were conducted, and exploratory analyses of immune
cells (lymphocytes and monocytes) in brain and hippocampus were conducted to better
understand effects of early lead exposure on microglial cells and the early neuroimmune system.
3.3.1 Descriptive statistics for flow cytometry data. To ensure sufficient numbers of
hippocampal cells, brain tissue from 3 subjects were combined, creating 4 samples per group,
N=12, generated from 36 animals. (See Appendix A Tables 7-11 for descriptive statistics of flow
cytometry data.) All analyses were calculated with N=12. It is also important to note that flow
cytometry data including forward and side scatter, and mean fluorescence intensity (MFI) are
dependent on the numbers of cells counted, and these vary according to the amount of sample
run. Thus flow cytometry does not yield meaningful estimates of absolute cell density.
Moreover, several outcome variables violated the assumptions of homogeneity of variance
and/or distribution normality (see Appendix A Tables 30-47). For this reason, non-parametric
tests were selected to examine possible differences between groups.
Chi-square analyses are commonly used in flow cytometry studies. Because of the large
numbers of parent population cells counted however, chi-square analyses are extremely liberal
and commonly all analyses are “statistically significant.” For this reason, additional median
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comparison analyses were used for count and percentage data, and median comparisons were
also used for analyses of geometric mean fluorescence intensity (MFI, measured on a log scale).
Group differences for count data were not interpreted unless both chi-square and median
comparison analyses were statistically significant. The drawback of this approach however was
that because subjects had to be combined into groups of 3, median comparison tests and
associated post-hoc comparisons were extremely conservative. Nonetheless, all main analyses
were calculated using N=12.
As will be described below, the most robust findings (using N=12) were not with regard
to microglia, but with regard to macrophages. For exploratory purposes, and for only
hippocampal macrophage results, simulated data distributions were generated randomly (SPSS)
using minimum and maximum values from each sample by variable by group, to create an
additional 8 subject data lines per group, producing a simulated dataset including 12 animals per
group within the minimum and maximum variable values produced by 12 animals group.
Median comparisons with post-hoc tests were then calculated again using this simulated sample.
The simulation results are interpreted and discussed separately below and clearly indicated in
relevant tables.
3.3.2 Inferential statistics for flow cytometry data. (see Appendix A Tables 12-24 for
inferential statistics).
3.3.2.1 Hippocampal microglia.
Microglia percentage of parent population. Chi-square test revealed a significant
difference between groups with regard to the percentage of microglial cells in hippocampus, X²
(df = 2, N = 1421.166) = 1437.33, p < 0.01, (controls = 58.1%; low-dose = 45.0%; high-dose =
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70.9%) and suggested fewer microglia in the low-dose exposure group. Independent samples
median test did not detect significant differences between groups.
Microglia cell number. Independent samples median test revealed significant differences
between groups with regard to the number of microglial cells in hippocampus, MEDCOMP teststatistic (df = 2) = 8.00, p < 0.05. Post-hoc analyses examining differences between groups
indicated that the high-dose group (Mdn = 12883) had an increased number of microglial cells in
hippocampus as compared to the low-dose group (Mdn = 1846), MEDCOMP test statistic = 8.00,
p < 0.014. Post-hoc tests showed no significant difference between the high-dose group and
control group (Mdn = 4656), or between the low-dose group and control group.
Overall analyses of MHC II and CCR7 in hippocampal microglia.
Microglia MHC II mean fluorescence intensity. Independent samples median test did
not detect significant differences between groups with regard to MFI of MHC II in microglial
cells.
Microglia CCR7 mean fluorescence intensity. Independent samples median test showed
significant differences between groups with regard to MFI of CCR7 in hippocampal microglia,
MEDCOMP test-statistic (df = 2) = 6.00, p < 0.05. Contrary to what was hypothesized, post-hoc
analyses indicated that the low-dose group (Mdn = 4656) had decreased MFI of CCR7 in
microglial cells as compared to the control group (Mdn = 5604), MEDCOMP test-statistic =
8.00, p < 0.05. No significant difference was detected between the high-dose and control group,
or between the high-dose and low-dose group (see Figure 15).
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Figure 15. Representative histograms of effects of low-level lead exposure on hippocampal
microglia on mean fluorescence intensity of CCR7 (overall analyses). Histogram shifts
towards the right show higher mean fluorescence intensity and thus increased CCR7. Low-level
lead exposed animals had decreased number of CCR7 (measured as mean fluorescence intensity)
on their hippocampal microglial membrane surface as compared to controls. As can be noted
however low-dose groups had an outlier expressing high levels of CCR7.

Quadrant-specific analyses of “single positive” hippocampal microglia.
Microglia MHC II percentage of parent population, single positive. Chi-square tests
revealed significant differences between groups with regard to percentage of MHC II in
hippocampal microglial cells, X² (df = 2, N = 36052) = 6.494, p < 0.05 (controls = 0.4%; lowdose = 0.2%; high-dose = 0.5%). Independent samples median test however did not show
statistically significant differences between groups.
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Microglia MHC II cell number, single positive. Independent samples median test
indicated significant differences between groups, MEDCOMP test-statistic (2) = 8.00, p < 0.05.
Post-hoc analyses indicated that the high-dose group (Mdn = 83) had increased number of MHC
II positive microglial cells in hippocampus as compared to the low-dose group (Mdn = 15),
MEDCOMP test-statistic = 8.00, p < 0.05. No statistically significant difference was detected
however between the high-dose and control group, or between the low-dose and control group.
Microglia CCR7 percentage of parent population, single positive. Chi-square tests
showed a significant difference between groups with regard to percentage of CCR7 positive
hippocampal microglial cells, X² (df = 2, N = 36154) = 46.801, p < 0.01 (controls = 0.2%; low
dose = 0.2%; high dose = 0.6%). Independent samples median test however did not show a
statistically significant difference between groups.
Microglia CCR7 cell number, single positive. Independent samples median test showed
significant differences between groups, MEDCOMP test-statistic (df = 2) = 6.00, p < 0.05
(controls Mdn = 25 ; low-dose Mdn = 9; high-dose Mdn = 45). Post-hoc analyses however did
not reveal statistically significant differences between groups. The decreased cell number in the
low-dose group was noted however.
Microglia CCR7 mean fluorescence intensity, single positive. Independent samples
median tests did not reveal statistically significant differences between groups.
Quadrant-specific analyses of “double positive” hippocampal microglia.
Microglia percentage of parent population, double positive. Chi-square tests did not
reveal statistically significant differences between groups with regard to the percentage of
microglial cells that simultaneously express membrane MHC II and CCR7.
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Microglia MHC II mean fluorescence intensity, double positive. Independent samples
median test showed significant differences between groups, MEDCOMP test-statistic (df = 2) =
6.00, p < 0.05. Post-hoc analyses indicated that the low-dose group (Mdn = 13532) had
decreased MFI of MHC II in hippocampal microglial cells as compared to the control group
(Mdn = 18395), MEDCOMP test statistic = 8.00, p < 0.05. No statistically significant difference
was detected between the high-dose and control group and between the high-dose and low-dose
group (See Figure 16).

Figure 16. Representative histograms of effects of low-level lead exposure on hippocampal
microglia mean fluorescence intensity of MHC II (double positive cells). Histogram shifts
towards the right show higher mean fluorescence intensity and thus increased MHC II. Lowlevel lead exposed animals had decreased number of MHC II on their hippocampal microglia
membrane surface as compared to controls in double positive cells.
Microglia CCR7 mean fluorescence intensity, double positive. Independent samples
median test did not reveal significant differences between groups.
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3.3.2.2 Brain microglia.
Microglia percentage of parent population. Chi-square test revealed a significant
difference between groups with regard to percentage of microglial cells in brain, X² (df = 2, N
=165507) = 879.41, p < 0.01 (controls = 79.2%; low-dose = 84.7%; high-dose = 77.7%).
Independent samples median test however did not show significant differences between groups.
Microglia cell number. Independent samples median test did not show significant
differences between groups.
Overall analyses of MHC II and CCR7 in brain microglia.
Microglia MHC II mean fluorescence intensity. Independent samples median test did
not show significant differences between groups.
Microglia CCR7 mean fluorescence intensity. Independent samples median test did not
show significant differences between groups.
Quadrant-specific analyses of “single positive” brain microglia.
Microglia MHC II percentage of parent population, single positive. Chi-square tests
showed a significant difference between groups with regard to the percentage of MHC II positive
microglial cells in hippocampus, X² (df = 2, N =165508) = 859.48, p < 0.01 (controls = 0.3%;
low-dose = 0.3%; high-dose = 1.8%). Independent samples median test however did not reveal
significant differences between groups.
Microglia MHC II cell number, single positive. Independent samples median test did not
show significant differences between groups.
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Microglia MHC II mean fluorescence intensity, single positive. Independent samples
median test did not show significant differences between groups.
Microglia CCR7 percentage of parent population, single positive. Chi-square tests
revealed a significant difference between groups with regard to percentage of CCR7 positive
microglial cells in brain, X² (df = 2, N = 165507) = 40.01, p < 0.01 (controls =1.2%; low-dose =
0.8%; high-dose = 0.9%). Independent samples median test showed significant differences
between groups (controls Mdn = 0.18%; low-dose Mdn = 0.22%; high-dose Mdn = 0.23%). Posthoc analyses however did not reveal significant differences between groups.
Microglia CCR7 cell number, single positive. Independent samples median test did not
show significant differences between groups.
Microglia CCR7 mean fluorescence intensity, single positive. Independent samples
median test did not show significant differences between groups.
Quadrant-specific analyses of “double positive” brain microglia.
Microglia percentage of parent population, double positive. Chi-square tests showed a
significant difference between groups with regard to percentage of double positive (MHC
II/CCR7) microglial cells in brain, X² (df = 2, N = 165508) =19.84, p < 0.01 (controls = 0.1%;
low-dose = 0.001%; high-dose = 0.1%). However, independent samples median test did not
show significant differences between groups.
Microglia cell number, double positive. Independent samples median test did not show
significant differences between groups.
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Microglia MHC II mean fluorescence intensity, double positive. Independent samples
median test did not show significant differences between groups.
Microglia CCR7 mean fluorescence intensity, double positive. Independent samples
median test did not show significant differences between groups.
3.3.2.3 Hippocampal macrophages.
Macrophages percentage of parent population. Chi-square test showed a significant
difference between groups with regard to percentage of macrophages in hippocampus, X² (df = 2,
N = 36072) = 215.97, p < 0.01 (controls = 6.5%; low-dose = 3.7%; high-dose = 3.1%).
Independent samples median tests showed significant differences between groups, MEDCOMP
test-statistic (df = 2) = 6.00, p < 0.05. Post-hoc analyses however were not significant.
Macrophages cell number. Independent samples median tests showed significant
differences between groups, MEDCOMP test-statistic (df = 2) = 6.00, p < 0.05. Post-hoc
analyses indicated that the high-dose group (Mdn = 520) had an increased number of
macrophages in hippocampus as compared to the low-dose group (Mdn = 210), MEDCOMP teststatistic = 8.00, p < 0.05. No significant difference however was detected between the high-dose
and control group, or between the low-dose and control group. (The simulated dataset however
suggested that with additional subjects, the low-dose group differed from the control group
MEDCOMPS test-statistic (df = 2) = 6.00, p < 0.05.)
Overall analyses of MHC II and CCR7 in hippocampal macrophages.
Macrophages MHC II mean fluorescence intensity. Independent samples median test
did not show a significant difference between groups.
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Macrophages CCR7 mean fluorescence intensity. Independent samples median test did
not show significant differences between groups.
Quadrant-specific analyses of “single positive” hippocampal macrophages.
Macrophages MHC II percentage of parent population, single positive. Chi-square test
showed a significant difference between groups with regard to the percentage of macrophages
that express MHC II in hippocampus, X² (df = 2, N = 36034) = 14.07, p < 0.01 (controls = 1.8%;
low-dose = 1.2%; high-dose = 1.3%). Independent samples median test however did not show
significant differences between groups.
Macrophages MHC II cell number, single positive. Independent samples median test
showed significant differences between groups, MEDCOMP test-statistic (df = 2) = 6.00, p <
0.05. Post-hoc analyses indicated that the high-dose group had increased number of macrophages
expressing MHC II in hippocampus (Mdn = 262) as compared to the low-dose group (Mdn = 86),
MEDCOMP test-statistic = 8.00, p < 0.05. No significant difference was detected between the
high-dose and control group or between the low-dose and control group.
Macrophages MHC II mean fluorescence intensity, single positive. Independent
samples median test did not show significant differences between groups.
Macrophages CCR7 percentage of parent population, single positive. Chi-square test
showed a significant difference between groups with regard to the percentage of CCR7 positive
macrophages in hippocampus, X² (df = 2, N = 36075) = 74.66, p < 0.01 (controls = 0.3%; lowdose = 0.6%; high-dose = 0.001%).
Independent samples median test showed significant differences between the groups,
MEDCOMPS test-statistic (df = 2) = 8.00, p < 0.05. Post-hoc analyses indicated that the high98

dose group (Mdn = 0.32%) had decreased percentage of macrophages expressing CCR7 in the
hippocampus as compared to the control group (Mdn = 5.24 %), MEDCOMP test-statistic =
8.00, p < 0.05. No significant difference however was detected between the low-dose group
(Mdn = 7.46%) and control group, or between the low-dose group and high-dose group (see
Figure 17, below). Simulated data however revealed that the high-dose group differed from the
low-dose group MEDCOMP test-statistic (df = 2) = 24.00, p < 0.01.

Figure 17. Hippocampal macrophages CCR7 “single positive” percentage of parent
population in young C57BL6/J mice, with and without early chronic lead exposure.

Macrophages CCR7 cell number, single positive. Independent samples median test did
not show significant differences between groups.
Macrophages CCR7mean fluorescence intensity, single positive. Independent samples
median test did not show significant differences between groups.
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Quadrant-specific analyses of “double positive” hippocampal macrophages.
Macrophages percentage of parent population, double positive. Chi-square test showed
a significant difference between groups with regard to the percentage of macrophages expressing
MHC II and CCR7 in brain, X² (df = 2, N = 33126) = 434.93, p < 0.01 (controls = 27%; low-dose
= 14%; high-dose = 21%). Independent samples median test however did not show significant
differences between groups.
Macrophages MHC II mean fluorescence intensity, double positive. Independent
samples median tests showed significant differences between groups, MEDCOMP test-statistic
(df = 2) = 6.00, p < 0.05. Post-hoc analyses indicated that the high-dose group (Mdn = 29264)
had increased MFI of MHC II in hippocampal macrophages as compared to the control group
(Mdn = 21371), MEDCOMP test-statistic = 8.00, p < 0.014 (see Figure 18). No significant
differences were detected between the high-dose and the low-dose group (Mdn = 21720), or
between the low-dose and control group. (The simulated dataset suggested that with increased
sample size, the high-dose group would differ from the low-dose group MEDCOMPS teststatistic = 24.00, p < 0.01.)
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Figure 18. Representative histograms of effects of high-level lead exposure on hippocampal
macrophages on mean fluorescence intensity of MHC II (in double positive cells).
Histogram shifts towards the right show higher mean fluorescence intensity and thus increased
MHC II. High-level lead exposed animals had increased number of MHC II on their
hippocampal macrophage membrane surface as compared to controls and low-dose groups.

3.3.2.4 Brain macrophages.
Macrophages percentage of parent population. Chi-square test showed a significant
difference between groups with regard to the percentage of macrophages in brain, X² (df = 2, N =
165508) = 215.97, p < 0.01(controls = 5.1%; low-dose = 2.5%; high-dose = 3.6%). Independent
samples median test however did not show significant differences between groups.
Macrophages cell number. Independent samples median test did not show significant
differences between groups.
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Overall analyses of MHC II and CCR7 in brain.
Macrophages MHC II mean fluorescence intensity. Independent samples median test
did not show significant differences between groups.
Macrophages CCR7 mean fluorescence intensity. Independent samples median test did
not show significant differences between groups.
Quadrant-specific analyses of “single positive” brain macrophages.
Macrophages MHC II percentage of parent population, single positive. Chi-square test
showed a significant difference between groups with regard to the percentage of macrophages
expressing MHC II in brain, X² (df = 2, N = 36034) = 14.07, p < 0.01 (controls = 1.2%; low-dose
= 0.8%; high-dose = 0.9%). Independent samples median test did not show significant
differences between groups.
Macrophages MHC II cell number, single positive. Independent samples median test did
not show significant differences between groups.
Macrophages MHC II mean fluorescence intensity, single positive. Independent
samples median test did not show significant differences between groups.
Macrophages CCR7 percentage of parent population, single positive. Chi-square test
showed a significant difference between groups with regard to the percentage of macrophages
expressing CCR7 in brain, X² (df = 2, N =165508) = 74.66, p < 0.01 (controls = 0.1%; low-dose
= 0.1%; high-dose = 0.01%). Independent samples median did not reveal significant differences
between groups.
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Macrophages CCR7 number, single positive. Independent samples median test did not
show significant differences between groups.
Macrophages CCR7 mean fluorescence intensity, single positive. Independent samples
median test did not show significant differences between groups.
Quadrant-specific analyses of “double positive” brain macrophages.
Macrophages percentage of parent population, double positive. Chi-square test showed
a significant difference between groups with regard to the percentage of macrophages that
simultaneously express membrane MHC II and CCR7 in brain, X² (df = 2, N = 165507) = 56.27,
p < 0.01 (controls = 1.4%; low dose = 0.6%; high dose = 0.6%). Independent samples median
test did not show significant differences between groups.
Macrophages cell number, double positive. Independent samples median test did not
show significant differences between groups.
Macrophages MHC II mean fluorescence intensity, double positive. Independent
samples median test showed significant differences between groups, MEDCOMP test-statistic
(df = 2) = 6.00, p < 0.05. Post-hoc analyses indicated that the high-dose group had increased MFI
(Mdn = 25588) in macrophages expressing MHC II in brain as compared to the low-dose group
(Mdn = 18752), MEDCOMP test-statistic = -7.25, p < 0.05 (see Figure 19, below). No
significant effects however were detected between the low-dose and control group (Mdn =
24117), or between the high-dose and control group.
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Figure 19. Representative histograms of effects of high-level lead exposure on brain
macrophages on mean fluorescence intensity of MHC II (in double positive cells).
Histogram shifts towards the right show higher mean fluorescence intensity and thus increased
MHC II. High-level lead exposed animals had increased number of MHC II on the surface of
macrophages in brain as compared to the low-dose groups in double positive cells.

Macrophages CCR7 mean fluorescence intensity, double positive. Independent samples
median test did not show significant differences between groups.
3.3.2.5 Hippocampal immune cells.
Immune cell percentage of parent population. Chi-square test showed a significant
difference between groups with regard to the percentage of immune cells in hippocampus, X² (df
= 2, N = 79040) = 2585.21, p < 0.01 (controls = 50.3%; low-dose = 35.4%; high-dose = 60.5%).
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Independent samples median test showed significant differences between groups, MEDCOMP
test-statistic (df = 2) = 8.00, p < 0.05. Post-hoc analyses indicated that the high-dose group (Mdn
= 56.65%) had an increased percentage of immune cells in hippocampus as compared to the lowdose group (Mdn = 33.30%), MEDCOMP test-statistic = 8.00, p < 0.05 (see Figure 20 below).
No significant differences were detected between the high-dose and control group (Mdn =
46.40%), or between the low-dose group and the control group.

Figure 20. Hippocampal immune cell percentage of parent population in young C57BL6/J
mice with and without early lead exposure.

Immune cell number. Independent samples median test showed significant differences
between groups, MEDCOMP test-statistic (df = 2) = 8.00, p < 0.05. Post-hoc analyses indicated
that the low-dose group (Mdn = 4742) had a decreased number of immune cells in hippocampus
as compared to the high-dose group (Mdn = 21934), MEDCOMP test-statistic = 8.00, p < 0.05.
No significant differences however were detected between low-dose and control group, or
between the high-dose group and control group (Mdn = 10882).
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3.3.2.6 Brain immune cells.
Immune cell percentage of parent population. Chi-square test showed a significant
difference between groups with regard to the percentage of immune cells in brain, X² (df = 2, N =
226980) = 2876.67, p < 0.01 (controls = 65.7%; low-dose = 74.1%; high-dose = 77.4%).
Independent samples median test however did not reveal significant differences between groups.
Immune cell number. Independent samples median test showed significant differences
between groups, MEDCOMP test-statistic (df = 2) = 6.00, p < 0.05. Post-hoc analyses indicated
that the high-dose group had increased number of immune cells (Mdn = 80001) as compared to
the control group (Mdn = 53304), MEDCOMP test-statistic = 8.00, p < 0.05. No significant
differences were detected between the high-dose and low-dose group, or between the low-dose
and control group.
3.4

Summary of Neuroimmune System Studies Results
Overall, significant group effects were observed primarily in hippocampus and not in

brain (see summary Table 12).
3.4.1 Hippocampal microglia. Hippocampal microglial cells in low-dose mice, as
compared to the control group, had decreased MFI of MHC II (in double positive cells) (see
Figure 16), and decreased MFI of CCR7 (overall analyses) (see Figure 15). In other words, lowlevel lead exposure reduced the quantity of MHC II and CCR7 expressed on the surface of
hippocampal microglial cells. No other significant differences were detected between groups
with regard to percentage of parent population or MFI of the measured parameters.
3.4.2 Hippocampal macrophages. Hippocampal macrophages in high-dose exposed
animals had an increased MFI of MHC II (in double positive cells), as compared to controls (see
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Figure 18). At the same time, hippocampal macrophages in high-dose exposed animals had
decreased percentage of CCR7 (single positive cells), as compared to controls (see Figure 17).
Thus higher-level lead exposure reduced the number of hippocampal macrophages that
expressed CCR7 on their membrane surface, but increased the quantity of MHC II present on the
surface of hippocampal macrophages. No other significant effects were detected between groups
with regard to percentage of parent population or MFI in the measured parameters.
3.4.3 Hippocampal immune cells. Independent samples median test revealed that
higher-dose exposed animals had an increased percentage and number of immune cells in
hippocampus as compared to the low-dose group (see Figure 20). Thus higher-level lead
exposure caused an increase in the number of immune cells in the hippocampus. No other effects
were detected.
3.4.4 Brain microglia. Independent samples median test did not detect any significant
differences between groups with regard to the measured parameters in brain microglia.
3.4.5 Brain macrophages. Independent samples median test revealed that high-dose
animals as compared to the low-dose animals had increased MFI of MHCII in macrophages
(double positive cells) (see Figure 19). Thus high-level lead exposure increased the quantity of
MHC II in macrophages in brain regions other than hippocampus. No other significant effects
were detected between groups with regard to percentage of parent population or MFI for the
measured parameters.
3.4.6 Brain immune Cells. Independent samples median test revealed that the high-dose
group had increased number of immune cells in brain as compared to the control group.
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Table 12. Summary of significant effects in hippocampal and brain cells in young
C57BL6/J mice with and without chronic lead exposure.
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CHAPTER 4
DISCUSSION

The present studies build on previous studies conducted in our laboratory (see
Introduction). These studies were designed to examine whether additional behavioral tests would
be sensitive to the effects of early chronic low-level lead exposure in young C57BL/6J male
mice; and to examine the presence of biological markers in microglial cells that could stimulate
their trafficking away from brain perhaps via meningeal and/or para-vascular brain lymphatics.
In order to examine these questions behavioral studies and a neuroimmune system study were
conducted.
4.1

Behavioral System Studies
Animals chronically dosed with lead from PND 0 to PND 28 were developmentally

monitored at 7-days intervals (body weight, eye-opening, and righting reflex) and tested
behaviorally at PND 28 with regard to exploratory ambulation, rearing, anxiety, and olfactory
memory. It was hypothesized that lead-exposed mice would have a delay in achieving
developmental milestones and would have disrupted motor function and reduced olfactory
memory. The BLLs induced were within expected ranges and clearly differentiated
experimental groups from controls. It was found that early chronic low-level lead exposure
increased body weight and decreased exploratory (rearing) behavior in the open field. The odor
habituation/dishabituation task was effective at detecting habituation for two of five scents and
dishabituation for one of four scent transitions, however the test was not sensitive to the effects
of early chronic low-level lead exposure and may have been too difficult for pre-adolescent
animals.
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4.1.1 Blood lead levels. The BLLs of children in the U.S. are usually reported in
relation to a current threshold of concern, or a level considered “elevated.” Nationwide it is
estimated that 97.5% of children have blood lead levels below 5 µg/dL and for this reason, as of
January 2012, 5 µg/dL became the current level for “elevated” child blood lead. It is broadly
accepted however that no level of lead exposure is safe in children and yet the numbers of
children with blood lead below this current threshold are not known. Studies in our laboratory
have shown that 50% of children living in lower income neighborhoods of downtown El Paso
have BLLs that range between approximately 2.5 to 7.0 µg/dL (Sobin et al., 2015). Importantly,
at these low BLLs, deficits in cognition and fine-motor dexterity have been repeatedly shown
(e.g. Lanphear et al., 2005; Sobin, Flores-Montoya, Gutierrez, Parisi, & Schaub, 2015).
In order to understand effects at lowest levels of lead exposure, in past studies in our
laboratory, we have used murine models and successfully induced BLLs and ranges similar to
those measured in 50% of children from downtown El Paso (Flores-Montoya & Sobin, 2014;
Flores-Montoya et al., 2015; Sobin et al., 2013; Basgen & Sobin, 2014). (See Table 13 below for
a summary of BLLs averaged across four previous studies, Sobin et al., 2017.)
Table 13. Means and standard deviations (SDs) for BLLs measured with ICP-MS in young
C57BL/6J mice with and without early chronic lead exposure.*
Lead exposure group
Negative controls n = 51 (0 ppm)
Low-dose n = 51 (30 ppm)
High-dose n = 26 (230 ppm)
High-dose n = 25 (330 pm)

Blood lead levels (µg/dL)
0.2 (0.1)
3.3 (0.7)
12.3 (2.6)
14.4 (2.6)

*Mean BLLs of male and female mice were averaged across four studies (see citations in text above) (N = 159,
males n = 91, females n = 68)

In the present study, C57BL/6J male mice were exposed chronically to one of three
treatment levels, 0 ppm (controls), 30 ppm (low-dose), or 430 ppm (high-dose) of lead acetate
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via dams’ milk from birth until weaning (PND 21) (day at which dams were removed from the
litter). From weaning until PND 28 (time of sacrifice) mice ingested lead directly from water
bottles.
The present study was designed to test male mice only because past studies in our laboratory
have shown that typically C57BL/6J dams produce an unbalanced number of males and females
per litter (Flores-Montoya & Sobin, 2014, Flores-Montoya et al., 2015, Sobin et al., 2017) and
achieving balanced numbers of males and females simultaneously requires very large breeding
schemes. More importantly, studies have suggested that chronic low-level lead exposure, while
detrimental to both sexes, might have different mechanisms of action for disrupting brain and
behavior in males as compared to females (e.g. Leasure et al., 2008, Kasten-Jolly et al., 2012).
Thus, the present study was designed to more thoroughly characterize effects of early chronic
low-level lead exposure in pre-adolescent male mice. Future studies will need to examine the
same effects in females.
At PND 7, litters were culled to five pups per litter (C57BL/6J litter sizes typically range
from five to nine pups). In instances when litters had less than five male pups, female pups were
kept with the litter in order to achieve equal litter sizes. This was done in order to reduce possible
variability in BLLs that could be induced from factors such as possible maternal neglect (as
shown in larger litters) (Agnish & Keller, 1997) and restricted access to dams’ milk and/or water
due to animal competition for resources (Hager, Cheverud, & Wolf, 2012).
At PND 28 (the last day of behavioral testing and sacrifice) BLLs were measured in 36
C57BL/6J male mice with ICP-MS. It is important to note that ICP-MS is the most precise
method thus far developed for detecting lowest levels of lead in blood (Sobin, Parisi, Schaub, &
de La Riva, 2011). One-way ANOVA was used to examine possible differences between groups
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and revealed that the low-dose group had higher mean BLLs (M = 4.24, SD = 0.61) as compared
to the control group (M = 0.55, SD = 0.49) and the high-dose group had higher mean BLLs (M =
21.30, SD = 7.03) as compared to the low-dose group and as compared to controls.
The mean BLLs induced in low-dose mice in the present study approximated those
induced in 30 ppm exposed mice in five previously published studies from our laboratory. Very
few laboratories have attempted to replicate low child-relevant blood lead levels in animals, and
very few have demonstrated the achievement of these levels using precise measurement (ICPMS) of lead in blood. Additionally, as of 2014, there were no published studies reporting BLLs
of young (preadolescent) mice exposed chronically to low-levels of lead. In this way, these
studies have been among the first to model lead exposure in an animal model with improved
clinical relevance to effects in children. Our consistent replication of low child-relevant BLLs in
these studies suggested that for future studies chronic exposure to 30 ppm in C57BL/6J mice is a
valuable approach for understanding effects of early chronic low-level lead exposure in children.
With regard to the higher-dose lead-exposed animals, our laboratory has used 230, 330
and in the present study 430 ppm. In the present study, BLLs measured with ICP-MS in higher
level lead exposed mice (430 ppm) revealed that mice had mean BLLs that ranged from 12.71 to
33.32 µg/dL. In this study and others (summarized in Table 13 above), the high-dose group
BLLs were more variable. There are several possibilities as to why this might have occurred.
Even though attempts were made to fully dissolve lead particles in water (using glacial acetic
acid) it could be that some lead particles were not fully dissolved causing some animals to ingest
higher concentrations of lead than others. In this way, uneven suspension of higher level lead in
the drinking water could have resulted in greater differences in both dam exposure, absorption
and delivery to pups. Another possibility is that some mice ingested more milk that others
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during lactation. Another possibility is that individual pup differences in absorption rates reflect
true variability and could be important for understanding absorption differences in children.
Future studies should examine whether at preadolescence higher levels of exposure alter
absorption rates.
To date, circulating blood lead measured in whole blood is the most widely accepted
biological marker for assessing chronic child lead toxicity (Barbosa, Tanus-Santos, Gerlach, &
Parsons, 2005). Even though this is the most common method used, it is not yet understood
whether circulating blood lead is the most accurate representation of child lead exposure. Until
novel assessments of child lead exposure are developed BLL remains the gold standard for
evaluating effects of low-level lead in both child studies and animal studies.
4.1.2 Body weight. In the present study, body weight was increased in low-dose mice
as compared to high-dose and control mice. Our laboratory has observed this effect in previous
studies. Specifically, in this study at PND 28 low-dose mice weighed 11% more as compared to
controls and 20% more as compared to high-dose mice. On the other hand, high-dose mice
weighed 7% less as compared to controls. Similarly, other studies have shown that adult male
(but not female) mice exposed chronically to low-levels of lead (27-32 ppm) during development
had increased body weight as compared to controls (Leasure et al., 2008; Wu et al., 2016; Faulk
et al., 2013).
It is not yet known why chronic low-level lead exposure altered body weight in male
mice. Interestingly however a few studies have provided some clues. Specifically, two studies
have provided evidence that changes in gut microbiota, that is a collection of microorganisms
that reside in the gut (Shreiner, Kao, and Yung, 2016), and altered metabolism were associated
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with increased body weight in chronic low-level lead exposed male mice (Wu et al., 2016; Gao
et al., 2017).
4.1.2.1 Low-level lead exposure and the gut microbiota. Particular attention has been
paid to the gut microbiota over the past few years because studies have shown that it plays an
important role in health and disease (Shreiner, Kao, & Yung, 2016). Among some of its
functions, the gut microbiota aids in metabolic processes and thus the regulation of body weight.
In a recent study, Avy wild type non-agouti mice were exposed to low-levels of lead
during gestation and lactation (32 ppm) until PND 21 (weaning) (N = 28) (Wu et al., 2016). In
order to investigate long-lasting effects of lead after exposure, from PND 21 until the day of
sacrifice, all mice were given distilled water only. Animals were weighed in weekly intervals
from PND 21(week 3) until week 33 and sacrificed at week 40 at which point their colons were
harvested. The tissues were homogenized and bacteria colonies were plated (on agar nutrient
plates) and incubated for later DNA sequencing analyses of bacterial 16S ribosomal RNA genes
(genes commonly sequenced to characterize different types of bacteria).
It was found that low-level lead exposed male but not female mice had increased body
weight as compared to controls. Additionally, it was found that lead-exposed male and female
mice had changes in the quantity of gut microbiota. Specifically, an increased number of
bacterial anaerobes (not dependent on oxygen) and a decreased number of bacterial aerobes
(consumers of oxygen), and a smaller proportion of bacteroidetes as compared to firmicutes
(bacterias commonly found in gut) were found in low-level lead exposed male mice as compared
to controls. Studies have shown that changes in the proportion of gut microbiota are associated
with obesity (e.g. Turnbaugh et al., 2009). The study suggested that even after exposure to lead
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has ended, low-level lead can have long-lasting effects on gut microbiota composition and thus
body weight.
In a similar study, C57BL/6J mice were exposed to low-levels of lead (10 ppm) via
drinking water starting at 8 weeks after birth, and until 21 weeks (Gao et al., 2017) (n = 5) (BLLs
were not reported). In order to retrieve gut microbiota, fecal pellets were obtained before
exposure and at 4 and 13 weeks post-exposure. At a later time, fecal pellets were homogenized
for DNA sequencing of the 16S ribosomal genes, whole genome sequencing, and examination of
metabolites via gas chromatography spectrometry. It was found that low-level lead exposure
altered the development of the gut microbiome, disrupted the diversity of gut bacteria, and
altered several metabolic pathways including vitamin E, bile acids, nitrogen metabolism, energy
metabolism, oxidative stress, and defense/detoxification mechanisms.
The results of the studies described above suggested that low-level lead might alter body
weight in part through disruption of gut microbiota and of metabolic pathways in male mice.
Other mechanisms could also contribute to increased body weight in low-level lead exposed
male mice. For example, it could be that low-level lead exposure alters feeding behavior in
preadolescent male mice and thus increases body weight.
4.1.2.2 Is feeding behavior associated with chronic low-level lead exposure? No
studies thus far have examined whether chronic low-level lead exposure alters feeding behavior
in preadolescent C57BL/6J mice. It could be important to examine whether feeding behavior
and/or preference for a low-fat vs. high-fat diet is altered as a result of chronic low-level lead
exposure. If studies reveal significant effects, it could suggest alterations in brain areas
associated with turning “on” and “off” satiety signals (e.g. in the hypothalamus) and/or changes
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in brain areas associated with the rewarding effects of feeding behavior (e.g. dopaminergic
regions) (Volkvow, Wang, and, Baler, 2011, review).
4.1.2.3 Future directions. Thus far, changes in the gut microbiome have been the primary
focus of research for understanding changes in body weight as a result of chronic low-level lead
exposure. These results are compelling and suggested that chronic low-level lead exposure
results in metabolic disruptions and could predispose organisms to obesity. More studies
however should attempt to replicate these findings and expand on implications of metabolic
changes for the long-term health of exposed organisms and whether these changes are associated
with metabolic diseases such as diabetes. Additionally, future studies should examine whether
and how chronic low-level lead exposure alters feeding behavior (and/or other goal-directed
behaviors) in preadolescent mice. This could in turn provide a better understanding of whether
increased body weight in early chronic low-level lead exposure occurs from metabolic
disruption, disruptions in feeding brain centers, or a complex combination of mechanisms acting
at different times during development.
4.1.3 Open field. The open field test is traditionally used for assessing spontaneous
exploratory ambulation and activity in rodents (Tanaka et al., 2012). In previous studies, our
laboratory has used the open field test in a square arena and has not found group differences. In
the present study, in an attempt to improve detection of effects of chronic low-level lead
exposure in preadolescent male mice, a larger round arena was used and several behaviors were
measured. These behaviors included rearing (standing up on hind legs), total distance travelled
rather than quadrants crossed (exploratory ambulation), and time and distance travelled in the
periphery (used to assess thigmotaxis, i.e. anxiety) during a 5 minute testing trial. It was found
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that chronic low-level lead exposure was associated with reduced rearing behavior in the
periphery and center of the arena.
For rearing in the periphery, low-level lead exposed male mice had approximately 32%
fewer rearing events; and high-dose male mice had approximately 23% fewer rearing events as
compared to controls. No significant difference however was detected between the high-dose and
low-dose group. For rearing in the center of the open field arena, low-dose mice had
approximately 50% fewer rears; and high-dose mice had approximately 75% fewer rears as
compared to controls. The clinical significance of center rearing however are questionable
because the number of rears displayed in the center of the arena was extremely low for all
animals. The possible significance of changes in rearing behavior will be considered below.
4.1.3.1 Rearing in open field. Rearing behavior is a common complex exploratory
rodent behavior that is understood to facilitate learning in a novel environment (Alves et al.,
2012). When animals rear, they change their body position from a horizontal (monocular 2D
vision) to a vertical (binocular 3D vision) and the elevated position which allows acquisition of
additional information about a novel environment through increased visual and olfactory cues.
Rearing is facilitated by several brain areas. These include but are not limited to areas
associated with memory including frontal cortex and hippocampus (Lever at al., 2006), motor
function including cortico-basal ganglia thalamic pathways (Kim, Ling, and Kang, 2016) and
affective states including amygdala (Bailey & Crawley, 2009). In order to understand specific
effects and brain areas associated with a decrease in rearing behavior observed in chronic lowlevel lead mice, and what the current results might suggest, it is important to consider results
from previous and current findings relevant to exploration in low-level lead exposed mice.

117

Similarity of current findings to previous studies in low-level lead exposed mice of
exploratory activity. Reduced exploratory behavior as suggested by reduced rearing in an open
field is consistent with one previous study conducted in our laboratory. In that study exploratory
activity in a novel environment was measured using the unbaited nose poke task (FloresMontoya & Sobin, 2014). Briefly, using the same lead exposure protocol as that described for the
current study, lead-exposed and control mice were allowed to explore an elevated platform with
16 equally spaced holes for a period of 3 min. It was found that as BLL increased, exploratory
activity in the nosepoke task decreased. Also similar to the current study in which no differences
were observed in total distance traveled, in the previous study gross motor function measured
with the rotarod task and distance traveled measured as total quadrants crossed with four paws,
revealed no significant effects. These results suggested that reduced exploratory activity in the
nosepoke task was not due to changes in ambulation or gross motor function and instead
suggested that animals had either decreased “curiosity” or increased anxiety for exploring a
novel environment.
Thus, the results of the study described above follow a pattern similar to results from our
previous studies. Both studies revealed that chronic low-level lead exposure decreased
exploratory activity in a novel environment. Additionally in the present study, no significant
effects were detected for differences in exploratory ambulation or motor function; and no effects
were found suggesting increased anxiety (i.e. thigmotaxis). In this way, the current results
suggested that a more complex cognitive function such as “curiosity” and not motor function or
anxiety, might have been primarily responsible for the decreased exploratory activity observed in
mice.
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Rearing behavior as an index of “curiosity.” “Curiosity” has been defined as a complex
form of cognitive function that precedes learning (Litman et al., 2005). Despite its importance
for understanding rodent learning, very few studies have attempted to examine this complex
cognitive function. One such recent study showed that mouse nicotinic receptors in the ventral
tegmental area expressing the β2 subunit were responsible for curiosity, and as the authors
suggested “uncertainty seeking” when exploring a novel environment (Naude et al., 2016).
Additional studies are needed to understand which factors drive “curiosity” in mice, to what
extent rearing behavior is associated with the construct of “curiosity,” and whether chronic lowlevel lead exposure alters this cognitive function.
Rearing behavior as an index of memory. Many studies have suggested that rearing
behavior is closely linked to hippocampal function (Lever at al., 2006). For example, one study
showed that lesions to the hippocampus CA3 (cornus ammonis 3) and hippocampus DG (dentate
gyrus) resulted in decreased rearing behavior (Hunsaker, Rosenberg, & Kesner, 2005). It would
be very interesting to examine whether these hippocampal regions are selectively vulnerable to
early chronic low-level lead exposure particularly with regard to down-regulation of cellular
function or cell loss. It is also important to note that studies frequently examine rearing behavior
primarily as a measure of anxiety or motor function rather than a measure of hippocampal
function. Future studies are needed to better characterize types of rearing behavior and
associations with disruption of hippocampal regions with regard to early chronic low-level lead
exposure.
Differences between studies in measures of exploratory activity. In past studies in our
laboratory, we have found specific effects on rearing behavior in chronic low-level lead exposed
mice during memory retrieval in the object in place visual recognition paradigm (OIP) (Sobin et
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al., 2017). In this study, it was found that low-dose and high-dose exposed mice as compared to
controls had markedly increased rearing during retrieval memory trials. Rearing behavior during
the retrieval memory differs fundamentally from rearing behavior in the open field task because
in the open field task no cognitive challenge other than self-initiated exploration is involved.
With regard to the effects of early chronic low-level lead exposure, there are several ways to
explain increased rearing during retrieval memory and decreased rearing in an open field. One
explanation is that visuo-perceptual impairments and/or perceptual disorientation were
responsible for an increase in rearing behavior observed in the OIP task. On the other hand, and
as discussed above, decreased rearing in open field and decreased exploration in the nose poke
tasks might have been mediated by brain areas associated with native “curiosity” and memory in
a novel environment. The results from tests of memory in mice with early chronic low-level lead
exposure are discussed next.
4.1.4

Memory. Past studies in our laboratory and others have shown that chronic low-

level lead exposure disrupts memory in rodents. Specifically, studies examining rodents exposed
to low-levels of lead and tested during adulthood have shown that low-level lead alters spatial
recognition memory (Kasten-Jolly et al., 2012) and object recognition memory (Azzaoui et al.,
2009). Perhaps with greater relevance to child chronic low-level lead exposure, a previous study
completed in our laboratory showed that olfactory memory measured with a two-choice
paradigm was disrupted in preadolescent mice (Flores-Montoya et al., 2015). At preadolescence
however no effects were detected in young mice on a spatial and object recognition memory task
(OIP task) (Sobin et al., 2017). These results suggested that olfactory memory tests might be
more sensitive to the effects of chronic low-level lead exposure at preadolescence. For this
reason, in the present study, another type of olfactory memory task was tried in an attempt to
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broaden the total number of tests determined to be sensitive to early chronic low-level lead
exposure in young mice.
4.1.4.1

Odor habituation/dishabituation task. In the present study, an odor

habituation/dishabituation task was used. Briefly, the task used treated cotton swabs affixed to
the ends of water bottle feeding tubes to present odors to the young mice. For the acclimation
phase, the cotton swab carried only plain water; in the first testing phase non-social (almond and
orange) scents were presented; in the second testing phase, social odors (social scent 1 and a
different social scent 2) were used. Each phase included three consecutive trials of the same
scent. Habituation to odors and thus intact memory was demonstrated when mice gradually
decreased the time spent exploring the odors from Trial 1 to Trial 3. Dishabituation from odors
and thus intact discrimination was demonstrated when mice increased the time spent exploring a
new odor beginning the next testing phase.
This study is the first to attempt this task with pre-adolescent mice and overall, the
findings suggested that the task may have been too challenging for young mice. With regard to
habituation, it was found that all mice regardless of treatment group demonstrated habituation to
only two of five stimuli presented. Specifically, they habituated to the water-treated cotton swab
and the almond-treated cotton swab (the first non-social odor presented). No habituation was
apparent for orange, social scent 1, or social scent 2.
With regard to dishabituation, it was found that all mice, regardless of treatment group
demonstrated dishabituation to only one (orange) of four stimuli presented. (As compared to
Trial 3 of the orange scent, exploration times for all mice were significantly greater when the
social scent 1 was presented indicating that mice recognized social scent 1 as a novel odor.) No
dishabituation was detected for water, almond, or social scent 1. Thus the task was successful at
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inducing habituation in mice only at the beginning of the task, within the first 20 min of testing;
and the task successfully induced detection of novelty (of a social odor) only when mice had
been exposed previously (and dishabituated) to a non-social scent.
It might be important to note that significant effects might not have been detected
because of high variability within groups, perhaps an effect of individual differences in memory
development. In fact, although low-dose mice did not differ significantly from controls or highdose mice with regard to habituation or dishabituation, low-dose mice seemed to follow a
different pattern in exploration time. As compared to controls and high-dose mice, it appeared
that low-dose mice took longer to habituate to the odors and had little recognition of social scent
1 as a novel odor.
The development of olfactory memory in young mice has not been well-studied. These
findings bring into question the possibility that at preadolescence the brains of mice have not
matured fully enough to complete a relatively complex behavioral olfactory task. In fact, a study
showed that major maturational events within the hippocampus occur between embryonic day 16
to PND 30 (Mody et al., 2001). The variability of performance on this task suggested that
developmental studies of olfactory memory are needed before a task such as this can be used to
distinguish experimental groups from controls.
4.1.4.2 Future directions. The odor habituation/dishabituation test has been shown to
measure habituation/dishabituation in adult mice, typically tested at six weeks of age (PND 42)
or older (Yang & Crawley, 2009). For pre-adolescent mice, a different test design might be
needed to capture differences between groups. There are several possibilities regarding how to
adapt the odor habituation/dishabituation task for younger animals. First of all, the task used in
this study involved a 30 min acclimation period to a dry cotton swab and after acclimation, full
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testing lasted one additional hour. That duration is probably too long for PND 28 mice. Thus for
future studies, it will be important to simplify and shorten the task so that animals are tested for
habitation and dishabituation of perhaps two odors only. In one of our past studies, a simple test
of non-social odor olfactory memory that lasted only 8 min was successful at detecting effects of
chronic low-level lead exposure in preadolescent mice (Flores-Montoya et al., 2015). Thus, a
shorter testing period may be more effective at detecting effects of lead in olfactory memory in
young mice.
It might also be important to capitalize on the fact that in the present study mice seemed
to recognize a social novel odor more readily than a non-social novel odor. Thus, future studies
could examine whether simpler tests of olfaction using a neutral stimulus (e.g. cotton swab with
water only) for habituation and a social odor for dishabituation, could better detect effects of
chronic low-level lead measured at preadolescence. This in turn could reveal whether chronic
low-level lead exposure alters hippocampal regions shown to mediate social memory such as
CA2 (cornus ammonis 2) (Hitti & Siegelbaum, 2014). Additionally, testing a larger sample size
of young mice would improve statistical power to detect group differences when individual
differences in memory development produce broad within group variability.
4.1.4.3 Summary of behavioral findings and possible mechanism of action. Studies
examining chronic low-level lead exposed young mice have shown that chronic low-level lead
alters body weight, exploratory activity, and olfactory memory in young mice (as shown in a past
study of a two-choice paradigm). The specific mechanisms by which these effects occur are not
known. Studies in the literature have shown that body weight of low-level lead exposed mice is
altered via disruptions of gut microbiota. It would be important to examine whether feeding
behavior might also contribute to these effects. The results also suggested that chronic low-level
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lead exposure disrupts rearing behavior and that alterations in hippocampus might be responsible
for these effects.
In an attempt to understand the underlying mechanisms of behavioral disruptions caused
by chronic low-level lead exposure, and since past studies have shown disruption in microglial
cells in hippocampus which are responsible for the construction neural pathways during
development, the present study also examined whether specific biological markers were altered
in hippocampal neuroimmune cells. These findings are discussed next.
4.2

Neuroimmune System Studies
After the discovery in 2015 that lymphatic vessels exist in the meninges and paravascular

regions in brain, new hypotheses developed with regard to how the CNS and neuroimmune
system interact (Aspeleund et al., 2015; Louveau et al., 2015). Importantly, these studies
revealed that immune cells in brain accessed brain lymphatics and that CSF (cerebrospinal fluid)
and ISF (interstitial fluid) drained into deep cervical lymph nodes, perhaps allowing the passage
of immune cells into the periphery (below the neck). This could in turn allow immune cells from
brain to exchange information with peripheral immune cells and perhaps exacerbate or otherwise
modify immune responses.
Previous neurostereological studies in our laboratory showed that in low-level lead
exposed mice, microglia cell density in hippocampus/dentate gyrus was less than that of controls
(Sobin et al., 2013) and less than high-dose (330ppm) animals. Since those findings, our
laboratory has been considering different possible explanations for why and how early chronic
low-level lead exposure reduced hippocampal microglia. The present study was designed to
examine whether neuroimmune mechanisms, which could cause microglial cells to exit the brain,
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were upregulated in hippocampal microglial cells of chronic low-level lead exposed young mice
as compared to controls and high-dose mice.
Thirty-six mice were exposed to one of three treatment levels including 0 ppm (controls),
30 ppm (low-dose), and 430 ppm (high-dose). At PND 28, mice were sacrificed and their
hippocampus and brains were retrieved. Immune cells were isolated and FACS (fluorescence
activated cell sorting) analyses were used to examine the possible presence of MHC II and CCR7
in cells. It was hypothesized that as compared to controls, low-dose mice would have
upregulation of MHC II and CCR7 in hippocampal microglia. Additional exploratory analyses
were conducted to examine these same effects in brain microglia, and in hippocampal and brain
macrophages and immune cells.
4.2.1 Microglial cells.
4.2.1.1 Hippocampal microglia had decreased MHC II and CCR7. Contrary to our
hypotheses, hippocampal microglial cells in chronic low-level lead exposed mice expressed
reduced quantity of MHC II on the membrane surface of double positive cells (Mdn = 13532) as
compared to controls (Mdn = 18395). Similarly, it was found that low-level lead exposed mice
expressed reduced quantity of CCR7 on the membrane surface of single positive cells (Mdn =
4656) as compared to controls (Mdn = 5604). No significant effects however were detected for
microglia in whole brain regions without hippocampus. There are at least three possible
explanations for these findings. It could be that by PND 28 microglial cells with upregulated
MHC II and CCR7 had already exited the hippocampus of low-level lead exposed mice.
Another plausible explanation could be that chronic low-level lead exposure somehow
diminished levels of MHC II and CCR7 in hippocampal microglia. It is also possible that early
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chronic low-level lead exposure diminishes mechanisms responsible for the expression of MHC
II and CCR7 in hippocampal microglia. Further studies are needed to explore each of these
possibilities. These possible explanations will be considered in greater detail below.
Studies in our laboratory showed that chronic low-level lead exposure reduced the
number of microglial cells (measured with unbiased stereology methods) in the dentate gyrus of
the hippocampus (Sobin et al., 2013). These studies were replicated and expanded on a more
recent neurostereological study in which young mice with early chronic low-level lead exposure
were shown to have reduced numbers of microglial cells in the entire hippocampus (Dominguez
et al., 2017, unpublished data, manuscript in preparation). In the present study, chi-square tests
revealed a similar pattern of findings to what was described above. Specifically, as compared to
controls and high-dose animals, low-dose mice had a reduced percentage of parent population
microglial cells (the number of microglial cells relative to the total number of immune cells
examined in the sample). Specifically, the mean percentage of hippocampal microglial cells was
45% in low-dose, 58% in controls, and 71% in high-dose mice. While independent sample
median tests did not detect significant differences between groups, it is possible that significant
effects were not detected because the power to detect effects was diminished by using
nonparametric tests for N = 12 (hippocampi of mice combined in samples of 3 to ensure
adequate cell populations). Also it should be noted that FACS was not designed to provide
unbiased cell counts. Cell counts in FACS are relative to the amount of sample tested.
Neurostereology is one of very few methods that provide unbiased cell count estimates in threedimensional space. Nonetheless, the fact that the FACS cell counts replicate findings of our
neurostereology studies is interesting and corroborative. A recent study providing evidence that
hippocampal immune cells exit brain via CCR7 may give some clues as to additional
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mechanisms by which chronic low low-level reduces numbers of microglial cells in
hippocampus at pre-adolescence.
Study suggesting that CCR7 is responsible for the exiting of immune cells from
hippocampus into cervical lymph nodes. In a very recent study, C57BL/6J mice were injected
with bone marrow derived dendritic cells and LPS (liposaccharide) in their right frontal lobe in
order to elicit upregulation of CCR7 in dendritic cells (Clarkson et al., 2016). Some animals were
injected with dendritic cells that were CCR7 wild type (CCR7 +/+) and other cells that were
homozygously deleted in the CCR7 locus (CCR7 -/-). Flow cytometry, confocal microscopy, and
immunohistochemistry were used to investigate the fate of these cells. Perhaps of particular
relevance to the present study, it was found that CCR7 -/- dendritic cells accumulated more
readily in hippocampus and brains of mice as compared to CCR7 +/+ dendritic cells.
Interestingly, CCR7 +/+ dendritic cells were found in cervical lymph nodes but CCR7 -/dendritic cells were not. Additionally, it was found that some CCR7 +/+ dendritic cells seemed to
accumulate along areas in close proximity to DG (dentate gyrus) and CA3 (cornus ammonis 3)
of hippocampus suggesting that dendritic cells may have exited the brain along the DG and
hippocampus CA3.
These results suggested that CCR7 is one mechanism that promotes exiting of
hippocampal dendritic cells from brain, and that these cells then move into cervical lymph nodes.
Importantly, dendritic cells have a similar phenotype and share several functional characteristics
with microglial cells and macrophages. For example, all three cell types express CD45, MHC II,
and CCR7, and are also responsible for antigen presentation to cells of the adaptive immune
system (Clarkson et al., 2016; Guilliams et al., 2014; Derecki, Cronk, and Kipnis, 2012; Merad et
al., 2013). Thus, it is plausible to suggest that by PND 28 microglial cells of chronic low-level
127

lead exposed mice could have upregulated MHC II and CCR7 and exited the hippocampus. This
could explain why there was a lower quantity of microglial cells with MHC II and CCR7 in
hippocampus. It is acknowledged however that this model for microglial cells remains
speculative. Future studies should examine whether hippocampal microglia of chronic low-level
lead exposed mice access brain lymphatics and cervical lymph nodes.
Chronic low-level lead exposure might reduce MHC II and CCR7. Another possibility
is that chronic low-level lead exposure reduced the levels of MHC II and CCR7 in hippocampal
microglial cells. The effects of low-level lead on these molecules could range from changes at
the level of gene expression to changes for example in the folding of MHC II and CCR7.
A recent study showed that chronic low-levels of lead altered the transcription of several
genes (measured with reverse transcriptase PCR) that are associated with neuroimmune system
function in whole brain of BALB/c mice (Kasten-Jolly et al., 2012). Interestingly, it was found
that the expression of MHC II, chemokine receptors, and chemokine ligands was altered. It is
important to mention however that effects were measured in full brain and not specifically in
hippocampus. Future studies should examine whether changes in MHC II and CCR7 transcripts
occur in the hippocampus. Another possibility is that effects occurred at a higher level of
molecular processing such as disruptions in folding of MHC II and CCR7. In fact, in vitro
studies have shown that at higher levels of exposure lead binds to the chaperone protein GRP78
(e.g. Qian et al., 2005). This might in turn result in disruption of the otherwise proper folding of
proteins and thus proper function. Future studies should examine whether chronic low-level lead
exposure alters MHC II and CCR7 at the level of gene expression and/or protein level in
hippocampus.
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It is important to note that the effects observed were based on relatively low numbers of
hippocampal microglia cells expressing MHC II and CCR7 across all conditions. Future studies
are needed that use methods specifically designed to amplify the total amounts of MHC II and
CCR7 detected. For example, experimental methods that trigger high MHC II and CCR7
expression could be used in lead exposed animals to answer questions regarding the “health” of
mechanisms regulating MHC II and CCR7 expression. It is also possible that mechanisms other
than MHC II and CCR7 might have been responsible for the reduced number of microglial cells
in hippocampus. Future studies need to examine additional neuroimmune factors that might be
altered as a result of chronic low-level lead exposure.
4.2.2 Macrophages and immune cells.
4.2.2.1 Macrophages had a decreased percentage of cells with CCR7 but increased
quantity of MHC II in double positive cells. Similar to effects in hippocampal microglia in the
low-dose group, hippocampal macrophages in the high-dose lead exposed group had a decreased
percentage of macrophages expressing membrane surface CCR7. Unlike hippocampal microglia
however, hippocampal macrophages had an increased quantity of membrane surface MHC II on
double positive cells.
In high-dose lead exposed animals, a dramatic decrease in the percentage of hippocampal
macrophages with membrane surface CCR7 was detected (Mdn = 0.32%; MFI Mdn = 19903) as
compared to controls (Mdn = 5.24%; MFI Mdn = 20778) and as compared to low-dose (Mdn =
7.46%; MFI Mdn = 45687) while at the same time, an increased quantity of MHC II (measured
as mean fluorescence intensity) was found in double positive cells. Moreover, in high-dose
animals an increased quantity of MHC II in double positive brain macrophages was detected.
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These results suggested that similar mechanisms might have mediated results in
microglia and macrophages. That is, it could be that hippocampal macrophages exited the brain
to reach cervical lymph nodes while (fewer) MHC II-expressing macrophages remained in
hippocampus and brain to continue neuroimmune surveillance. Alternatively, it could be that
MHC II and CCR7 were directly reduced as a result of high-level lead exposure. The former
possibility seems more plausible however because the decrease in percentage of CCR7 positive
hippocampal macrophages was concomitant with an increase in the percentage of immune cells
(lymphocytes and monocytes) in hippocampus. Thus, hippocampal macrophages might have
exited brain and reached cervical lymph nodes to communicate to other immune cells that there
was damage or threat to brain tissue, which in turn would promote increased trafficking of
immune cells into hippocampus. Future studies should investigate whether T-cells and/or B-cells
for example are present in higher than expected quantities in hippocampus of higher-level lead
exposed young mice.
The findings of increased number of immune cells in high-level lead exposed animals is
also consistent with findings at higher levels of lead exposure that revealed that macrophages
upregulated MHC II and primed T-cells towards a Th2 phenotype (humoral responses, i.e.,
antibody mediated immunity), and suggested that macrophages accessed lymph nodes (Dietert &
Piepenbrink, 2006, review; Kasten-Jolly & Lawrence, 2014, review).
4.2.3 Strengths of the neuroimmune studies. This is the first whole organism study to
examine neuroimmune mechanism effects of chronic low-level lead exposure on primary
hippocampal cells in young mice. Moreover, it is one of very few studies that have examined
factors associated with the trafficking of immune cells out of hippocampus and brain (and
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perhaps into deep cervical lymph nodes). Additionally, the present study is translational and
might increase the relevance of animal models for understanding effects in children.
4.2.4 Limitations. Since this is the first study to examine effects of chronic low-level
lead exposure in MHC II and CCR7 in neuroimmune cells the interpretation of the results is
conservative. Additionally, it is acknowledged that a wealth of basic research needs to be
conducted in order to better understand whether microglial cells and macrophages exit brain via
CCR7 and reach cervical lymph nodes to present MHC II under threatening conditions such as
exposure to environmental toxins and/or pathogens.
4.2.5 Conclusions. Overall, significant effects were observed in hippocampus and not in
brain suggesting that the hippocampus is a critical structure to continue studying to understand
effects of lead exposure in the developing brain. Contrary to our hypotheses, at pre-adolescence,
low-dose lead exposed animals had down-regulated MHC II and CCR7 as compared with
controls and higher-dose animals. Studies are needed to determine whether early chronic lowlevel lead exposure directly altered (the structure of) MHC II and CCR7, altered mechanisms
responsible for regulation of MHC II and CCR7, or whether apparent down-regulation of these is
in fact a secondary effect of changes in some as yet unknown altered immune factor. Patterns of
percentages of cells detected appeared to corroborate previous findings from our laboratory
showing that microglia cell density is significantly reduced in low-level lead exposed animals.
Finally, interesting and unexpected findings with regard to effects in macrophages (but not
microglia) in higher-dose animals suggested that early chronic low-level exposure promotes
primary changes in hippocampal microglia, while early chronic higher-level exposure promotes
primary changes in hippocampal macrophages. The findings suggest several avenues for future
research.
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4.3

Is Behavior Associated with Changes in the Neuroimmune System in Chronic Low-

Level Lead Exposed Mice?
Because this is our first attempt to measure MHC II and CCR7 in hippocampus of
chronic low-level lead exposed young mice and because behavior within treatment groups was
highly variable there was no attempt to predict effects of CCR7 on behavior (using statistical
models). Future studies however should predict effects of CCR7 on behavior and possible
interactions between CCR7 and low-level lead on behavior. Interestingly, in the literature some
studies have examined the association between CCR7 and behavior and between reduced number
of immune cells in brain and behavior. The findings of these studies are discussed below.
4.3.1 Mouse studies showing a link between CCR7 and behavior. In a study CCR7 -/and CCR7 +/+ C57BL/6J mice were tested on a variety of behavioral tasks at 2-4 months in
intervals of one week and body weight was measured at 3 months (N = 56) (Jaehne & Baune,
2013). The behaviors examined included exploratory ambulation (open field test), exploratory
activity (nose poke task), object recognition memory (novel odor recognition task), spatial
learning and recognition memory (barns maze and Y-maze), anxiety (elevated zero maze),
depression-like behavior (forced swim test and saccharin preference test), and social behavior
(sociability test). Additionally, the cytokines TNF α, IL-1β, and IL-6 were measured in
prefrontal cortex and hippocampi of mice and examined with ELISA (enzyme-linked
immunosorbent assay.)
It was found that CCR7 -/- mice displayed spatial learning and memory deficits measured
with barns and Y-maze, increased anxiety measured with elevated zero maze, and increased
anhedonia (i.e. lack of pleasure) measured with saccharine preference test as compared to
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controls. No significant effects were detected for the other behavioral outcomes measured or for
cytokine analyses. Interestingly it was also found that at 3 months of age CCR7 -/- male mice
weighed less as compared to controls. These results suggested that in the healthy mouse CCR7
plays a role in regulating spatial learning and memory, anxiety, pleasure, and body weight.
In a similar study, the effects of CCR7 and the interaction between CCR7 and maternal
separation were measured in CCR7 -/- and CCR7 +/+ C57BL/6J mice (N = 50) (Harrison et al.,
2014). At PND 0 mice were randomly assigned to be reared under normal conditions (nonmaternal separation protocol, naïve mice) or they were separated from their dams 3 hours daily
from PND 1 to PND 14 (maternal separation protocol). At 10 weeks of age several tests were
performed to examine the effects of CCR7 in naïve mice and the effects of maternal separation
of CCR7 on behavior. These tests included measures of depression-like behavior (saccharine
preference test), exploratory ambulation and anxiety (open field test), anxiety (elevated zero
maze), and social behavior (sociability test). Additionally, corticosterone levels were measured
with ELISA to examine neuroendocrine function.
It was found that CCR7 -/- naïve mice had increased anxiety as compared to controls. It
was also found that maternally separated CCR7 -/- mice had reduced interest in social novelty
but increased corticosterone levels as compared to CCR7 -/- naïve mice and controls. These
results replicated the findings described above and suggested that CCR7 plays a role in anxiety.
Additionally, it was suggested that under circumstances of high stress such as maternal
separation CCR7 plays a role in social behavior and these effects might be influenced by changes
in corticosterone levels and thus alterations of the hypothalamic-pituitary-adrenal (HPA) axis.
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Future studies should examine whether CCR7 plays a role in regulating other types of
behaviors and cognitive functions including olfactory memory during both health and disease.
Additionally, future studies should examine whether and how CCR7 influences the development
and/or proper function of brain areas such as frontal cortex, hippocampus, and amygdala, and the
HPA axis. The lack of significant differences in the cytokines described above (TNF α, IL-1β,
and IL-6) suggested that when the animal is healthy CCR7 does not influence the levels of these
pro-inflammatory cytokines in hippocampus or prefrontal cortex. It would be important however
to examine whether CCR7 influences the levels of pro- and anti-inflammatory cytokines in
hippocampus and prefrontal cortex after an insult to the brain such as exposure to low-levels of
lead and its effects on behavior. Additionally, studies examining the relationship between CCR7
and body weight and lead exposure are needed.
4.3.2 How could CCR7 modulate behavior? It could be that when the animal is healthy
the normal circulation of immune cells via CCR7 in brain lymphatics and drainage into cervical
lymph nodes is necessary to support normal behavior. Although studies have not examined
directly this question yet, some studies have shown that reduced levels of immune cells in brain
caused changes on behavior and that these changes might be associated with normal circulation
of cells perhaps via CCR7. These studies are discussed next.
4.3.3 Does reduced number of immune cells in brain alter behavior? A recent study
showed that depletion of microglial cells in hippocampus resulted in deficits in object
recognition memory measured with the NOR task (novel object recognition task) and that these
deficits were associated with a reduction of BDNF (brain derived neurotrophic factor) (Parkhust
et al., 2013). These results suggested that microglia plays an important role in modulating object
recognition memory via BDNF. Future studies should examine whether the reduction of
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microglial cells in hippocampus of chronic low-level lead mice is associated with reduced BDNF
and whether these changes mediate deficits in memory and exploratory activity.
Interestingly, in another study it was found that MHC II -/- mice had decreased number of
CD4+ T cells in the meninges and that this reduction was associated with impaired spatial
memory measured with the MWM (morris water maze) (Radjavi, Smirnof, and Kipnis, 2014). In
a similar study it was found that reduced number of T-cells in meninges resulted in reduced IL-4
levels and reduced spatial memory (Derecki et al., 2010). Additionally, studies have shown that
removal of deep cervical lymph nodes results in increased numbers of CD4+ T cells in
meningeal spaces and reduced spatial memory measured in the MWM (Radjavi et al., 2013).
These results suggested that CD4+ T cells and perhaps the proper trafficking of these cells via
CCR7 into deep cervical lymph nodes is necessary for maintaining spatial memory. Additionally,
these results suggested that proper communication between CD4+ T cells and cells from the
innate immune system such as microglia, macrophages, and/or dendritic cells via MHC II is
needed for the recruitment of CD4+ T cells into meningeal spaces and thus modulation of spatial
memory. Future studies should examine whether interactions between microglia, macrophages,
and or dendritic cells via MHC II result in differential recruitment of CD4+ T cells and changes
on behavior after exposure to chronic low-levels of lead.
4.3.4

Conclusions. A small but growing body of literature is starting to reveal a strong

relationship between the CNS and the immune system in regulating behavior both during health
and disease. The studies described above and the recent findings of lymphatic vessels in brain
suggested that the pathway for communication between cells from the innate immune system
that reside in brain (e.g. microglia, macrophages, and/or dendritic cells) and the adaptive immune
system (e.g. T-cells) might be through trafficking of immune cells through brain lymphatics via
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CCR7 and drainage into deep cervical lymph nodes for antigen presentation of MHC II. Also,
these results suggested that during both health and disease this communication might regulate
behavior via changes in cytokine levels such as IL-4 and other proteins such as BNDF. It will be
important to examine whether these interactions are associated with behavior following
exposure to environmental toxins such as low-levels of lead.
4.4

Final Remarks
The present study is one of few that have examined effects of chronic low-level lead

exposure on behavior and the neuroimmune system in C57BL/6J young mice, perhaps with
greater relevance for understanding effects in exposed children. Past studies in our laboratory
have shown that chronic low-level lead exposure altered olfactory memory, exploratory activity,
and rearing behavior during a retrieval memory task in young mice (Flores-Montoya & Sobin,
2014; Flores-Montoya et al., 2015; Sobin et al., 2017). Additionally, two studies in our
laboratory have shown that low-level lead exposed mice have reduced microglial cell density in
DG (dentate gyrus) and whole hippocampus (Sobin et al., 2013; Dominguez et al., 2017,
manuscript in preparation). The present study showed that chronic low-level lead exposure
decreased exploratory activity and increased body weight in young mice. It was also found that
the percentage of microglial cells were reduced in hippocampus of low-level lead exposed mice
and that MHC II and CCR7 were reduced. Additional exploratory analyses showed that highlevel lead exposed mice had reduced macrophages expressing CCR7 but had higher levels of
MHC II.
The mechanisms mediating the above described effects on behavior and the
neuroimmune system are not known however past studies and present studies suggest that the
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hippocampus is a primary target of disruption for low-levels of lead and that MHC II and CCR7
might mediate some of these effects. A small but growing body of literature is starting to reveal
that MHC II and CCR7 play a role in behavior during health and disease and that trafficking of
immune cells outside of brain and into deep cervical lymph nodes might be associated with
behavioral deficits.
It has been known for decades that the CNS and immune system constantly communicate
however it is only recently that the extent to which this communication occurs and its impact on
behavior during health and disease is starting to be revealed. In fact for decades, it was thought
that the brain and immune system did not have a specific route of communication. New evidence
is suggesting that the communication between these systems is far more fluid than previously
thought, that immune cells residing in meninges are critical for regulating cognition and
behavior, and that cells might be constantly trafficking outside of brain and into deep cervical
lymph nodes perhaps in order to promote at type of immune cell communication that modulates
behavior. The extent to which behavioral deficits in early chronic low-level lead exposure occur
as a result of disruption in these mechanisms is not yet known. The findings of the present study
however suggested that mechanisms associated with trafficking and communication between
immune cells via MHC II and CCR7 were altered. Whether these mechanisms directly affect
behavior, and also perhaps body weight, remain a subject for further investigation.
4.5

Future Directions
Future studies of chronic low-level lead exposure in young animals should further

examine behavioral deficits associated with cognitive functions such as “curiosity” and should
use simpler olfactory memory tests to identify additional tests that are sensitive to the effects of
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chronic low-level lead exposure. Studies examining effects on body weight perhaps via changes
in CCR7 in lead-exposed mice will be important to conduct. Finally, future studies should
examine whether lead-exposure induces the trafficking of microglia and/or macrophages outside
of brain into deep cervical lymph nodes via CCR7 for antigen presentation of MHC II to T cells,
or whether lead-exposure alters the expression or levels of these markers. Determination of these
effects could provide the groundwork for the development of new and more effective treatments
for cognitive deficits in children associated with chronic low-level lead exposure, and perhaps
could prevent the development of secondary metabolic disorders.
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Table 1. Body weight group differences in young C57BL/6J mice with and without early lead
exposure examined with general linear model
df

F

p
Est

Body weight
PND
Group
PND x Group
PND14

PND 21

PND 28

2, 60
2, 30
4, 60

347.3
9.48
4.05

Parameter Estimate Solutions
SE
df
t

p

0.000
0.001
0.006
Intercept
0 ppm
30 ppm
430 ppm
Intercept
0 ppm
30 ppm
430 ppm
Intercept
0 ppm
30 ppm
430 ppm

N = 33

157

7.785
0
-0.218
-0.397
9.036
0
1.195
0.288
14.752
0
1.625
-1.063

0.302
.
0.427
0.427
0.310
.
0.439
0.439
0.442
.
0.624
0.624

.
60
60

.
-0.511
-0.929

.
0.613
0.360

.
60
60

.
2.723
0.655

.
0.011
0.517

.
60
60

.
2.603
-1.702

.
0.014
0.099

Table 2. Righting reflex group differences in young C57BL/6J mice with and without early lead
exposure examined with general linear model
df

F

p
Est

Righting reflex
PND
Group
PND x Group
PND7

PND 14

PND 21

2, 60
2, 30
4, 60

14.31
2.66
2.38

Parameter Estimate Solutions
SE
df
t

p

0.001
0.086
0.110
Intercept
0 ppm
30 ppm
430 ppm
Intercept
0 ppm
30 ppm
430 ppm
Intercept
0 ppm
30 ppm
430 ppm

N = 33

158

3.748
0
-0.969
5.539
0.434
0
0.207
0.357
0.224
0
-0.29
0.036

2.233
.
3.158
3.158
0.068
.
0.096
0.096
0.018
.
0.026
0.026

.
60
60

.
-0.307
1.754

.
0.761
0.090

.
60
60

.
2.154
3.712

.
0.039
0.001

.
60
60

.
-1.14
1.42

.
0.263
0.165

Table 3. Open field behavior group differences in young C57BL6/J mice with and without early
chronic lead exposure examined with generalized linear model

df

Likelihood
Ratio
X²

Parameter Estimate Solutions
p
Est

Rear Number
Periphery
Group

2

25.59

0.00

Center
Group

2

11.43

0.00

Distance travelled
(cm)
Total
Group

2

1.19

0.55

Periphery
Group

2

4.934

0.08

2

5.608

0.061

Time in periphery (s)
Group

SE

Intercept
0 ppm
30 ppm
430 ppm
Intercept
0 ppm
30 ppm
430 ppm

3.532
0
-.393
-.133
0.598
0
-0.88
-1.37

0.516
.
0.0723
0.0723
0.224
.
0.401
0.46

Intercept
0 ppm
30 ppm
430 ppm
Intercept
0 ppm
30 ppm
430 ppm
Intercept

4092.131
0
40.16
217.72
3034.45
.
153.64
367.27
0.772

157.69
.
218.32
214.26
118.74
.
164.38
161.33
0.018

0 ppm
30 ppm
430 ppm

0
0.040
0.063

.
0.026
0.025

N = 36

159

df

Wald
X²

p

.
1
1

.
24.58
3.38

.
0.000
0.066

.
1
1

.
4.867
8.676

.
0.027
0.003

.
1
1

.
0.034
1.033

.
0.854
0.310

.
1
1

.
0.87
5.18

.
0.350
0.023

.
1
1

.
2.375
5.988

.
0.123
0.014

Table 4. Non-social odor exploration time (habituation) test of group differences in young
C57BL6/J mice with and without early chronic lead exposure examined with general linear
model
df

F

p
Est

Water
Trial
Group
Trial x Group
Trial 1

2, 60
2, 30
4, 60

13.03
0.298
0.148

Intercept
0 ppm
30 ppm
430 ppm
Intercept
0 ppm
30 ppm
430 ppm
Intercept
0 ppm
30 ppm
430 ppm
Intercept

Trial 3

Almond
2, 60
2, 30
4, 60

6.83
0.31
1.35

Trial 3

Orange

Trial 2

Trial 3

2, 60
2, 30
4, 60

1.41
0.49
0.28

16.66
0
3.03
-1.23
8.44
0
-0.64
-1.79
3.77
0
3.54
-.958
4.7

0.02
0.73
0.26

Trial 2

Trial
Group
Trial x Group
Trial 1

p

0.00
0.74
0.96

Trial 2

Trial
Group
Trial x Group
Trial1

Parameter Estimate Solutions
SE
df
t

6.37
.
9.00
9.00
2.08
.
2.94
2.94
1.75
.
2.48
2.48
1.46
.

.
60
60
60
.
60
60
60
.
60
60
60
.

0 ppm
30 ppm
430 ppm
Intercept
0 ppm
30 ppm
430 ppm
Intercept
0 ppm
30 ppm
430 ppm
Intercept

0
-1.48
0.215
1.94
0
1.01
-0.593
3.03
0
-2.07
-1.19
1.24

.
2.07
2.07
0.66
.
0.93
0.93
0.82
.
1.16
1.16
0.91

.
60
60
60
.
60
60
60
.
60
60
60

0 ppm
30 ppm
430 ppm
Intercept
0 ppm
30 ppm
430 ppm
Intercept
0 ppm
30 ppm
430 ppm

0
0.79
1.05
.905
0
-0.44
-0.299
0.888
0
1.339
1.43

.
1.28
1.28
0.366
.
0.518
0.518
1.380
.
1.95
1.95

.
60
60
60
.
60
60
60
.
60
60

.
0.336
-.137

.
0.739
0.892

.
-0.218
-6.1

.
0.829
0.55

.
1.43
-0.387

.
0.163
0.702

.

.

.
-.72
0.104

.
0.478
0.918

.
1.08
-0.632

.
0.289
0.532

.
-1.77
-1.02

.
0.086
0.315

.
0.619
0.824
2.47
.
-.853
-.577
.644
.
.686
0.733

.
0.541
0.416
0.19
.
0.40
0.569
0.525
.
.498
0.469

0.25
0.61
0.88

N = 33
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Table 5. Social odor exploration time (habituation) test of group differences in young C57BL6/J
mice with and without early chronic lead exposure examined with general linear model
df

F

p
Est

Social Scent 1
Trial
Group
Trial x Group

2, 60
2, 30
4, 60

2.62
0.65
0.62

Intercept
0 ppm
30 ppm
430 ppm
Intercept
0 ppm
30 ppm
430 ppm
Intercept
0 ppm
30 ppm
430 ppm
Intercept

Trial 2

Trial 3

2, 60
2, 30
4, 60
Trial 1

Trial 2

Trial 3

0.109
0.317
0.250

t

p

0.08
0.52
0.65

Trial 1

Social Scent 2
Trial
Group
Trial x Group

Solutions for Fixed Effects
SE
df

10.93
0
-7.71
-3.05
3.81
0
0.76
0.16
2.77
0
-2.06
0.28
2.91

0.89
0.73
0.90
0 ppm
30 ppm
430 ppm
Intercept
0 ppm
30 ppm
430 ppm
Intercept
0 ppm
30 ppm
430 ppm

0
2.65
-.389
2.82
0
.378
-.186
2.17
0
1.00
1.80

N = 33

161

4.06
.
5.74
5.74
2.84
.
4.01
4.01
1.41
.
1.99
1.99
2.22
.

.
60
60
60
.
60
60
60
.
60
60
60
.

.
-1.34
-.532

.
0.19
.599

.
0.19
0.41

.
0.85
0.96

.
-1.03
0.14

.
0.31
0.88

.

.

.
3.13
3.136
1.73
.
2.45
2.44
2.32
.
3.28
3.28

.
60
60
60
.
60
60
60
.
60
60

.
0.84
-.124

.
0.40
.902

.
0.154
-0.76

.
0.87
0.94

.
0.30
0.55

.
0.763
0.587

Table 6. Social odor exploration time (dishabituation) test of group differences in young
C57BL6/J mice with and without early chronic lead exposure examined with general linear
model analyses
df

F

p
Est

Water T3 vs. Almond T1
Trial
Group
Trial x Group
Water Trial 3

1, 30
2, 30
2, 30

0.076
0.367
2.317

1,30
2,30
2,30

0.015
0.315
1.586

1, 30
2,30
2, 30

7.37
0.45
1.64

Social Scent 2 Trial 1

1, 30
2, 30
2,30

0.002
1.465
1.611

Intercept
0 ppm
30 ppm
430 ppm
Intercept
0 ppm
30 ppm
430 ppm

3.76
0
3.545
-0.958
4.71
0
-1.48
.215

1.75
.
2.478
2.478
1.463
.
2.07
2.07

Intercept
0 ppm
30 ppm
430 ppm
Intercept
0 ppm
30 ppm
430 ppm

3.03
0
-2.075
-1.192
1.24
0
0.79
1.05

0.82
.
1.167
1.167
0.91
.
1.28
1.28

Intercept
0 ppm
30 ppm
430 ppm
Intercept
0 ppm
30 ppm
430 ppm

0.88
0
1.339
1.430
10.932
0
-7.715
-3.055

1.30
.
1.95
1.95
4.065
.
5.748
5.748

Intercept
0 ppm
30 ppm
430 ppm
Intercept
0 ppm
30 ppm
430 ppm

1.500
0
-1.364
-0.545
1.136
0
-0.091
-0.733

0.501
.
0.708
0.708
0.415
.
0.587
0.587

.
30
30

.
1.431
-.387

.
0.163
0.702

.
30
30

.
-.718
.104

.
.478
.918

.
30
30
.
30
30

.
-1.77
-1.021
1.367
.
0.619
0.824

.
0.086
0.315
0.182
.
0.541
0.416

.
30
30

.
0.686
0.733

.
0.498
0.469

.
30
30

.
-1.342
-0.532

.
0.190
0.599

.
30
30

.
-1.925
-0.770

.
0.064
0.447

.
30
30

.
-0.155
-1.317

.
0.878
0.198

0.011
0.642
0.210

Social Scent 1 Trial 1

SS 1 T3 vs. SS 2 T1
Trial
Group
Trial x Group
Social Scent 1 Trial 3

p

0.905
0.732
0.221

Orange Trial 1

Orange T3 vs. SS 1 T1
Trial
Group
Trial x Group
Orange Trial 3

t

0.785
0.696
0.116

Almond Trial 1

Almond T3 vs. Orange T1
Trial
Group
Trial x Group
Almond Trial 3

Solutions for Fixed Effects
SE
df

0.967
0.247
0.216

N = 33
T. refers to trial
SS. refers to social scent
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Table 7. Hippocampal microglial cell median values for measured parameters in young
C57BL6/J mice with and without chronic lead exposure*
%

Cell Count

Mean Fluorescence Intensity (MFI)

Parent Population

(Median)

(GM/CV)**

(Median)
0
30
ppm ppm

430
ppm

0
ppm

30
ppm

430
ppm

0
ppm

30
ppm

430
ppm

Overall
Microglia

.4425 .3945 .6035

4656

1846

12883

…

…

…

MHC II

…

…

…

…

…

…

6341 ±117

4878 ±114

4987 ±69

CCR7

…

…

…

…

…

.…

5604 ± 38

4656 ± 36

3938 ± 36

MHC II

.0068 .0053 .0050

26

15

83

27946 ± 168 21386 ± 0136

16739±144

CCR7

.0160 .0067 .0035

25

9

45

14454 ± 544

11326 ± 8

10927±30

MHCII/CCR7

.0031 .0016 .0006

7

1

8

…

…

…

Quadrant

MHC II

…

…

…

…

…

…

18395±34

13532 ±0

18545±32

CCR7

…

…

…

…

…

…

15108±7

11080±0

11201.5± 0

*N = 12 samples, from 36 animals combined into groups of 3 to ensure sufficient cells for hippocampus tests.
** Geometric mean/Coefficient of variation
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Table 8. Brain microglial cell median values for measured parameters in young C57BL6/J mice
with and without chronic lead exposure*
Mean Fluorescence Intensity (MFI)
%
0
ppm

Count

30
ppm

430
ppm

0
ppm

30
ppm

(GM/CV)**
430
ppm

0

ppm

30

ppm

430
ppm

Overall
Microglia

0.8515 0.8285 0.7800

46068 44507

44507

…

…

…

MHC II

…

…

…

…

…

…

5307 ± 78

4722 ±108

5371± 66

CCR7

…

…

…

…

…

…

4163 ± 41

4278 ±49

4329 ± 41

MHC II

0.0039 0.0048 0.0024

164

199

159

18694 ± 113 18987±207 23095 ±153

CCR7

0.0018 0.0022 0.0023

72

97

141

12320 ± 109 13286±145 12006 ±127

MHCII/CCR7 0.0006 0.0007 0.0005

21

28

29

Quadrant

MHC II

…

…

…

…

…

…

CCR7

…

…

…

…

…

…

…

…

…

29374 ± 125 28039±125 23420 ± 71
12351 ± 18

13100±24

12604 ±19

*N = 12 samples, from 36 animals combined into groups of 3 to ensure sufficient cells for hippocampus tests.
** Geometric mean/Coefficient of variation
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Table 9. Hippocampal macrophage median values for measured parameters in young C57BL6/J
mice with and without chronic lead exposure*
Mean Fluorescence Intensity (MFI)
%
0
ppm

Count

30
ppm

430
ppm

0
ppm

(GM/CV)**

30 430
ppm ppm

0

ppm

30
ppm

430 ppm

Overall
Macrophages

.0408

.0506

.0298

171

210

520

MHC II

…

…

…

…

…

CCR7

…

…

…

…

MHC II

.3025

.4535

.5010

CCR7

.0524

.0746

MHC II/CCR7

.2655

MHC II
CCR7

…

…

…

…

10786 ±175 10920±247

15964±267

…

…

9695 ± 247

60

86

262

.0032

22

21

.1510

.2380

42

…

…

…

…

…

…

7342±67

6969±165

19555±181 17908±184

18879±288

2

20778±128

19903±40

45687±132

35

136

…

…

…

…

…

…

21371±79

21720± 49

29264±100

…

…

…

14753±89

13880±51

13360±28

Quadrant

*N = 12 samples, from 36 animals combined into groups of 3 to ensure sufficient cells for hippocampus tests.
** Geometric mean/Coefficient of variation
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Table 10. Brain macrophage median values for measured parameters in young C57BL6/J mice
with and without chronic lead exposure*
Mean Fluorescence Intensity (MFI)
%
0 ppm

Count

30
ppm

430
ppm

0
ppm

30
ppm

.0389

1878 1569

(GM/CV)**
430
ppm

0
ppm

30
ppm

430
ppm

Overall
Macrophages

.0390 .0334

3118

…

…

…

MHC II

…

…

…

…

…

…

7940 ± 275

7763 ± 357

8946 ± 311

CCR7

…

…

…

…

…

…

5346 ± 150

5315 ± 284

5722 ± 241

MHC II

.2810 .3040

2865

507

344

745

19088 ± 208 18678 ± 274 20745 ± 235

CCR7

.0282 .0265

.0049

61

34

15

17357 ± 167 19970 ± 222 26494 ± 189

.0807 .0578

.1465

131

81

337

Quadrant

MHC II/CCR7
MHC II

…

…

…

…

…

…

CCR7

…

…

…

…

…

…

…

…

…

24117 ± 228 18752 ± 104 25588 ± 159
3388 ± 53

13247 ± 31

12446 ± 47

*N = 12 samples, from 36 animals combined into groups of 3 to ensure sufficient cells for hippocampus tests.
** Geometric mean/Coefficient of variation
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Table 11. Hippocampal and brain immune cell median values for measured parameters in young
C57BL6/J mice with and without chronic lead exposure*

%

Count

0
ppm

30
ppm

430
ppm

0
ppm

30
ppm

430
ppm

Hippocampal immune cells

.4640

.3330

.5665

10882

4742

21934

Brain immune cells

.7530

.7685

.8360

53304

53136

80001

*N = 12 samples, from 36 animals combined into groups of 3 to ensure sufficient cells for hippocampus tests.
** Geometric mean/Coefficient of variation
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Table 12. Chi-square results for differences in microglial cell percentage of parent population
measured in hippocampus and brain in young C57BL6/J mice with and without early chronic
lead exposure*

Hippocampus

Brain

Chi-square

df

p-value

1437.326

2

.000

MHC II

6.494

2

.039

CCR7

46.801

2

.000

MHCII/CCR7

2.036

2

.361

879.414

2

.000

MHC II

859.479

2

.000

CCR7

40.006

2

000

MHCII/CCR7

19.837

2

.000

Microglia

Microglia

*N = 12 samples, from 36 animals combined into groups of 3 to ensure sufficient cells for hippocampus tests.
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Table 13. Chi-square results for differences in macrophage percentage of parent population
measured in hippocampus and brain in young C57BL6J mice with and without early chronic lead
exposure*

Hippocampus

Brain

Chi-square

df

p-value

215.970

2

.000

MHC II

14.066

2

.001

CCR7

74.665

2

.000

MHCII/CCR7

56.273

2

.000

434.930

2

.000

MHC II

14.066

2

.001

CCR7

42.695

2

.000

MHCII/CCR7

169.415

2

.000

Macrophages

Macrophages

*N = 12 samples, from 36 animals combined into groups of 3 to ensure sufficient cells for hippocampus tests.
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Table 14. Chi-square results for differences in immune cell percentage measured in hippocampus
and brain in young C57BL6J mice with and without early chronic lead exposure*

Chi-square

df

p-value

Hippocampus

Immune cells

2585.208

2

.000

Brain

Immune cells

2876.674

2

.000

*N = 12 samples, from 36 animals combined into groups of 3 to ensure sufficient cells for hippocampus tests.
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Table 15. Hippocampal microglial cell results examining differences between groups with
independent samples median tests in young C57BL6/J mice with and without chronic lead
exposure*
Test-statistic

df

p-value

%

2.00

2

0.368

Cell Count

8.00

2

0.018

MFI (GM)**

2.00

2

0.368

MFI (GM)

6.00

2

0.050

%

0.005

2

0.368

Cell Count

8.00

2

0.018

MFI (GM)

2.00

2

0.368

%

0.69

2

0.71

Cell Count

6.00

2

0.050

MFI (GM)

0.00

2

1.00

MHC II

MFI (GM)

6.00

2

0.050

CCR7

MFI (GM)

2.00

2

0.368

Overall Analyses
Microglia

MHC II
CCR7

Quadrant Analyses
“Single positive”
MHC II

“Single positive”
CCR7

“Double positive”
MHCII/CCR7***

*N = 12 samples, from 36 animals combined into groups of 3 to ensure sufficient cells for hippocampus tests.
** Mean fluorescence intensity/geometric mean.
***Chi-square did not show significant differences between group (see Table 12) thus double positives percentage
and count were not examined with independent samples median tests.
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Table 16. Brain microglial cell results examining differences between groups with independent
samples median tests in young C57BL6/J mice with and without chronic lead exposure*
Test-statistic

df

p-value

%

2.00

2

0.368

Cell Count

2.00

2

0.368

MFI (GM)**

2.00

2

0.368

MFI (GM)

2.00

2

0.368

%

2.00

2

0.368

Cell Count

2.00

2

0.368

MFI (GM)

2.00

2

0.368

%

6.00

2

0.050

Cell Count

2.00

2

0.368

MFI (GM)

2.00

2

0.369

%

2.00

2

0.368

Cell Count

2.00

2

0.368

MHC II

MFI (GM)

2.00

2

0.368

CCR7

MFI (GM)

0.00

2

1.00

Overall Analyses
Microglia

MHC II
CCR7

Quadrant Analyses
“Single positive”
MHC II

“Single positive”
CCR7

“Double positive"
MHCII/CCR7

*N = 12 samples, from 36 animals combined into groups of 3 to ensure sufficient cells for hippocampus tests.
** Mean fluorescence intensity/geometric mean
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Table 17. Hippocampal macrophages results examining differences between groups with
independent samples median tests in young C57BL6/J mice with and without chronic lead
exposure*
Test-statistic

df

p-value

%

6.00

2

0.050

Cell Count

6.00

2

0.050

MHC II

MFI (GM)

2.00

2

0.368

CCR7

MFI (GM)

2.00

2

0.368

%

2.00

2

0.368

Cell Count

6.00

2

0.050

MFI (GM)

2.00

2

0.368

%

8.00

2

0.018

Cell Count

2.00

2

0.368

MFI (GM)

1.253

2

0.535

%

0.00

2

1.00

Cell Count

2.00

2

0.368

MHC II

MFI (GM)

6.00

2

0.050

CCR7

MFI (GM)

0.00

2

1.00

Overall Analyses
Macrophages

Quadrant Analyses
“Single positive”
MHC II

“Single positive”
CCR7

“Double positive”
MHCII/CCR7

*N = 12 samples, from 36 animals combined into groups of 3 to ensure sufficient cells for hippocampus tests.
** Mean fluorescence intensity/geometric mean
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Table 18. Brain macrophages results examining differences between groups with independent
samples median tests in young C57BL6/J mice with and without chronic lead exposure*

Test-statistic

df

p-value

%

2.00

2

0.368

Cell Count

2.00

2

0.368

MHC II

MFI (GM)

2.00

2

0.368

CCR7

MFI (GM)

0.00

2

1.00

%

0.00

2

1.00

Cell Count

2.00

2

0.368

MFI (GM)

2.00

2

0.368

%

2.00

2

0.368

Cell Count

2.00

2

0.368

MFI (GM)

2.00

2

0.368

%

2.00

2

0.368

Cell Count

2.00

2

0.368

MHC II

MFI (GM)

8.00

2

0.018

CCR7

MFI (GM)

2.00

2

0.368

Overall Analyses
Macrophages

Quadrant Analyses
“Single positive”
MHC II

“Single positive”
CCR7

“Double positive”
(MHCII/CCR7)

*N = 12 samples, from 36 animals combined into groups of 3 to ensure sufficient cells for hippocampus tests.
** Mean fluorescence intensity/geometric mean
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Table 19. Hippocampal and brain immune cell results examining differences between groups
with independent samples median tests in young C57BL6/J mice with and without chronic lead
exposure*

Hippocampal Immune cells

Brain Immune cells

Test-statistic

df

p-value

%

8.00

2

0.018

Cell Count

8.00

2

0.018

%

2.00

2

0.368

Cell Count

6.00

2

0.050

*N = 12 samples, from 36 animals combined into groups of 3 to ensure sufficient cells for hippocampus tests.
** Mean fluorescence intensity/geometric mean
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Table 20. Post-hoc analyses for significant main effect group comparisons in hippocampal
microglial cells of young C57BL6/J mice with and without chronic lead exposure*
Group Comparison Statistics
0 ppm vs. 30 ppm

0 ppm vs. 430

30 ppm vs. 430 ppm

ppm
test

p

test

p

test

p

Overall
Microglia

Cell Count

0.00

1.00

2.00

0.427

8.00

0.014

CCR7

MFI (GM)

8.00

0.014

2.00

0.472

2.00

0.472

MHC II

Cell Count

0.00

1.00

2.00

0.472

8.00

0.014

CCR7

Cell Count

2.00

0.472

2.00

0.472

2.00

0.472

MFI (GM)

8.00

0.014

0.00

1.00

2.00

0.472

Quadrant

MHC II¹

*N = 12 samples, from 36 animals combined into groups of 3 to ensure sufficient cells for hippocampus tests.
¹ Refers to MHCII measure of double positive microglial cell measured in hippocampus.
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Table 21. Post-hoc analyses for significant main effect group comparisons in brain microglial
cells of young C57BL6/J mice with and without chronic lead exposure*
Variables

Group Comparisons Statistics
0 ppm vs. 30 ppm

0 ppm vs. 430 ppm

30 ppm vs. 430 ppm

test

p

test

p

test

p

2.00

0.472

2.00

0.472

0.533

1.00

Quadrant
CCR7

%

*N = 12 samples, from 36 animals combined into groups of 3 to ensure sufficient cells for hippocampus tests.
¹ Refers to MHCII measure of double positive microglial cell measured in brain.
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Table 22. Post-hoc analyses for significant main effect group comparisons in hippocampal
macrophages of young C57BL6/J mice with and without chronic lead exposure*
Group Comparison Statistics
0 ppm vs. 30 ppm

0 ppm vs. 430 ppm

30 ppm vs. 430
ppm

Test

p

Test

p

Test

p

Overall
Macrophages

%

0.00

1.00

2.00

0.472

2.00

0.472

Macrophages

Cell Count

0.00

1.00

2.00

0.472

8.00

0.014

Simulated**

6.00

0.043

0.00

1.000

24.00

0.000

Cell Count

0.00

1.00

2.00

0.472

8.00

0.014

Simulated

0.66

1.00

2.67

0.310

24.00

0.000

%

0.00

1.00

8.00

0.014

2.00

0.472

Simulated

0.67

1.00

24.00

0.000

24.00

0.003

MFI (GM)

0.00

1.00

8.00

0.014

2.00

0.472

Simulated

0.67

1.00

16.67

0.000

24.00

0.000

Quadrant
MHC II

CCR7

MHCI I¹

*N = 12 samples, from 36 animals combined into groups of 3 to ensure sufficient cells for hippocampus tests.
**Simulated refers to database representing N = 36.
¹ Refers to MHCII measure of double positive microglial cell measured in brain.
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Table 23. Post-hoc analyses for significant main effect group comparisons in brain macrophages
of young C57BL6/J mice with and without chronic lead exposure*
Variables

Group Comparison Statistics
0 ppm vs. 30 ppm

MHC II¹

MFI (GM)

0 ppm vs. 430 ppm

30 ppm vs. 430 ppm

Test

p

Test

p

Test

p

4.00

0.350

-3.25

0.61

-7.25

0.013

*N = 12 samples, from 36 animals combined into groups of 3 to ensure sufficient cells for hippocampus tests.
¹ Refers to MHCII measure of double positive microglial cell measured in brain.
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Table 24. Post-hoc analyses for significant main effect group comparisons hippocampal and
brain immune cells of young C57BL6/J mice with and without chronic lead exposure*
Group Comparison Statistics
0 ppm vs. 30 ppm

Hippocampal immune cells

Brain immune cells

0 ppm vs. 430 ppm 30 ppm vs. 430 ppm

Test

p

Test

p

Test

p

%

0.00

1.00

0.00

1.00

8.00

0.014

Count

2.00

0.472

2.00

0.472

8.00

0.014

Count

0.00

1.00

8.00

0.014

2.00

0.472

*N = 12 samples, from 36 animals combined into groups of 3 to ensure sufficient cells for hippocampus tests.
¹ Refers to MHCII measure of double positive microglial cell measured in brain.
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Table 25. Tests of homogeneity of variance for behavioral outcomes measured at one time point
in young C57BL6/J mice with and without early chronic lead exposure*

Inverted screen test
Open Field
Rearing
Periphery
Center
Distance travelled
Total
Periphery
Time in Periphery

Test statistic

df

P

4.677

2, 30

0.017

1.801
2.691

2, 33
2, 33

0.181
0.083

2.521
1.768
0.165

2, 33
2, 33
2, 33

0.096
0.076
0.848

*Levene’s statistic was used to examine homogeneity of variance in outcome variables measured at one time point
(PND 28).
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Table 26. Tests of sphericity for behavioral outcomes measured at different time points in young
C57BL6/J mice with and without early chronic lead exposure*
Test statistic

df

p

0.957
0.003

2
2

0.532
0.000

0.273
0.765
0.652
0.496
0.990

2
2
2
2
2

0.000
0.021
0.002
0.000
0.859

1.00
1.00
1.00
1.00

0
0
0
0

.
.
.
.

BLLs
Developmental Milestones
Body weight
Righting reflex
Odor habituation/dishabituation
Habituation
Water
Almond
Orange
Social Scent 1
Social Scent 2
Dishabituation
WT3 TO AT1
AT3 OT1
OT3 SST1
SS1 T3 SS2 T1

*Mauchly’s test of sphericity statistic was used to examine homogeneity of variance in outcome variables measured
at different time points.
T. refers to trial.
SS. refers to social scent.
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Table 27. Tests of normality distribution for behavioral outcomes on developmental milestones
and open field in young C57BL6/J mice with and without early chronic lead exposure*
Developmental Milestones
Eye-opening
Body weight
PND 14

Test statistic

df

P

0.183
0.363
0.153
0.238
0.184
0.231
0.197
0.167
0.201

11
11
11
11
11
11
11
11
11

0.200
0.000
0.200
0.083
0.200
0.104
0.200
0.200
0.189

0.255
0.255
0.280
0.208
0.158
0.131
0.302
0.263
0.318
0.197
0.325
0.158

11
11
11
11
11
11
11
11
11
11
11
11

0.044
0.044
0.041
0.198
0.200
0.200
0.006
0.032
0.003
2.000
0.002
2.000

0.200
0.226
0.140
0.339
0.396
0.428

11
11
11
11
11
11

0.200
0.092
0.200
0.001
0.000
0.000

0.943
0.906
0.911
0.154
0.200
0.204
0.153
0.159
0.102

11
11
11
11
11
11
11
11
11

0.551
0.192
0.188
0.492
0.391
0.249
0.200
0.200
0.200

0 ppm
30 ppm
430 ppm

PND 21

0 ppm
30 ppm
430 ppm

PND 28

0 ppm
30 ppm
430 ppm

PND 7

0 ppm
30 ppm
430 ppm

PND 14

0 ppm
30 ppm
430 ppm

PND 21

0 ppm
30 ppm
430 ppm

Righting reflex

Inverted screen test

0 ppm
30 ppm
430 ppm

Open Field
Rearing
Periphery

0 ppm
30 ppm
430 ppm

Center

0 ppm
30 ppm
430 ppm

Distance travelled
Total

Periphery

Time in Periphery

0 ppm
30 ppm
430 ppm
0 ppm
30 ppm
430 ppm
0 ppm
30 ppm
430 ppm

*Kolmogorov-smirnov test was used to examine distribution properties.
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Table 28. Tests of normality distribution for behavioral outcomes on odor
habituation/dishabituation task (non-social odors) in young C57BL6/J mice with and without
early chronic lead exposure.
Group

Test statistic

df

p

Trial 1

0 ppm
30 ppm
430 ppm

Trial 2

0 ppm
30 ppm
430 ppm

Trial 3

0 ppm
30 ppm
430 ppm

0.150
0.310
0.360
0.137
0.201
0.187
0.284
0.324
0.208

11
11
11
11
11
11
11
11
11

0.200
0.004
0.000
2.000
2.000
0.012
0.013
0.002
0.200

Trial 1

0 ppm
30 ppm
430 ppm

Trial 1

0 ppm
30 ppm
430 ppm

Trial 3

0 ppm
30 ppm
430 ppm

0.189
0.153
0.314
0.280
0.166
0.182
0.326
0.255
0.253

11
11
11
11
11
11
11
11
11

2.00
2.00
0.003
0.016
0.200
0.200
0.002
0.043
0.048

Trial 1

0 ppm
30 ppm
430 ppm

Trial 2

0 ppm
30 ppm
430 ppm

Trial 3

0 ppm
30 ppm
430 ppm

0.349
0.238
0.280
0.405
0.312
0.332
0.257
0.478
0.411

11
11
11
11
11
11
11
11
11

0.001
0.081
0.016
0.000
0.004
0.001
0.042
0.000
0.000

Water

Almond

Orange

*Kolmogorov-smirnov test was used to examine distribution properties.
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Table 29. Tests of normality distribution for behavioral outcomes on odor
habituation/dishabituation task (social odors) in young C57BL6/J mice with and without early
chronic lead exposure.
Group

Test statistic

df

p

0 ppm
30 ppm
430 ppm

0.325
0.494
0.355
0.403
0.442
0.294
0.393
0.450
0.406

11
11
11
11
11
11
11
11
11

0.002
0.000
0.000
0.000
0.000
0.009
0.000
0.000
0.000

0.528
0.379
0.305
0.416
0.352
0.350
0.457
0.444
0.332

11
11
11
11
11
11
11
11
11

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.001

Social Scent 1

0 ppm
30 ppm
430 ppm
0 ppm
30 ppm
430 ppm

Social scent 2
0 ppm
30 ppm
430 ppm
0 ppm
30 ppm
430 ppm
0 ppm
30 ppm
430 ppm

*Kolmogorov-smirnov test was used to examine distribution properties.
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Table 30. Tests of homogeneity of variance for hippocampal microglia outcomes in young
C57BL6/J mice with and without early chronic lead exposure*

Test-statistic

df

p-value

%

5.57

2, 9

0.027

Cell Count

2.94

2. 9

0.104

MHC II

MFI (GM)

0.77

2, 9

0.490

CCR7

MFI (GM)

1.53

2, 9

0.260

%

2.61

2, 9

0.127

Cell Count

2.43

2, 9

0.146

MFI (GM)

1.91

2, 9

0.204

5.00

2, 9

0.035

Cell Count

5.05

2, 9

0.034

MFI (GM)

17.17

2, 9

0.001

%

3.30

2, 9

0.084

Cell Count

1.41

2, 9

0.294

MHC II

MFI (GM)

0.83

2, 9

0.465

CCR7

MFI (GM)

1.76

2, 9

0.225

Overall Analyses
Microglia

Quadrant Analyses
“Single positive”
MHC II

“Single positive”
CCR7

%

“Double positive”
MHCII/CCR7

* Levene’s test statistic was used to examine possible unequal variances.
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Table 31. Tests of homogeneity of variance for brain microglia outcomes in young C57BL6/J
mice with and without early chronic lead exposure*

Test-statistic

df

p-value

%

3.267

2, 9

0.086

Cell Count

2.902

2, 9

0.106

MHC II

MFI (GM)

1.356

2, 9

0.306

CCR7

MFI (GM)

0.854

2, 9

0.458

%

7.67

2, 9

0.011

Cell Count

8.10

2, 9

0.010

MFI (GM)

3.05

2, 9

0.097

%

1.16

2, 9

0.354

Cell Count

2.237

2, 9

0.163

MFI (GM)

4.41

2, 9

0.046

%

3.31

2, 9

0.084

Cell Count

3.34

2, 9

0.082

MHC II

MFI (GM)

0.626

2, 9

0.556

CCR7

MFI (GM)

2.74

2, 9

0.117

Overall Analyses
Brain Microglia

Quadrant Analyses
“Single positive”
MHC II

“Single positive”
CCR7

“Double positive”
MHCII/CCR7

* Levene’s test statistic was used to examine possible unequal variances.
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Table 32. Tests of homogeneity of variance for hippocampal macrophages outcomes in young
C57BL6/J mice with and without early chronic lead exposure*

Test-statistic

df

p-value

%

2.07

2, 9

0.182

Cell Count

6.01

2. 9

0.022

MHC II

MFI (GM)

0.29

2, 9

0.374

CCR7

MFI (GM)

0.093

2, 9

0.912

%

0.835

2, 9

0.465

Cell Count

2.940

2, 9

0.104

MFI (GM)

0.123

2, 9

0.886

Overall Analyses
Hippocampal
macrophages

Quadrant Analyses
“Single positive”
MHC II

“Single positive”
CCR7

2, 9
%

4.20

0.051

Cell Count

8.49

2, 9

0.009

MFI (GM)

4.526

2, 9

0.055

%

2.32

2, 9

0.154

Cell Count

4.23

2, 9

0.051

MHC II

MFI (GM)

1.169

2, 9

0.354

CCR7

MFI (GM)

1.869

2, 9

0.210

“Double positive”
MHCII/CCR7

* Levene’s test statistic was used to examine possible unequal variances.

188

Table 33. Tests of homogeneity of variance for brain macrophages outcomes in young C57BL6/J
mice with and without early chronic lead exposure*

Test-statistic

df

p-value

%

0.355

2, 9

0.711

Cell Count

0.258

2. 9

0.778

MHC II

MFI (GM)

0.784

2, 9

0.486

CCR7

MFI (GM)

0.421

2, 9

0.669

%

1.275

2, 9

0.326

Cell Count

0.170

2, 9

0.846

MFI (GM)

6.20

2, 9

0.020

Overall Analyses
Brain
macrophages

Quadrant Analyses
“Single positive”
MHC II

“Single positive”
CCR7

2, 9
%

6.99

0.015

Cell Count

0.67

2, 9

0.534

MFI (GM)

2.25

2, 9

0.161

%

1.37

2, 9

0.300

Cell Count

4.349

2, 9

0.048

MHC II

MFI (GM)

0.659

2, 9

0.541

CCR7

MFI (GM)

4.476

2, 9

0.045

“Double positive”
MHCII/CCR7

* Levene’s test statistic was used to examine possible unequal variances.
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Table 34. Tests of homogeneity of variance for hippocampal and immune cell outcomes in
young C57BL6/J mice with and without early chronic lead exposure*

Test-statistic

df

p-value

%

5.601

2, 9

0.026

Cell Count

7.855

2. 9

0.011

%

2.786

2, 9

0.114

Cell Count

0.563

2, 9

0.589

Hippocampal
Immune cells

Brain
Immune cells

* Levene’s test statistic was used to examine possible unequal variances.
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Table 35. Tests of normality distribution for hippocampal microglia outcomes (overall analyses)
in young C57BL6/J mice with and without early chronic lead exposure*

Hippocampal

%

Microglia
Cell Count

MHC II

CCR7

MFI (GM)

MFI (GM)

Test-statistic

df

p-value

0 ppm

0.983

4

0.917

30 ppm

0.805

4

0.110

430 ppm

0.977

4

0.884

0 ppm

0.867

4

0.287

30 ppm

0.896

4

0.412

430 ppm

0.976

4

0.876

0 ppm

0.387

4

0.685

30 ppm

0.404

4

0.653

430 ppm

0.436

4

0.056

0 ppm

0.782

4

0.074

30 ppm

0.918

4

0.527

430 ppm

0.981

4

0.906

* Shapiro-Wilk test statistic (for small sample sizes) was used to examine distribution properties.
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Table 36. Tests of normality distribution for hippocampal microglia outcomes (single positive) in
young C57BL6/J mice with and without early chronic lead exposure*

Test-statistic

df

p-value

0 ppm

0.288

4

0.039

30 ppm

0.346

4

0.012

430 ppm

0.282

4

0.002

0 ppm

0.891

4

0.347

30 ppm

0.742

4

0.339

430 ppm

0.926

4

0.547

0 ppm

0.964

4

0.804

30 ppm

0.901

4

0.435

430 ppm

0.969

4

0.837

0 ppm

0.864

4

0.276

30 ppm

0.787

4

0.080

430 ppm

0.939

4

0.650

0 ppm

0.963

4

0.797

30 ppm

0.963

4

0.972

430 ppm

0.963

4

0.205

0 ppm

0.782

4

0.074

30 ppm

0.918

4

0.527

430 ppm

0.981

4

0.906

Hippocampal Microglia
“Single positive”
MHC II

%

Cell Count

MFI (GM)

“Single positive”
CCR7

%

Cell Count

MFI (GM)

* Shapiro-Wilk test statistic (for small sample sizes) was used to examine distribution properties.
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Table 37. Tests of normality distribution for hippocampal microglia outcomes (double positive)
in young C57BL6/J mice with and without early chronic lead exposure*
T-statistic

df

p-value

0 ppm

0.874

4

0.312

30 ppm

0.808

4

0.117

430 ppm

0.882

4

0.349

0 ppm

0.916

4

0.512

30 ppm

0.737

4

0.029

430 ppm

0.920

4

0.539

0 ppm

0.891

4

0.387

30 ppm

0.742

4

0.032

430 ppm

0.926

4

0.574

0 ppm

0.944

4

0.677

30 ppm

0.645

4

0.002

430 ppm

0.987

4

0.039

Hippocampal Microglia
“Double positive”
MHCII/CCR7

%

Cell Count

MHC II

CCR7

MFI (GM)

MFI (GM)

* Shapiro-Wilk test statistic (for small sample sizes) was used to examine distribution properties.

193

Table 38. Tests of normality distribution for brain microglia outcomes (overall analyses) in
young C57BL6/J mice with and without early chronic lead exposure*

Brain Microglia

%

Cell Count

MHC II

CCR7

MFI (GM)

MFI (GM)

Test-statistic

df

p-value

0 ppm

4

0.026

30 ppm

4

0.070

430 ppm

4

0.304

0 ppm

4

0.446

30 ppm

4

0.888

430 ppm

4

0.129

0 ppm

4

0.669

30 ppm

4

0.400

430 ppm

4

0.822

0 ppm

4

0.151

30 ppm

4

0.424

430 ppm

4

0.056

* Shapiro-Wilk test statistic (for small sample sizes) was used to examine distribution properties.
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Table 39. Tests of normality distribution for brain microglia outcomes (single positive) in young
C57BL6/J mice with and without early chronic lead exposure*

Test-statistic

df

p-value

0 ppm

4

0.687

30 ppm

4

0.055

430 ppm

4

0.002

0 ppm

4

0.693

30 ppm

4

0.275

430 ppm

4

0.002

0 ppm

4

0.080

30 ppm

4

0.185

430 ppm

4

0.058

0 ppm

4

0.062

30 ppm

4

0.681

430 ppm

4

0.759

0 ppm

4

0.598

30 ppm

4

0.681

430 ppm

4

0.759

0 ppm

4

0.016

30 ppm

4

0.164

430 ppm

4

0.355

Brain Microglia
“Single positive”
MHC II

%

Cell Count

MFI (GM)

“Single positive”
CCR7

%

Cell Count

MFI (GM)

* Shapiro-Wilk test statistic (for small sample sizes) was used to examine distribution properties.

195

Table 40. Tests of normality distribution for brain microglia outcomes (single positive) in young
C57BL6/J mice with and without early chronic lead exposure*

Test-statistic

df

p-value

0 ppm

4

0.717

30 ppm

4

0.921

430 ppm

4

0.012

0 ppm

4

0.497

30 ppm

4

0.670

430 ppm

4

0.005

0 ppm

4

0.852

30 ppm

4

0.339

430 ppm

4

0.867

0 ppm

4

0.029

30 ppm

4

0.564

430 ppm

4

0.103

Brain Microglia
“Double positive”
MHCII/CCR7

%

Cell Count

MHC II

CCR7

MFI (GM)

MFI (GM)

* Shapiro-Wilk test statistic (for small sample sizes) was used to examine distribution properties.
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Table 41. Tests of normality distribution for hippocampal macrophages outcomes (overall
analyses) in young C57BL6/J mice with and without early chronic lead exposure*

Hippocampal
Macrophages

%

Cell Count

MHC II

CCR7

MFI (GM)

MFI (GM)

Test-statistic

df

p-value

0 ppm

0.995

4

0.983

30 ppm

0.801

4

0.116

430 ppm

0.902

4

0.391

0 ppm

0.686

4

0.008

30 ppm

0.938

4

0.518

430 ppm

0.846

4

0.229

0 ppm

0.681

4

0.007

30 ppm

0.803

4

0.121

430 ppm

0.771

4

0.048

0 ppm

0.941

4

0.663

30 ppm

0.928

4

0.481

430 ppm

0.914

4

0.433

* Shapiro-Wilk test statistic (for small sample sizes) was used to examine distribution properties.

197

Table 42. Tests of normality distribution for hippocampal macrophages outcomes (single
positive) in young C57BL6/J mice with and without early chronic lead exposure*

Test-statistic

df

p-value

0 ppm

0.990

4

0.958

30 ppm

0.963

4

0.633

430 ppm

0.998

4

0.906

0 ppm

0.736

4

0.029

30 ppm

0.900

4

0.384

430 ppm

0.910

4

0.417

0 ppm

0.975

4

0.870

30 ppm

0.938

4

0.519

430 ppm

0.984

4

0.757

0 ppm

0.796

4

0.095

30 ppm

0.996

4

0.876

430 ppm

0.929

4

0.485

Hippocampal Macrophages
“Single positive”
MHC II

%

Cell Count

MFI (GM)

“Single positive”
CCR7

%

0.485
Cell Count

MFI (GM)

0 ppm

0.937

4

0.634

30 ppm

0.987

4

0.780

430 ppm

0.750

4

0.000

0 ppm

0.876

4

0.323

30 ppm

1.000

4

0.242

430 ppm

0.970

4

0.074

* Shapiro-Wilk test statistic (for small sample sizes) was used to examine distribution properties.
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Table 43. Tests of normality distribution for hippocampal macrophages outcomes (double
positive) in young C57BL6/J mice with and without early chronic lead exposure*

Test-statistic

df

p-value

0 ppm

0.820

4

0.142

30 ppm

0.999

4

0.942

430 ppm

0.891

4

0.537

0 ppm

0.650

4

0.003

30 ppm

0.792

4

0.094

430 ppm

0.953

4

0.581

0 ppm

0.926

4

0.574

30 ppm

0.986

4

0.777

430 ppm

0.899

4

0.382

0 ppm

0.952

4

0.729

30 ppm

0.989

4

0.797

430 ppm

0.983

4

0.753

Hippocampal Macrophages
“Double positive”
MHCII/CCR7

%

Cell Count

MHC II

CCR7

MFI (GM)

MFI (GM)

* Shapiro-Wilk test statistic (for small sample sizes) was used to examine distribution properties.
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Table 44. Tests of normality distribution for brain macrophages outcomes (overall analyses) in
young C57BL6/J mice with and without early chronic lead exposure*

Brain Macrophages

%

Cell Count

MHC II

CCR7

MFI (GM)

MFI (GM)

Test-statistic

df

p-value

0 ppm

0.917

4

0.519

30 ppm

0.985

4

0.930

430 ppm

0.970

4

0.839

0 ppm

0.965

4

0.810

30 ppm

0.937

4

0.634

430 ppm

0.930

4

0.596

0 ppm

0.954

4

0.740

30 ppm

0.955

4

0.750

430 ppm

0.959

4

0.775

0 ppm

0.977

4

0.887

30 ppm

0.831

4

0.171

430 ppm

0.830

4

0.161

* Shapiro-Wilk test statistic (for small sample sizes) was used to examine distribution properties.
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Table 45. Tests of normality distribution for brain macrophages outcomes (single positive) in
young C57BL6/J mice with and without early chronic lead exposure*

Test-statistic

df

p-value

0 ppm

0.895

4

0.407

30 ppm

0.915

4

0.510

430 ppm

0.788

4

0.083

0 ppm

0.959

4

0.774

30 ppm

0.822

4

0.148

430 ppm

0.959

4

0.776

0 ppm

0.858

4

0.253

30 ppm

0.681

4

0.007

430 ppm

0.903

4

0.448

0 ppm

0.996

4

0.985

30 ppm

0.734

4

0.027

430 ppm

0.855

4

0.242

0 ppm

0.948

4

0.703

30 ppm

0.936

4

0.630

430 ppm

0.914

4

0.502

0 ppm

0.841

4

0.198

30 ppm

0.777

4

0.066

430 ppm

0.823

4

0.150

Brain Macrophages
“Single positive”
MHC II

%

Cell Count

MFI (GM)

“Single positive”
CCR7

%

Cell Count

MFI (GM)

* Shapiro-Wilk test statistic (for small sample sizes) was used to examine distribution properties.
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Table 46. Tests of normality distribution for brain macrophages outcomes (double positive) in
young C57BL6/J mice with and without early chronic lead exposure.*

Test-statistic

df

p-value

0 ppm

0.833

4

0.176

30 ppm

0.830

4

0.169

430 ppm

0.861

4

0.265

0 ppm

0.970

4

0.840

30 ppm

0.921

4

0.540

430 ppm

0.973

4

0.863

0 ppm

0.891

4

0.389

30 ppm

0.923

4

0.556

430 ppm

0.910

4

0.481

0 ppm

0.943

4

0.674

30 ppm

0.887

4

0.369

430 ppm

0.998

4

0.992

Brain Macrophages
“Double positive”
MHCII/CCR7

%

Cell Count

MHC II

CCR7

MFI (GM)

MFI (GM)

* Shapiro-Wilk test statistic (for small sample sizes) was used to examine distribution properties.
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Table 47. Tests of normality distribution for brain macrophages outcomes (double positive) in
young C57BL6/J mice with and without early chronic lead exposure*

Test statistc

df

p-value

0 ppm

0.983

4

0.918

30 ppm

0.899

4

0.424

430 ppm

0.966

4

0.814

Cell

0 ppm

0.959

4

0.774

Count

30 ppm

0.973

4

0.861

430 ppm

0.972

4

0.852

0 ppm

0.837

4

0.188

30 ppm

0.966

4

0.817

430 ppm

0.707

4

0.014

0 ppm

0.935

4

0.623

30 ppm

0.993

4

0.971

430 ppm

0.791

4

0.088

Hippocampal Immune Cells

%

Brain Immune Cells
%

Count

* Shapiro-Wilk test statistic (for small sample sizes) was used to examine distribution properties
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APPENDIX B. SUPPLEMENTARY FIGURES
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Figure 1. Fluorescence intensity of stained and unstained immune cells with FITC MHC II.
As shown in the figure there was a shift towards the right for cells stained with FITC MHC II as
compared to unstained cells. This shift indicates that the antibody FITC MHC II did bind to
immune cells and that the fluorophore FITC emitted higher fluorescence intensity than the
potential autofluoresence emitted by unstained cells.

205

Figure 2. Fluorescence intensity of stained and unstained immune cells with APC CCR7. As
shown in the figure there was a shift towards the right for cells stained with APC CCR7 as
compared to unstained cells. This shift towards the right indicates that the antibody APC CCR7
did bind to immune cells and that the antibody emitted higher fluorescence intensity than the
potential autofluoresence emitted by unstained cells.
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Figure 3. Unstained sample of cells plotted against PE CD11b and A700 CD45. As shown in
the figure PE CD11b was plotted on the x-axis whereas Alexa 700 CD45 was plotted on the yaxis. Unstained cells had negative values for PE CD11b and A700 CD45. The cells of interest
were gated outside of the range of fluorescence emitted by the unstained cells. The circular gates
show areas where microglia and macrophages were gated for fully stained cells.
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Figure 4. Fluorescence minus one for Alexa 700 CD45. Cells were stained with all the markers
of interest with the exception of Alexa 700 CD45 to delimit the gates for double positive cells.
That is, for the selection of microglia and macrophages that are positive for both CD45 and
CD11b. As shown in the figure there was very little unspecific signal for CD45. The circular
gates show areas where microglia and macrophages were gated for fully stained cells.
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Figure 4. Fluorescence minus one for APC CCR7 in microglial cells. Cells were stained with
all the markers of interest with the exception of APC CCR7 to delimit the gates for CCR7 and
double positive cells (MHC II/CCR7). As shown in the figure there was no unspecific signal for
CCR7.
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Figure 5. Fluorescence minus one for FITC MHC II in microglial cells. Cells were stained
with all the markers of interest with the exception of FITC MHC II to delimit the gates for MHC
II and double positive cells (MHC II/CCR7). As shown in the figure there was little unspecific
staining for MHC II.
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Figure 4. Fluorescence minus one for APC CCR7 in macrophages. Cells were stained with all
the markers of interest with the exception of APC CCR7 to delimit the gates for CCR7 and
double positive cells (MHC II/CCR7). As shown in the figure there was no unspecific staining
for CCR7.
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Figure 6. Fluorescence minus one for FITC MHC II in macrophages cells. Cells were stained
with all the markers of interest with the exception of FITC MHC II to delimit the gates for MHC
II and double positive cells (MHC II/CCR7). As shown in the figure there was little unspecific
staining for MHC II.
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